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Synopsis 
Autophagy is a conserved eukaryotic mechanism for the sequestration and degradation of cellular 
components. Upon nutrient depletion or stress, a double-membrane vesicle referred to as 
autophagosome engulfs a section of cytoplasm and delivers it to lysosome for degradation. Apart 
from its classical role, autophagy is involved in human immunity, especially in capturing and 
clearance of intracellular pathogens. One of the key players in autophagy, ATG16L1, essential for 
autophagosome formation and elongation, recently came into focus of interest due to mutations in 
the gene locus that result in increased susceptibility to the inflammatory bowel disease Morbus 
Crohn. ATG16L1, in complex with autophagy-related proteins ATG5 and ATG12, localizes on the 
autophagosome and has also been shown to be recruited by the cytosolic pattern recognition 
receptors NOD1 and NOD2 to the entry site of cell invading bacteria, thus linking autophagy with the 
intracellular bacterial sensing. 
Autophagy has been extensively studied in yeast, and more than 36 proteins have been identified as 
important for this process. Most of yeast autophagy proteins have mammalian homologues, 
including ATG16. Yeast ATG16 has an N-terminal ATG5 binding domain (ATG5 BD), and a coiled coil 
domain (CCD) responsible for dimerization. Human ATG16L1 also has these two domains, which are 
essential and sufficient for functional canonical autophagy. In addition to ATG5 BD and the CCD, 
human ATG16L1 has a C-terminal domain which is absent in its yeast homologue. Precisely this 
domain was shown to interact with NOD1 and NOD2, in addition to TLR2, TMEM59 and DDB1. In the 
course of this work, various biophysical methods were used to study these interactions using purified 
proteins. Under the experimental conditions tested, these interactions could not be detected. 
Further work is needed to identify possible factors missing in the experimental set up and detect 
mediating factors essential for macromolecular interactions with the C-terminal domain of the 
human ATG16L1. 
C-terminal domain of human ATG16L1 was used for crystallographic studies and a high resolution 
structure of this domain was solved. Structure of the C-terminal domain of human ATG16L1 revealed 
that it folds into a typical WD-40 propeller with seven blades, each composed of four anti-parallel β-
strands. The WD-40 proteins are a large family found in all eukaryotes and usually serve as 
interaction platform for peptides, nucleic acids and other proteins. Detailed analysis of the structure 
identified a region on the WD-40 domain of ATG16L1 with high flexibility and a possible functional 
relevance. Additionally, two symmetry related molecules of the WD-40 domain of ATG16L1 bury a 
large surface area, which might be physiologically important in mediating dimerization of the WD-40 
domains. N-termini of these two molecules point in the same direction, indicative of an orientation in 
agreement with a parallel dimer formed via a CCD of the ATG16L1. Based on these observations, the 
WD-40 domain of ATG16L1 might form a WD-40/WD-40 interaction surface for other 
macromolecules and peptides, making this domain an interesting candidate for an intersection 
between autophagy and other cellular processes. 
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Synopsis 
Autophagie ist ein konservierter eukaryotischer Mechanismus für die Sequestrierung und den Abbau 
von intrazellulären Komponenten. Bei Nährstoffverarmung oder Stress umschließt ein Doppel-
Membran-Vesikel, welches als Autophagosom bezeichnet wird, einen Teil des Cytoplasmas und 
transportiert den Inhalt weiter zum Abbau durch Lysosomen. Abgesehen von ihrer klassischen Rolle 
ist Autophagie an zahlreichen Prozessen im Kontext der menschlichen Immunität beteiligt, 
insbesondere an der Erkennung und Beseitigung von intrazellulären Pathogenen. Einer der 
wichtigsten Akteure in Autophagie, ATG16L1, das für die Ausbildung und Reifung des 
Autophagosoms bedeutend ist, rückte vor kurzem in den Fokus des Interesses aufgrund von 
Mutationen im Gen-Locus, welche zu einer erhöhten Anfälligkeit für die entzündliche Darm-
erkrankung Morbus Crohn führen. ATG16L1, im Komplex mit den Autophagie verwandten Proteinen 
ATG5 und ATG12, ist auf dem Autophagosom lokalisiert und wird durch die cytosolischen Muster 
erkennenden Rezeptoren NOD1 und NOD2 zur Eintrittstelle von invasiven Bakterien rekrutiert, was 
eine direkte Verbindung zwischen Autophagie und der Erkennung intrazellulärer Bakterien aufzeigt. 
Autophagie wurde ausgiebig in Hefe untersucht und mehr als 36 für diesen zellulären Prozess 
essentielle Proteine wurden identifiziert. Die Mehrzahl dieser Proteine hat Säugerhomologe, 
einschließlich ATG16. Hefe-ATG16 hat eine N-terminale ATG5 Bindungsdomäne (ATG5 BD) und eine 
Coiled-Coil-Domäne (CCD), welche für die Dimerisierung verantwortlich ist. Menschliches ATG16L1 
besitzt diese Domänen ebenfalls, welche für eine funktionierende kanonische Autophagie notwendig 
und ausreichend sind. Neben ATG5 BD und der CCD besitzt menschliches ATG16L1 eine C-terminale 
Domäne, die im Hefe Homolog des ATG16L1 fehlt. Gerade bei dieser Domäne wurde eine Interaktion 
mit NOD1 und NOD2, neben TLR2, TMEM59 und DDB1 nachgewiesen. Im Rahmen dieser Arbeit 
wurden verschiedene biophysikalische Methoden verwendet, um diese Interaktionen mit gereinigten 
Proteinen zu untersuchen. Unter den hier verwendeten Versuchsbedingungen konnten diese 
Wechselwirkungen jedoch nicht bestätigt werden. Weitere Arbeiten sind erforderlich, um eventuelle 
zusätzliche Faktoren zu ermitteln, welche als verbrückendes Bindeglied für die makromolekularen 
Wechselwirkungen mit der C-terminalen Domäne des menschlichen ATG16L1 essentiell sind. 
Zusätzlich wurde die C-terminale Domäne des menschlichen ATG16L1 für kristallographische 
Untersuchungen verwendet und die Struktur dieser Domäne aufgeklärt. Die hochaufgelöste Struktur 
der C-terminalen Domäne von menschlichem ATG16L1 zeigt, dass die Faltung der Domäne der eines 
WD-40 Propeller mit sieben Propeller-Blättern entspricht, wobei sich jedes Blatt aus vier 
antiparallelen β-Strängen zusammensetzt. Die WD-40-Proteine sind eine große Familie, die in allen 
Eukaryoten präsent ist und in der Regel als Interaktionsplattform für Peptide, Nukleinsäuren und 
andere Proteine dient. 
Durch eine detaillierte Analyse der Struktur wurde eine Region auf der WD-40-Domäne des ATG16L1 
mit hoher Flexibilität und einer möglichen funktionellen Bedeutung identifiziert. Zusätzlich wurde 
eine durch symmetrie-verwandte Moleküle der WD-40-Domäne generierte Interaktionsfläche  
identifiziert, die eine Dimerisierung der WD-40 vermitteln und von physiologischer Relevanz sein 
könnte. Die N-Termini dieser zwei Moleküle weisen in die gleiche Richtung, was auf eine Ausrichtung 
in Übereinstimmung mit einem parallelen Dimer hindeutet, das über die CCD des ATG16L1 gebildet 
wird. Auf Basis dieser Beobachtungen könnte die WD-40 Domäne von ATG16L1 eine WD-40/WD-40 
Interaktionsfläche für andere Makromoleküle und Peptide bilden, so dass diese Domäne einen 
interessanten Kandidaten für die Funktion als Bindeglied zwischen Autophagie und anderen 
zellulären Prozessen darstellt.  
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1 Introduction 
1.1 Cell maintenance and turn over mechanisms 
All living organisms on Earth depend on three basic and essential macromolecules for their biological 
functions: DNA, RNA and proteins. Proteins are large biopolymers, generated as a string of a 
combination of 20 essential amino acids which can fold into different three dimensional moieties, 
generally called domains. Proteins can be further diversified by posttranslational modifications or 
binding to cofactors, other proteins, or nucleic acids. The amount of a protein in the cell at any given 
time is determined by two factors: rate of its synthesis and rate of its degradation. The degradation 
rate of proteins (and other cellular components) is a crucial step in cellular regulation. Depending on 
their function, some proteins must be synthesized and degraded quickly to adapt to ever changing 
cellular environment and extracellular stimuli. Other proteins are degraded upon reception of certain 
signals, to prevent overstimulation. Due to a vast amount of proteins being manufactured in the cell 
at any given time, some of them have errors leading to protein misfolding or their aggregation. Such 
proteins must be rapidly degraded. Eukaryotic cells have two major pathways responsible for 
degradation of faulty proteins: proteasome pathway and lysosome pathway (Figure 1).  
 
Figure 1: Two main routes of intracellular degradation in eukaryotic systems. A) Proteasome pathway. 
Proteins are targeted to the proteasome via ubiquitin tag (yellow circles). B) Lysosome pathway. 
Extracellular and membrane proteins are taken up by endocytosis, while large intracellular aggregates and 
damaged organelles are taken up by autophagy, and delivered to the lysosome for degradation. 
Proteasome is a large cylindrical complex of proteases responsible for recycling of misfolded 
proteins. Protein folding is often facilitated by chaperons, which ensure proper environment for the 
polypeptide chain to assume its three dimensional structure. If the protein is unable to fold properly, 
chaperons prevent its aggregation and escort it for ubiquitination.  
Endosome
Lysosome
Proteasome Peptides
A Proteasome pathway
B Lysosome pathway
Autophagosome
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Ubiquitin is a small, highly conserved polypeptide and a major marker for degradation of damaged 
proteins. Proteins destined for degradation are marked by covalent attachment of ubiquitin, a multi-
step, ATP dependent process referred to as ubiquitination (Figure 6). The isopeptide bond is formed 
between the amino group of the lysine side chain on the target protein and the carboxy-terminal 
glycine residue on the ubiquitin. Three main types of proteins are required for ubiquitination: 
ubiquitin activating enzyme (E1), ubiquitin conjugating enzyme (E2) and lastly ubiquitin-protein ligase 
(E3). Ubiquitin is synthesized as a precursor and processed by E1 enzyme to expose the carboxy-
terminal glycine residue. From E1, ubiquitin is transferred to E2 enzyme. Depending on the ubiquitin 
ligases family type, E2, in complex with E3, can directly transfer the ubiquitin to the target protein, 
or, E2 first transfers the ubiquitin to the E3 enzyme, which in turn catalyzes thioester bond formation 
between the glycine on the ubiquitin and the active lysine on the target protein. The mode of action 
depends on the type of E3 ligase and the protein target, and E2 and E3 enzymes provide specificity to 
the system.  
Following ubiquitination, the misfolded protein is targeted for degradation by the proteasome. For 
proteolytic degradation, ubiquitin is removed and recycled, and proteins are unfolded in order to 
pass through the proteasome (Figure 1). In the proteasome, proteins are cleaved into short peptides 
(7 - 9 amino acids long). Main shortcoming of the proteasome is - due to its constrained shape - only 
proteins of a limited size can be degraded by this system. Misfolded proteins and large aggregates 
which escape the proteasome are degraded by the second degradation system: lysosome-mediated 
pathway.  
Autophagy is a lysosome-mediated turnover system evolutionarily conserved across eukaryotic 
systems. Autophagy, whose name stems from Greek and means ‘self-eating’, mediates degradation 
of not only large protein aggregates, but also damaged organelles and microbes. This system has 
many more functions than initially expected. Apart from its canonical role in starvation and 
degradation of bulk cytoplasmic materials, autophagy is involved in a vast range of different 
physiological and pathophysiological processes, summarized in Figure 2.  
 
Figure 2: Autophagy and its roles. Apart from its basic role in starvation and removal of damaged organelles, 
autophagy is intertwined with many other cellular processes, some of which are presented in this figure 
(adapted from Klionsky, 2011). 
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1.2 Autophagy types 
Autophagy can be categorized into three main types: chaperone-mediated autophagy, 
microautophagy and macroautophagy (Figure 3). In contrast to microautophagy and 
macroautophagy, which involve vesicles for delivering of cargo to the lysosome, chaperone-mediated 
autophagy (CMV) allows direct targeting of proteins and their delivery to the lysosomal lumen. 
Proteins detected by CMV harbor a specific pentapeptide KFERQ-like motif and are bound by a 
chaperon complex (heat shock 70 and its co-chaperones) in the cytoplasm. Chaperon complex brings 
the target protein to the surface of the lysosome and binds the cytosolic tail of lysosome-associated 
membrane protein type 2A (LAMP-2A), which in its free form is a monomer. Once bound to the 
target protein, LAMP-2A oligomerizes and forms a translocation pore. Upon transfer of the target 
protein to the lumen of the lysosome, LAMP-2A oligomer is quickly disassembled into single units, 
ready to bind the next target. Main inducers of CMV are prolonged starvation and oxidative stress 
(Cuervo et al. 2014). 
 
Figure 3: Types of autophagy. Chaperone-mediated autophagy is a turn-over process targeting specific signal 
sequence on proteins whose capture and delivery to the lysosome is facilitated by Hsp 70 and its co-
chaperons. Microautophagy is characterized by formation of cup-like invaginations or finger protrusions by 
the lysosomes and engulfment of neighboring sections of the cytoplasm. Macroautophagy is characterized by 
de novo formation of a membrane which expands around cargo and fuses to form a double-membrane 
autophagosome. Mature autophagosome fuses with the lysosome and delivers contents for degradation. 
(adapted from Okamoto 2014) 
Unlike CMV, which only targets proteins with the signal pentapeptide, micro- and macroautophagy 
can be both selective and nonselective (bulk) processes. In the case of nonselective microautophagy 
in mammalian systems, lysosomes have the ability to either form cup-like invaginations of their 
membrane, or to extend arm-like protrusions which can fold back onto itself. In both cases, the result 
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is formation of intralysosomal vesicles containing cytosolic constituents which are degraded by 
lysosomal enzymes (Figure 3). 
In the case of macroautophagy, the most prominent physical characteristic is formation of a double-
membrane vesicle, the autophagosome. As autophagosomal membrane grows, it engulfs part of the 
cytoplasm. Mature autophagosomes eventually fuse with the lysosomes, delivering the contents for 
degradation (Figure 3). The morphology and the mechanism of action of macroautophagy are 
conserved from yeast to humans. So far, mouse models only exist for macroautophagy, and 
extensive research on this pathway has revealed clear connections between macroautophagy and 
human diseases. This work is focused on macroautophagy, and therefore in the sections hereafter - 
unless specified otherwise - macroautophagy will be referred to as autophagy.  
1.3 Autophagy core machinery  
Autophagy has been extensively studied in budding yeast Saccharomyces cerevisiae, with more than 
30 proteins (encoded by autophagy-related ATG genes) identified as being essential for the process. 
More than half of the yeast autophagy proteins have homologs in mammalian systems. A subset of 
ATG genes is involved in all subtypes of autophagy and is collectively termed as the core molecular 
machinery. Core machinery proteins are further classified into functional groups. (Nakatogawa et al. 
2009; Yang et al. 2010; Levine et al. 2011) These classifications are shown in Table 1.  
Core subgroups Core mammalian proteins belonging to the 
subgroup 
unk-51-like kinase (ULK1) complex ULK1, ULK2, ATG13, FIP200, ATG101 
transmembrane ATG9 and associated proteins ATG9, ATG2, WIPI1-4, DFCP1, VMP1 
class III phosphatidylinositol-3-OH kinase (PI(3)K) 
complex 
Vps34, p150 (Vps15), ATG14L, Beclin1, ultraviolet 
irradiation resistance associated gene (UVRAG), 
Ambra1, Rubicon  
ubiquitin-like conjugation system LC3 and 
ATG12/ATG5/ATG16 
ATG4, LC3/GABARAP, ATG12, ATG3, ATG7, 
ATG10, ATG5, ATG16 
Table 1: List of core autophagy proteins in mammalian system and their functional classifications. 
The process of autophagy can be roughly divided into three morphological stages: initiation, 
elongation, and maturation and fusion with lysosome (Figure 4).  
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Figure 4: Overview of autophagy machinery. Autophagy can be divided into three major stages: initiation, 
elongation, maturation and fusion. Each step is orchestrated by a subset of core autophagy components. 
ULK1 complex is important for induction of autophagy and subsequent recruitment of other members of 
autophagy machinery. PI(3)K complex plays an essential role in nucleation. Phagophore elongation requires 
ATG9 and two ubiquitin-like systems (ATG12 and LC3). Each step is further described in the text. 
1.3.1 Autophagosome initiation 
Most of the core ATG proteins are recruited to phagophore assembly site (PAS), the site of 
autophagosome formation. Under nutrient rich conditions, mTOR is found in association with ULK1 
complex and phosphorylates ULK1 and ATG13, keeping it in the inhibited state. Upon induction of 
autophagy (i.e. nutrient depletion or rapamycin treatment) mTOR is released from the complex and 
the ULK1 kinase is activated by partial dephosphorylation. Active ULK1 autophosphorylates and 
phosphorylates mammalian ATG13 and FIP200 (Figure 5) (Hosokawa et al. 2009; Yang et al. 2010; 
Mercer et al. 2009). In addition to ULK1, ATG9 appears to be one of the first proteins recruited to PAS 
from late endosome and Golgi membranes, where it resides under nutrient-rich conditions (Orsi et 
al. 2012; Young et al. 2006). However, whether ULK1 recruits ATG9 or the other way around requires 
further investigation (Feng et al. 2014; Orsi et al. 2012). Another equally important initiation complex 
is class III phosphatidylinositol-3-OH kinase (PI(3)K) complex, composed of Vps34, p150, ATG14L and 
Beclin-1. Ambra1 retains PI(3)K complex at the microtubules and, upon phosphorylation of Ambra1 
by ULK1, the complex is released and allows translocation to the site of phagophore formation. ULK1 
has also been shown to phosphorylate Beclin-1 (Russell et al. 2013) and thus enhance activity of the 
PI(3)K complex. Once both ULK1 and PI(3)K complexes are recruited to the PAS, Vps34, a member of 
PI(3)K complex, generates phosphatidylinositol-3-phosphate (PtdIns(3)P). PtdIns(3)P recruits 
autophagy effectors such as DFCP1 (double FYVE-containing protein 1) and WIPI (WD-repeat domain 
phosphoinositide-interacting) proteins, which recruit other ATG core proteins important for 
membrane elongation (Polson et al. 2010). 
Autophagosome
Lysosome
ULK1 
complex
PI(3)K 
complex
LC3
ATG12~5/16
ATG9
PtdIns(3)P
Cargo
Initiation Elongation Maturation and Fusion
Phagophore
Introduction 
 
6 
 
 
Figure 5: Core autophagy complexes involved in nucleation and initiation of autophagy. Under nutrient-rich 
conditions, ULK1-ATG13-FIP200 complex is kept inactive (phosphorylated) by and bound to mammalian 
TORC1. Once nutrient supply becomes limited, partial dephosphorylation of the ULK1-ATG13-FIP200 complex 
releases the complex from mTORC1. Active ULK1 phosphorylates AMBRA1 and releases it, in complex with 
Beclin-1 and PI(3)K from microtubules. Beclin-1 is also phosphorylated by ULK1. Vps34 is another member of 
the PI(3)K complex essential for generating PtdIns(3)P at the PAS.  
1.3.2 Autophagosome elongation 
Further growth of the autophagosomal membrane depends on two ubiquitin-like systems: 
ATG12~ATG5/ATG16L1 and LC3. ATG12~ATG5/ATG16L1 complex interacts with ULK1 complex 
(ULK1/ATG13/FIP200/ATG101) probably by direct binding of ATG16L1 to FIP200 (Gammoh et al. 
2013; Nishimura et al. 2013) Once PtdIns(3)P are generated, further association of ATG16L1 with the 
expanding membrane is facilitated via WIPI2-ATG16L1 complex (Dooley et al. 2014). ATG16L1 binds 
ATG5~ATG12 conjugate and serves as E3 for conjugation of LC3 with phosphatidylethanolamine (PE) 
on the phagophore and autophagosome membrane. Both conjugation reactions (ATG5~ATG12 and 
LC3~PE) are mechanistically similar to that of canonical ubiquitination. Shortly, in canonical 
ubiquitination, precursor ubiquitin is processed by a protease which cleaves it at a glycine residue. 
Cleaved ubiquitin is activated by binding to E1, in an ATP dependent manner. From E1, ubiquitin is 
transferred to E2. Depending on the type of ubiquitin ligase, either E2 directly, or E3, after ubiquitin 
transfer from E2, catalyzes the final conjugation of ubiquitin to the lysine on the target protein. In 
autophagy, ATG12 is not previously cleaved and is directly activated by E1-like enzyme ATG7. E2-like 
enzyme ATG10 drives the conjugation between the active glycine on ATG12 and lysine on ATG5, 
resulting in covalently linked ATG12~ATG5 complex. (Mizushima et al. 1998) In this case, E3 enzyme 
is not needed, and the specificity for the substrate comes from E2. Notably, unlike ubiquitin which 
has many different substrates, ATG12 is exclusively conjugated to ATG5 which can bind ATG16L1, 
generating ATG12~ATG5/ATG16L1 complex (Mizushima et al. 1999) (Figure 6B).  
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Figure 6: Ubiquitin-like conjugation systems required for autophagosome elongation. A) Canonical 
ubiquitination process. Ubi=ubiquitin. E1=ubiquitin activating enzyme. E2=ubiquitin conjugating enzyme. 
E3= ubiquitin ligase. Precursor ubiquitin molecule is activated by E1 enzyme in ATP dependent manner. 
Activated ubiquitin is transferred to E2 which transfers the ubiquitin to E3, which is specific for the substrate 
protein. E3 catalyzes final covalent link between ubiquitin and protein, marking the protein for degradation. 
B) ATG12 ubiquitin-like conjugation system. ATG7 is E1-like enzyme. ATG10 is E2-like enzyme. ATG12 is 
conjugated to ATG5. ATG12~ATG5 conjugate binds ATG16 via ATG5 C) LC3 (mammalian homolog of yeast 
ATG8) ubiquitin like system. LC3/ATG8 is conjugated to the lipid (PE) on the phagophore and 
autophagosome, instead to another protein. LC3/ATG8 precursor is cleaved by ATG4. ATG7 is E1-like enzyme. 
ATG3 is E2-like enzyme. Role of E3 enzyme is played by ATG12~ATG5/ATG16. LC3/ATG8 is bound to PE on 
the membrane and can be cleaved of by the ATG4. (Geng et al. 2008) 
Studies of yeast homologues predicted this complex to form a tetramer of ATG12~ATG5/ATG16 
(Fujioka et al. 2010). However, recent studies of the coiled-coil domain of human ATG16L1 show it to 
form a dimer in solution (Parkhouse et al. 2013). ATG16L1 dimerizes through a coiled-coil domain in 
the middle of the protein resulting in a complex likely to be composed of two copies of 
ATG12~ATG5/ATG16L1.  
In the case of the second ubiquitin-like system in autophagy, yeast ATG8 is cleaved by a cysteine 
protease ATG4 which exposes the glycine, prior to activation by the E1-like enzyme ATG7. In this 
case, E2-like enzyme ATG3 takes over the ATG8. (Ichimura et al. 2000) Final covalent link between 
ATG8 and phosphatidylethanolamine (PE) on the phagophore and autophagosome membrane is 
catalyzed by ATG12~ATG5/ATG16 complex, an unusual E3-like enzyme (Fujita et al. 2008) (Figure 6C). 
The exact mechanism of this process is still under investigation (Geng et al. 2008). Interestingly, 
unlike canonical ubiquitination and ATG5~ATG12/ATG16, ATG8 is not conjugated to another protein, 
but to a lipid on an autophagosome membrane. Mammalian homologs of the ATG8 are divided into 
two main subgroups, based on their sequence homology: LC3 (LC3A, LC3B, LC3C) and GABARAP 
(GABARAP, GABARAP L1, GABARAP L2 or GATE16, GAABRAPL3) which all undergo similar 
modifications described for the yeast ATG8 (Kabeya et al. 2004; Kabeya et al. 2000). Another 
Introduction 
 
8 
 
mammalian homologue of yeast ATG8 has been reported (ATG8L) (Hemelaar et al. 2003) and shown 
to be a substrate of ATG4, ATG7, and ATG3 (Tanida et al. 2006). Due to the tight association between 
LC3 and PE, the conversion between unbound, cytosolic LC3 (LC3I, 18kDa) and LC3-PE (LC3II, 16kDa), 
LC3 has been best characterized as a cellular readout of autophagy levels and is commonly detected 
by Western blot to monitor autophagy. (Mizushima et al. 2014)  
Both ubiquitin-like systems are essential for an expansion of the autophagosome. Apart from acting 
like an E3 enzyme, studies using the yeast homologues showed that ATG12~ATG5/ATG16 complex 
also marks the exact location of ATG8 lipidation (Suzuki et al. 2001; Fujita et al. 2008). 
ATG12~ATG5/ATG16 complex primarily localizes on the outer membrane, while ATG8 is present on 
both, outer and inner face of the membrane of the growing autophagosome. Shortly before or upon 
completion of the autophagosome, ATG12~ATG5/ATG16 complex dissociates from the outer 
membrane (Figure 4) (Mizushima 2003; Mizushima et al. 2001). Lipidated LC3 also dissociates from 
the outer autophagosomal membrane prior to autophagosome/lysosome fusion (Yang et al. 2010).  
1.3.3 Autophagosome maturation and lysosomal fusion 
Fusion event has been extensively studied, and autophagosomes have been observed to fuse with 
early and late endosomes, and with lysosomes (Dunn 1990; Eskelinen 2005). TECPR1 (tectonin β-
propeller repeat-containing protein 1) a lysosomal membrane protein has been identified as a 
component of autophagy network (Behrends et al. 2010). TECPR1 exists in an auto-inhibited form 
which is disrupted by its binding to ATG5 (of the ATG12~ATG5/ATG16L1 complex). TECPR1 displaces 
ATG16L1 from the ATG5~ATG12 conjugate. Once in complex with the ATG5~ATG12, 
phosphoinositides-binding domain of TECPR1 becomes available to interact with PtdIns(3)P on the 
autophagosomal membrane, thus providing specificity of the fusion event. (Chen et al. 2012) 
Autophagosome maturation and its fusion with the lysosome are tightly regulated events. Many 
additional proteins involved in the final stages of autophagy have been identified so far, including: 
LC3/GABARAP proteins (mammalian homologues of ATG8) (Wang et al. 2015), class III 
phosphatidylinositol 3-kinase and Rubicon (Sun et al. 2011), SNAREs (Moreau et al. 2011; Nair et al. 
2011), and a small GTP binding protein Rab7 (Jäger et al. 2004). However, the exact mechanism of 
the fusion events is still not clear.  
1.4 Selective autophagy 
Autophagy has long been considered an essential but non-selective bulk degradation pathway. 
However, mounting evidence suggests the selective elimination of atypical protein aggregates, 
dysfunctional organelles and invading pathogens by autophagy. Based on the remarkable substrate 
specificity of this process, selective autophagy is classified into several types, including: mitophagy 
(selective degradation of mitochondrion), nucleophagy (selective degradation of parts of nucleus), 
pexophagy (selective degradation of peroxisomes) and xenophagy (selective degradation of 
intracellular pathogens) (Figure 7).  
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Figure 7: Modes of selective autophagy. Damaged or dysfunctional organelles (mitochondrion, nucleus and 
peroxisome) as well as intracellular pathogens (including pathogen-containing phagosomes and their 
remains) are tethered to the autophagosome by a specific molecule which binds ubiquitin on one side, and 
LC3/GABARAP on the autophagosome membrane on the other. In this way, autophagy receptors selectively 
deliver cargo for degradation by autophagy.  
Specific cargo is targeted for degradation by specific autophagy receptors and adapters. The 
discovery and characterization of cargo-recognizing receptors revealed some mechanistic details of 
selective autophagy. Autophagy specific receptors are dispensable for bulk, non-specific autophagy. 
These molecular receptors recognize and bind ubiquitinated substrates, tether them to the site of 
autophagosome engulfment, and act as a physical link between substrates and autophagosome-
specific proteins, such as the members of the LC3/GABARAP family (Johansen et al. 2014; Isakson et 
al. 2013). The binding between autophagy receptors and LC3/GABARAP family members is facilitated 
through a short hydrophobic sequence (D/E-D/E-D/E-W/F/Y-X-X-L/I/V) on the receptors, termed LIR 
(LC3-interacting region) motif (Bjørkøy et al. 2005; Johansen et al. 2014). The growing list of 
autophagy receptors includes: p62 (Bjørkøy et al. 2005), NBR1 (neighbor of Brca1 gene) (Kirkin et al. 
2009), NDP52 (Thurston et al. 2009) and optineurin (Wild et al. 2011). These autophagy receptors 
have an ubiquitin-recognition domain and at least one LIR domain. In this way, they can bind 
ubiquitinated cargo on one end and LC3 on the autophagosome membrane on the other. p62 plays a 
role in mitophagy (Ding et al. 2010; Geisler et al. 2010), xenophagy (Dupont et al. 2009; Yoshikawa et 
al. 2009; Zheng et al. 2009) and pexophagy (Kim et al. 2008); while NDP52 and optineurin have so far 
been linked only to xenophagy (Thurston et al. 2009; Wild et al. 2011). So far, autophagy receptor 
p62 has been shown mediate xenophagy for Salmonella enterica serovar Typhimurium (S. 
Typhimurium) (Zheng et al. 2009), Shigella flexneri (Dupont et al. 2009), and Listeria monocytogenes 
(Yoshikawa et al. 2009). In addition to p62, S. Typhimurium is restricted by optineurin and NDP52 
(Wild et al. 2011). The molecular machinery of selective autophagy is just starting to be unraveled, 
and further work is needed to deeper explore which autophagy receptors are involved in recognition 
of the various types of cargo for selective autophagy. 
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1.4.1 Autophagy in pathogen defense 
One kind of selective autophagy, xenophagy, eliminates intracellular pathogens by restricting their 
replication and survival. Xenophagy is able to target damaged and intact pathogen-containing 
vacuoles as well as free pathogens in the cytosol and transport them to the lysosome for degradation 
(Figure 8).  
 
Figure 8: Xenophagy. Intracellular viruses and bacteria, cytosolic and vacuolar, are recognized and 
ubiquitinated by an unknown mechanism, marking them for degradation by autophagy. Ubiquitinated 
pathogens recruit autophagy receptors (note: the receptor is colored pink in the figure for simplicity purpose, 
however there is more than one receptor involved in xenophagy), which tether them to the expanding 
phagophore where they are engulfed by autophagosome and delivered to the lysosome for degradation.  
In the case of Salmonella Typhimurium, autophagy contained the infection at the early stage by 
targeting damaged Salmonella-containing-vacuoles and prevented colonization of the cytoplasm 
(Birmingham et al. 2006). Streptococcus pyogenes escapes the phagosomes upon invasion of 
nonpathogenic cells. Once free in the cytosol, S. pyogenes is captured in the autophagosomes and 
delivered to the lysosomes for degradation. In this way, autophagy effectively restricted pathogenic 
growth. (Nakagawa et al. 2004) Mycobacterium tuberculosis is an intracellular pathogen which 
resides inside phagosomes and prevents their maturation. Autophagy induced by starvation 
increased localization of Beclin-1 with mycobacterium-containing phagosomes. Accumulation of 
critical autophagy proteins eventually overrides the block of phagosomal maturation and inhibits 
mycobacterial survival. (Gutierrez et al. 2004) Autophagy is not specific against bacterial invasions. 
Toxoplasma gondii is an obligate intracellular protozoan. Once inside the cell, T. gondii resides within 
a vacuole void of any proteins which could recruit lysosomes. Treatment of T. gondii infected 
macrophages stimulated fusion of T. gondii containing vacuoles with lysosomes through autophagy. 
(Andrade et al. 2006) Also viruses have been reported to succumb to the process of autophagy 
(Tallóczy et al. 2005; Orvedahl et al. 2010a) Based on these and similar studies, autophagy has 
emerged as a specialized cytoplasmic system for elimination of pathogens. However, autophagy is 
not a foolproof mechanism in pathogenic defense. Many pathogens have developed ways to escape 
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autophagy or to take advantage of the autophagy machinery for their benefit (Ogawa et al. 2005; 
Pizarro-Cerda et al. 1998; Beron et al. 2002; Dorn et al. 2001). 
Interplay between autophagy and immunity does not stop at clearance of cytosolic pathogens. Once 
pathogen-containing autophagosome fuses with the late endosome, viral, bacterial and parasitic 
antigens are presented on MHC (major histocompatibility complex) class II molecules for priming of 
T (CD4+) cell specific response (Schmid & Münz 2007). 
Two main open questions remain about xenophagy (and selective autophagy in general): how are 
substrates recognized and sorted into the autophagy pathway? Which ubiquitin ligases are important 
for marking the substrates for degradation by autophagy? 
1.4.1.1 ATG16L1: link between autophagy and pathogen control?  
To better understand the connection between autophagy and immunity two main questions have to 
be answered. One question is how pathogens become labelled for degradation by autophagy. Due to 
a vast spectrum of pathogens targeting human cells, it is not easy to answer this question. Some 
evidence comes from studies with S. Typhimurium. Membranes of Salmonella-containing vacuoles 
become damaged by bacteria entering the cytosol. Galectin - 8 is recruited as a danger molecule to 
damaged membranes and its presence is specifically sensed by NDP52 (Thurston et al. 2012). 
Galectin - 8 also coats phagocytes harboring S. flexneri and L. monocytogenes, indicating that also 
these membranes, once damaged by escaping bacteria, are sensed though galectin - 8/NDP52 link. 
Once free in the cytosol, bacteria are poly-ubiquitinated (Perrin et al. 2004). Based on this, both 
galectin - 8 and ubiquitin serve as markers for uptake by autophagy, and both are recognized by 
NDP52. More extensive research is needed to confirm this mechanism for other intracellular 
pathogens or to reveal novel marker molecules. 
Since ubiquitination is a factor in marking pathogens for autophagy, ubiquitin ligase responsible for 
labeling cytosol-exposed bacteria for autophagy degradation would provide a way to assess the 
importance of the ubiquitin coat in the antipathogenic defense. As a candidate for pathogen-specific 
ubiquitin ligase, DDB1-CUL4 complex emerged from the study performed by He et al. (He et al. 
2006). 
1.4.1.2 ATG16L1: a true DCAF? 
DDB1-CUL4 is a member of a large cullin-RING E3 ubiquitin ligase family. Binding of RING family 
members to E2 is either mediated by an intrinsic RING finger domain or a small RING protein, such as 
ROC1/RBX1. There are at least seven cullins, and each can assemble into specific cullin-RING ligase 
complexes (Lee et al. 2007). The cullin complexes are highly modular and each of the cullins binds a 
specific adaptor or adaptor/receptor molecule for recruitment of distinct substrates for 
ubiquitination (Figure 9A). The above mentioned CUL4, binds ROC1/RBX1 at the C-terminal end while 
the other side of the arc-shaped protein recruits its adapter, DDB1 (DNA damage binding protein 1) 
forming the DDB1-CUL4 ubiquitin ligase complex. In turn, the adaptor DDB1 recruits receptor 
molecules, a wide range of WD40 domain containing proteins, collectively termed DDB1-CUL4 
associated factors (DCAFs). These DCAFs act as binding platform for the ubiquitination substrate and 
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provide substrate specificity to the DDB1-CUL4 ubiquitin ligase complex. Sequentially, the adaptor 
DDB1 recruits receptor molecules.  
 
Figure 9: Graphical and structural model of CUL4-DDB1-DCAF. A) Graphical representation of CUL4-DDB1-
DCAF mode of action. DCAF recruits a substrate which is ubiquitinated by E2 enzyme bound to the C-terminal 
end of CUL4. B) Structural model of CUL4-DDB1 bound to DCAF (DDB2) and substrate (DNA). Arc-like 
structure of CUL4 is represented in gray. DDB1 domains are separately colored: β-propeller B responsible for 
binding to CUL4 is in purple. The other two domains (β-propeller A in red and C in yellow) form a cleft for 
DCAF binding (here, DDB2 in green). DDB2 recruits DNA, represented as part of a-helix in gray, allowing for 
ubiquitination of DNA-associated proteins (Scrima et al. 2011) 
Structure of DDB1, in complex with CUL4 and DDB2 (a DCAF involved in DNA damage repair), is 
shown in Figure 9B and reveals three WD40 propeller domains of DDB1 (Fischer & Scrima et al. 
2011). One of the domains (BPB) is involved in binding to CUL4, while the other two form a pocket 
for binding of the DCAF. (Angers et al. 2006; He et al. 2006) He et al. identified a member of core 
autophagy machinery, ATG16L1, as a DCAF, suggesting a role for ATG16L1 as receptor molecule 
involved in recruitment of ubiquitination substrates for DDB1-CUL4 ubiquitin ligase complex. 
Furthermore, they identified a DWD (DDB1-binding and WD40 repeat) box, a 16 residue motif 
recognized by CUL4-DDB1. Alanine substitution of a conserved arginine in the DWD box on ATG16L1 
abolished the DCAF phenotype (He et al. 2006). Structural and biophysical studies are needed to 
confirm the direct interaction between ATG16L1 and DDB1, and the importance of DWD box for this 
interaction.  
1.4.1.3 ATG16L1: a link between pathogen sensing and pathogen degradation? 
If ATG16L1 is a true DCAF and thus recruits substrates (pathogens) for ubiquitination, the question 
still remains: how are pathogens recognized as targets of autophagy? Literature search provides 
multiple accounts linking ATG16L1 to pattern recognition receptors (PRRs). PRRs recognize various 
pathogen-associated molecular patterns (PAMPs) and initiate a cascade of events to fight the 
infection. PRRs can be membrane bound, such as Toll-like receptors (TLRs) or cytosolic, such as 
nucleotide-binding oligomerization domain (NOD) receptors. (Kawai et al. 2006) First characterized 
members of NOD family, NOD1 and NOD2, localize to the plasma membrane, sense components of 
peptidoglycan bacterial wall, and initiate a proinflammatory response (Girardin et al. 2003). NOD1 
senses a unique diaminopimelate-containing GlcNAc-MurNAc tripeptide muropeptide (GM-TriDAP) 
present only on the wall of Gram-negative bacteria (Girardin et al. 2003; Chamaillard et al. 2003), 
while NOD2 is a sensor for muramyl dipeptide (MDP, N-acetylmuramyl-L-analyl-D-isoglutamine), a 
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more general, minimal active motif on both Gram-positive and Gram-negative peptidoglycan wall 
(Inohara et al. 2003; Girardin et al. 2003).  
A study done by Travassos et al. in 2010 reported that mice, which were induced with NOD1 and 
NOD2 agonists, showed a robust increase of autophagy in peritoneal macrophages. Additionally, they 
demonstrated that NOD1 and NOD2 co-localize with ATG16L1 on the plasma membrane, 
surrounding the invading bacteria (Shigella flexneri). ATG16L1 lacking the first 85 amino acids 
(required for interaction with ATG5) exhibited the same behavior as full length ATG16L1. The 
interaction was confirmed with endogenous ATG16L1 and NOD proteins, as well as with co-
immunoprecipitation. (Travassos et al. 2010; Ramjeet et al. 2010) Furthermore, NOD1 and NOD2 
induced by bacterial entry recruit ATG16L1 and induce autophagy in a NF-κB independent manner 
(Travassos et al. 2010), unlike previously demonstrated mode of action (Abbott et al. 2004; Inohara 
et al. 2000). Based on their findings, Travassos et al. proposed a mechanism, illustrated in Figure 10, 
by which NOD2 recruits ATG16L1 to the site of the invading bacteria. By recruiting ATG16L1, entire 
autophagy machinery is brought into close proximity with the pathogen, which is engulfed by 
autophagosome and delivered to the lysosome for degradation (Travassos et al. 2010).  
 
Figure 10: Proposed mechanism of autophagy recruitment to the bacterial entry site by NOD2. NOD2 is a 
cytosolic pathogen recognition receptor which is recruited to the plasma membrane by invading pathogens 
and senses muramyl dipeptide on the bacterial peptidoglycan wall via leucine-rich domain (pink circles). 
Upon activation, NOD2 triggers two pathways: proinflammatory response via NF-κB pathway, and 
autophagy by recruiting ATG16L1. Variant of NOD2 (L1007fs) most commonly present in Crohn’s disease 
patients is not recruited to the plasma membrane upon bacterial invasion and fails to activate either 
pathway. (Travassos et al. 2010) 
Introduction 
 
14 
 
What further strengthens the NOD2-ATG16L1 link between pathogen sensing and autophagy is the 
presence of mutations on both proteins in patients suffering from Crohn’s disease (CD). CD is a 
chronic inflammatory disease of the gastrointestinal (GI) tract. Any part from mouth to anus can be 
affected, but CD is most commonly observed in the ileum. Depending on the severity of the disease, 
it can manifest itself as small erosions ranging to deep ulcers of the inner surface of the GI wall. Deep 
and large ulcers can lead to obstruction of the bowel and formation of physical holes in the wall of 
the GI tract. In such severe cases, disease can spread to the neighboring organs. Approximately half a 
million people are affected by CD in North America and Europe (Naser et al. 2012). CD is difficult to 
diagnose since it can affect any part of the GI tract, and its symptoms (diarrhea, abdominal pain, 
fever and weight loss) can be easily associated with many other conditions. The cause of CD is not 
known in detail but is attributed to a combination of environmental factors, genetics, immune 
dysfunction and microbiota composition (Sartor 2005). There is no cure for CD. Treatment of 
symptoms depends on the severity of the disease and includes nutritional management combined 
with therapeutic drugs. In most severe cases, surgery and removal of damaged areas are considered 
(Beattie et al. 2006). Based on genetic screens and population studies, NOD2 was the first identified 
CD susceptibility gene. Two missense mutations (R702W and G908R) and one frameshift mutation 
(L1007fsinsC (L1007fs)) on NOD2 have been associated with increased predisposition to CD (Hugot et 
al. 2001). Population studies have identified L1007fs variant of NOD2 as prevalent in CD patents on 
European and North American continents (Hampe et al. 2001; Ogura et al. 2001; Sventoraityte et al. 
2010; Vermeire et al. 2002; Hugot et al. 2001). While studying the link between NOD2 and ATG16L1, 
Travassos et al. also revealed that L1007fs variant of NOD2 does not get recruited to the site of 
bacterial entry, nor does it induce NF - κB signaling, nor does it recruit ATG16L1 and autophagy 
(Figure 10) (Travassos et al. 2010). 
Genome wide analysis of patients exposed a CD susceptibility variant in ATG16L1 (Libioulle et al. 
2007; Hampe et al. 2006). A single nucleotide polymorphism in ATG16L1 gene results in amino acid 
substitution of threonine with alanine at position 300 (T300A) in the amino acid sequence of the 
protein. This variant was shown to have the same expression level as the wild type and to be a risk 
factor for CD in the absence of NOD2 risk variants (Hampe et al. 2006). The effects this mutation has 
on behavior of ATG16L1 and how it could contribute to CD was considered and examined during the 
course of this work. In 2014, studies done in mice explained T300A variant of ATG16L1 is more prone 
to degradation by caspase 3 (Murthy et al. 2014) and caspase 7 (Lassen et al. 2014) resulting in 
protein instability and a reduction in pathogen control via autophagosome/lysosome pathway 
allowing bacteria to dominate (Lassen et al. 2014; Murthy et al. 2014). Moreover, NOD2 mediated 
autophagy leads to localization MHC II antigen presentation machinery members with LC3 and 
increased surface presentation of antigens on MHC II molecules. Dendritic cells harboring NOD2 
L1007fs and ATG16L1 T300A failed to demonstrate same behavior. (Cooney et al. 2010) In addition to 
cellular defects already mentioned, inability to present antigens and prime CD4+ T cell response, 
would lead to a persistent inflammatory response characteristic of the CD. Needless to say, NOD2 
and ATG16L1 are not the only genetic risk factors associated with CD. With next generation 
sequencing, more and more CD patients’ genomes can be analyzed and new loci are added to the 
growing list of variants contributing to CD (Liu & Anderson 2014). Interestingly, another autophagy 
protein, IRGM (immunity-related GTPase family M), contributes to the susceptibility to CD (Parkes et 
al. 2007). IRGM has been shown to play an essential role in autophagy-dependent pathogen 
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clearance (Singh et al. 2006). Unlike other autophagy proteins, IRGM has no homologs in yeast, and it 
has been suggested that IRGM contributes to autophagy indirectly (Singh et al. 2010; Singh et al. 
2006). Recently, IRGM has been shown to link members of autophagy-initiation complex (ULK1, 
Beclin-1, and AMBRA1) with NOD2. Moreover, IRGM co-localizes with NOD2 and ATG16L1 in co-
transfected cells, through direct interaction between IRGM and NOD2 (Chauhan 2015). 
These findings place three genetic risk factors for CD in a three partite complex important for 
bridging microbial sensing with autophagy degradation. This clearly demonstrates the complexity 
and importance of autophagy involvement in pathogen recognition, their control and clearance, and 
grave consequences defects in autophagy can have on the human system.   
Connection between NOD2 and ATG16L1 would provide only part of the answer: how cytosolic 
pathogens get recruited to autophagosomes. While the cytosol is under NOD2 surveillance, cellular 
membranes are protected by members of Toll-like receptors (TLRs), a major family of membrane-
bound PRRs. Among the TLRs, TLR1/TLR2 and TLR2/TLR6 heterodimers, TLR3, TLR4, TLR7/8 and TLR9 
have all been shown to induce autophagy-mediated defense (Chaturvedi et al. 2008; Delgado et al. 
2008; Shin et al. 2010). TLR1/TLR2 and TLR2/TLR6 heterodimers and TLR4 are localized on the 
mammalian cell surface, while TLR3, TLR7/8 and TLR9 oversee the inside of the endosomes. 
Involvement of TLR2 in autophagy is among the better understood. In 2007 Sanjuan et al. reported 
TLR2 signaling to recruit LC3 to the phagosomes, resulting in a fusion between LC3-positive 
phagosome with the lysosome (Sanjuan et al. 2007). Further evidence for TLR2 involvement in 
autophagy came in 2013, when Boada-Romero et al. identified a novel 19 residue ATG16L1 binding 
motif ([YX]-X3-[ED]-X4-[YWF]-X2-L) present on intracellular part of TLR2, N-terminal CARD (CARD1) of 
NOD2, and on a cytosolic part of transmembrane protein TMEM59. TMEM59 is present on late 
endosomes/lysosomes and was shown to co-localize with LC3, ATG16L1 and intracellular 
Staphylococcus aureus. The ATG16L1 binding motif was sufficient for each of the above mentioned 
interaction partners to co-localize and co-precipitate with C-terminal domain of ATG16L1. (Boada-
Romero et al. 2013) CARD domain of NOD1 was shown to bind to ATG16L1 (Travassos et al. 2010) 
but does not contain the complete ATG16L1 binding motif identified by Boada-Romero et al. and also 
does not co-precipitate with ATG16L1 (Boada-Romero et al. 2013). This suggests that not all ATG16L1 
interaction partners bind exclusively through this motif, and further studies are needed to fully 
describe the repertoire of macromolecules recruited by ATG16L1. Alternate functions of the 
identified ATG16L1 binding motif cannot be excluded. Additional biophysical experiments and 
structural data is needed to endorse these interactions and confirm the relevance of the identified 
motif.  
1.5 Structural knowledge of human ATG16L1  
ATG16L1 is a member of core autophagy machinery. In bulk autophagy, during autophagosome 
formation, ATG16L1 recruits ATG12~ATG5 conjugate, via ATG5 interaction, to the site of LC3 
lipidation on the autophagosome membrane (Fujita et al. 2008). ATG16L1 is a 607 amino acid long 
protein (~70 kDa) roughly divided into three major domains: ATG5 binding domain (ATG5-BD), coiled 
coil domain (CCD) and predicted WD40 domain (Figure 11A). ATG5 BD is a short helix on the N-
terminal part of the ATG16L1, also present in the yeast homolog. Structure of the ATG5 BD was 
recently solved, in complex with ATG12~ATG5 conjugate (Figure 11B) (Otomo et al. 2013). Another 
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similarity between ATG16L1 and its yeast counterpart is a coiled-coil domain (CCD), important for 
oligomerization of ATG16L1 molecules. So far, only CCD of the yeast ATG16 has a structural model 
(Fujioka et al. 2010). From the structure, shown in Figure 11B, ATG16 forms a parallel dimer through 
the CCD. In addition to being important for self-oligomerization of ATG16L1, CCD in human ATG16L1 
is also a docking site for WIPI2 (Dooley et al. 2014) and Rab33, a small Golgi-resident GTPase (Itoh et 
al. 2008). Both WIPI2 and Rab33 serve as modulators of autophagosome elongation through 
interaction with ATG16L1. Additionally, FIP200, a member of the ULK autophagy initiation complex, 
binds ATG16L1 in the region between CCD and predicted WD-40 domain (230-300 region) (Gammoh 
et al. 2013). Dimerization domain, WIPI2-, Rab33- and FIP200- interacting domains are all 
independent of each other (Dooley et al. 2014; Gammoh et al. 2013; Itoh et al. 2008). The stretch 
between CCD and predicted WD-40 domain of ATG16L1 also harbors a position of a natural variant of 
ATG16L1 (T300A), a risk factor for Crohn’s disease (Hampe et al. 2006) and cleavage site by caspase 3 
(Murthy et al. 2014) and caspase 7 (Lassen et al. 2014). 
 
Figure 11: Current structural knowledge of ATG16L1 A) Graphical domain representation of ATG16L1: ATG5 
binding domain (ATG5BD, 11-42, in orange), coiled coil domain (CCD, 78-230, in green) and WD-40 domain 
(320-607, in blue). Domain boundaries used here are from the UniProt (ID: Q676U5). Below each domain are 
interaction partners boxed in a color corresponding to the region of ATG16L1 with which they interact. An 
asterisk (*) indicates an approximate position of T300A mutation. B) Current structural knowledge of human 
and yeast ATG16. Structure of human ATG16L1 ATG5 binding domain (in orange) has been solved in complex 
with ATG5~ATG12 conjugate (ATG5 in purple, ATG12 in light blue) (Otomo et al., 2013). The structure is 
here modeled into a dimer using PyMOL. Structure of the coiled-coil domain of yeast ATG16 (in green) was 
solved and showed that the CCD domain assembles into a parallel dimer (Fujioka et al., 2010) indicating that 
ATG16 self-dimerizes. 
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ATG5BD and CCD are common to both yeast and human ATG16. The major difference to the yeast 
protein is a predicted WD-40 propeller domain on the C-terminal part, which is exclusively present in 
mammalian ATG16L1. So far, no structural information is available for this part of ATG16L1. The 
absence of this domain from the yeast protein indicates it is not essential for bulk autophagy, but 
might instead have evolved to fulfill specific needs of higher eukaryotic systems, such as control and 
clearance of pathogens. To further support this line of reasoning, molecules mentioned so far in the 
concept of linking autophagy with pathogen clearance (i.e. NOD2, NOD1, TLR2 and TMEM59) have all 
been shown to bind to precisely this domain of ATG16L1 (Travassos et al. 2010; Boada-Romero et al. 
2013). 
Given the ever growing importance selective autophagy has in the mammalian system, ATG16L1, and 
more specifically the predicted WD-40 domain of ATG16L1, seems to provide a direct link between 
autophagy and other cellular pathways. WD-40 domain of ATG16L1 might be an interaction platform 
for various proteins while the N-terminal part of ATG16L1 remains free for interactions with ATG5 
and other core autophagy proteins. However, structural details regarding the predicted WD-40 
domain are needed to confirm the fold of this domain. Additionally, structural knowledge would 
contribute to the better understanding of its function and the overall architecture of mammalian 
ATG16L1. 
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2 Aims of this work 
Autophagy is traditionally considered a bulk, unspecific, catabolic eukaryotic mechanism responsible 
for cellular maintenance and survival under starvation conditions. In recent decades, autophagy is 
being implicated in many other cellular processes, including (and not limited to) pathogenicity and 
immunity. Many bacteria, viruses and parasites are degraded via autophagy/lysosome pathway 
(Andrade et al. 2006; Birmingham et al. 2006; Gutierrez et al. 2004; Nakagawa et al. 2004; Orvedahl 
et al. 2010). However, the molecular details on pathogen recognition and recruitment by autophagy 
are still poorly understood. 
Invading pathogens are marked by ubiquitin and degraded by autophagy. Evidence suggests that 
pathogenic ubiquitination is catalyzed by CUL4-DDB1, a member of a large family of ubiquitin ligases, 
since one of the core autophagy proteins, ATG16L1, has been proposed as a DCAF (DDB1 CUL4 
associated factor) (He et al. 2006) and could recruit pathogens for ubiquitination. In this way, 
ubiquitinated pathogens can be directly engulfed by autophagy and degraded. Furthermore, 
ATG16L1 has been shown to bind NOD2. NOD2 is a pathogen recognition receptor which recognizes 
muramyl dipeptide on bacterial peptidoglycan wall and induces host’s inflammatory response. In 
parallel, NOD2 recruits ATG16L1 to the site of invasion, and with it the rest of the autophagy 
machinery. (Travassos et al. 2010; Ramjeet et al. 2010) The connection between ATG16L1 and NOD2 
in pathogen recognition and control is supported by the fact that mutations in both genes have been 
identified as risk factors for Crohn’s disease, an inflammatory disorder of the gastrointestinal tract.  
Taken together, this evidence identifies an autophagy core protein ATG16L1 as a good candidate for 
linking autophagy with pathogen control. The molecular mechanism of how ATG16L1 functions in 
these new roles is not very clear. A major addition to the human ATG16L1, compared to its yeast 
homolog, is a large (~30kDa) domain on the C-terminal end. The C-terminal half of ATG16L1 has been 
predicted to be a WD-40 propeller domain. Family of WD-40 propeller domains is very common in 
eukaryotic systems and is involved in interactions in many different cellular processes (Stirnimann et 
al. 2010). The WD-40 propeller of ATG16L1 has been demonstrated to bind both with DDB1 and 
NOD2, independent of the N-terminal half of ATG16L1. 
The main purpose of this work is structural and biochemical characterization of WD-40 propeller of 
ATG16L1. Since WD-40 domains are structurally conserved and very common in eukaryotes, the 
details of the loop regions and solvent-exposed strands are needed to provide functional 
information. The aim is to determine the structure of the mammalian ATG16L1 WD-40 domain, to 
confirm the organization of WD40-repeats and reveal the atomic and molecular details, providing a 
deeper insight into the role of this particular domain in the context of autophagy.  
Another objective of this project is functional characterization of the WD-40 ATG16L1 domain. 
Mapping of WD-40 of ATG16L1 as a DCAF would confirm a direct interaction between DDB1 and 
ATG16L1. Moreover, ATG16L1 has been reported to interact with CARD1 domain of NOD2, CARD 
domain of NOD1, cytosolic domain of TLR2, and with the cytosolic domain of TMEM59. The aim is to 
analyze these interactions in vitro, and, if confirmed, co-crystallize interacting domains with the WD-
40 of ATG16L1 to reveal accurate interaction surfaces. Only a crystal structure of the complex would 
reveal exactly which residues of the WD-40 propeller and its interaction partners are responsible for 
the interaction. 
Materials and Methods 
 
19 
 
3 Materials and Methods 
3.1 Materials 
3.1.1 Enzymes 
All enzymes, listed in the Table 2, were used according to the manufacturer’s instructions. 
Enzyme Manufacturer 
Calf Intestinal Phosphatase (CIP) New England Biolabs 
Restriction enzymes New England Biolabs 
T4 DNA ligase New England Biolabs 
KOD Polymerase Novagen 
Standards  
Smart Ladder (DNA) Eurogentech 
PageRuler unstained protein ladder Fermentas 
PageRuler Plus prestained protein ladder Fermentas 
2x Red PCR Master Mix pjk 
Table 2: Enzymes and standards used in this study, with their respective manufacturers 
3.1.2 Kits 
All kits, listed in Table 3, were used according to the manufacturer’s instructions.  
Kits Manufacturer 
QIAprep® Spin Miniprep Kit Qiagen 
QIAquick® PCR Purification Kit Qiagen 
QIAquick® Gel Extraction Kit Qiagen 
PureYieldTM Plasmid MidiPrep System Promega 
Proti-Ace Hampton Reseach 
Proti-Ace II Hampton Reseach 
Strep-tag® AP Detection Kit Iba 
Table 3: Kits used in this study, with their respective manufacturers DNA constructs 
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3.1.2.1 cDNA  
Complementary DNA (cDNA) used as for amplifying genes of interests in this study are listed in Table 
4. 
cDNA plasmid clone ID Supplier 
Hs_ATG16L1 Pincy I1382-8397581/ LIFESEQ2507216 Open Biosystems 
Mm_ATG16L1 pYX-Asc MMM1013-9498451 Open Biosystems 
Hs_NOD2 pENTR223.1 HsCD00297035 DNASU 
Hs_NOD1 pDONR223 CCSB 2450 CCSB  
Hs_TMEM59 pENTR223 HsCD00509837 DNASU 
Table 4: cDNA List of cDNA used as templates for cloning. Hs = Homo sapiens. Mm = Mus musculus
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3.1.2.2 DNA constructs 
All vectors in Table 5 have been designed and cloned previously, and used in this work.  
Gene expression system Vector Tag resistance reference 
drDDB2 Insect pFastBac-derived N-His6 Amp (Scrima et al. 2008) 
HsDDB1_1-1104 Insect pFastBac-derived N-His6 Amp (Scrima et al. 2008) 
HsATG16L1_T300A_M1-Y607 Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_T300A M1-Y607 Insect pFastbacDual-derived N-Strep Amp  
HsATG16L1_wt M1-Y607 Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_wt M1-Y607 Insect pFastbacDual-derived N-Strep Amp  
HsATG16L1_wt K266-Y607 Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_wt G284-Y607 Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_wt G303-Y607 Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_T300A K266-Y607 Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_T300A G284-Y607 Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_wt K266-Y607 Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_wt G284-Y607 Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_wt G303-Y607 Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_T300A K266-Y607 Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_T300A G284-Y607 Insect pFastbacDual-derived N-His6 Amp  
PSS013 HsNod2_M1-P209 insect/mammalian pFlpBtMII (F13/F14) N-Strep Amp  
pSS001 HsNod2_M1-L1040 insect/mammalian pFlpBtMII (F13/F14) N-Strep Amp  
Table 5: List of constructs used from previous work in our lab. Amp = ampicillin. Dr = Danio rerio. Hs = Homo sapiens  
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Gene expression system vector Tag resistance Reference 
hsLC3A E. coli pGEX4T N-GST Amp Trond Lamark 
hsLC3B E. coli pGEX4T N-GST Amp Trond Lamark 
hsGABARAP E. coli pGEX4T N-GST Amp Trond Lamark 
hsGABARAP L1 E. coli pGEX4T N-GST Amp Trond Lamark 
hsGABARAP L2 E. coli pGEX4T N-GST Amp Trond Lamark 
Table 6: List of constructs kindly provided by Trond Lamark from the Department of Medical Biology, The Artic University of Norway. Amp = ampicillin. Hs = Homo sapiens 
Constructs listed in Table 7 are designed and cloned independently for the purpose of this work. First multiple cloning site (MCSI) has NotI/KpnI restriction sites 
(unless otherwise noted) used for incorporation of genes of interest. 
Gene expression system Vector tag resistance Reference 
MmATG16L_wt_1-607 Insect pFastbacDual-derived N-His6 Amp  
MmATG16L_wt_1-607 Insect pFastbacDual-derived N-Strep Amp  
MmATG16L1_wt_P311-P607 Insect pFastbacDual-derived N-His6 Amp  
MmATG16L1_wt_P311-P607 Insect pFastbacDual-derived N-Strep Amp  
MmATG16L1_wt_A320-P607 Insect pFastbacDual-derived N-His6 Amp  
MmATG16L1_wt_A320-P607 Insect pFastbacDual-derived N-Strep Amp  
MmATG16L1_wt_P271-P607 Insect pFastbacDual-derived N-His6 Amp  
MmATG16L1_wt_P271-P607 Insect pFastbacDual-derived N-Strep Amp  
MmATG16L1_wt_P231-P607 Insect pFastbacDual-derived N-His6 Amp  
MmATG16L1_wt_P231-P607 Insect pFastbacDual-derived N-Strep Amp  
HsATG16L_A300D_1-607 Insect pFastbacDual-derived N-Strep Amp  
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Gene expression system Vector tag resistance Reference 
HsATG16L_A300E_1-607 Insect pFastbacDual-derived N-Strep Amp  
HsATG16L_S287E_1-607 Insect pFastbacDual-derived N-Strep Amp  
HsATG16L_S290E_1-607 Insect pFastbacDual-derived N-Strep Amp  
HsATG16L_S304E_1-607 Insect pFastbacDual-derived N-Strep Amp  
HsATG16L_A320-607 Insect pFastbacDual-derived N-Strep Amp  
HsATG16L1_266-607_SER1 (K469A/K470A) Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_266-607_SER2 (E354A/K355A) Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_266-607_SER3 (K306A/E307A) Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_266-607_SER4 (E569A/K570A) Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_284-607_SER1 (K469A/K470A) Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_284-607_SER2 (E354A/K355A) Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_284-607_SER3 (K306A/E307A) Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_284-607_SER4 (E569A/K570A) Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_303-607_SER1 (K469A/K470A) Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_303-Y607_SER2 (E354A/K355A) Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_303-P607_SER3 (K306A/E307A) Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_303-607_SER4 (E569A/K570A) Insect pFastbacDual-derived N-His6 Amp  
HsLC3C E. coli pGEX4T N-GST Amp  
HsATG16L1_wt_1-607 insect/mammalian pFlpBtMII (wt/F3) N-FLAG-HA Amp  
HsATG16L1_303-607 insect/mammalian pFlpBtMII (wt/F3) N-FLAG-HA Amp  
HsATG16L1_1-307 insect/mammalian pFlpBtMII (wt/F3) N-FLAG-HA Amp  
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Gene expression system Vector tag resistance Reference 
HsATG16L1_303-P607 Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_303-Y607_SER2 (E354A/K355A) Insect pFastbacDual-derived N-His6 Amp  
HsATG16L1_1-607 insect/mammalian pFlpBtMII (F13/F4) N-myc Amp  
HsATG16l1_1-307 insect/mammalian pFlpBtMII (F13/F4) N-myc Amp  
HsDDB1_M1-H1140 insect/mammalian pFlpBtMII (wt/F3) N-Strep Amp  
HsNOD2_1-209 E. coli pGEX-derived N-GST Amp  
HsNOD2_23-209 E. coli pGEX-derived N-GST Amp  
HsNOD2_1-209 E. coli pCOLA-Duet N-Strep Kan  
HsNOD2_23-209 E. coli pCOLA-Duet N-Strep Kan  
HsNOD2_1-112 E. coli pCOLA-Duet N-Strep Kan  
HsNOD2_1-121 E. coli pCOLA-Duet N-Strep Kan  
HsNOD2_23-121 E. coli pCOLA-Duet N-Strep Kan  
HsNOD2_28-119-Thrombin-218 E. coli pGEX-derived N-GST Amp  
HsNOD2_28-218 E. coli pGEX-derived N-GST Amp  
HsTMEM59_263-323 E. coli pGEX-derived N-GST Amp  
HsTMEM59_263-323 E. coli pET15b-derived C-GST Amp  
HsNOD1_1-106 E. coli pET15b-derived C-GST Amp  
HsTMEM59_263-281 E. coli pGEX-derived N-GST Amp  
Table 7: List of constructs cloned for this work. Amp = ampicillin; Kan = kanamycin. Hs = Homo sapiens. Mm = Mus musculus.  
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3.1.3 Oligonucleotides 
Oligonucleotides used are listed in the Table 8.  
oligonucleotide name sequence (5’ -> 3’) Organism RE 
HsATG16L_N_M1_f aagaatgcggccgcatgtcgtcgggcctccgcgc Homo sapiens NotI 
HsATG16L_Y607_K_r ggggtacctcagtactgtgcccacagcac Homo sapiens KpnI 
HsATG16L_Kdel_f gaagtgagggttccagctactgc Homo sapiens none 
HsATG16L_Kdel_r gcagtagctggaaccctcacttc Homo sapiens none 
HsATG16_K266_N_f aagaatgcggccgcaagcgactctcgcagcctgc Homo sapiens NotI 
HsATG16_G284_N_f aagaatgcggccgcgggagacgctctgtctcttcc Homo sapiens NotI 
HsATG16_G303_N_f aagaatgcggccgcggttctggtaaagaagtgaggg Homo sapiens NotI 
MmATG16L_P311-P607_f aagaatgcggccgcccaactactgcctcgtatgtc Mus musculus NotI 
MmATG16L_A320-P607_f aagaatgcggccgcgcgcatgacggagaggtcaac Mus musculus NotI 
MmATG16L_P271-P607_f aagaatgcggccgccctgctggaggccttctgg Mus musculus NotI 
MmATG16L_P231-P607_f aagaatgcggccgccctctacctgttgaacagg Mus musculus NotI 
MmATG16L_int_seq gaatgaagcaaagatttcgg Mus musculus NotI 
HsDDB1_G490_f gtcattgatgtcaagttcctatatgg Homo sapiens none 
HsDDB1_G961_f gttgtgtttgtcgggtctcgcc Homo sapiens none 
HsDDB1_G2221_f gaagtccaagacacgagtg Homo sapiens none 
HsDDB1_G2901_f ggctgaaaatgcctttaacttgtttg Homo sapiens none 
HsDDB1_T1601_f tggaacatgaagtggcttgcttg Homo sapiens none 
HsATG16L_A300D_f gtggatgatcatcctggttctggtaaag Homo sapiens none 
HsATG16L_A300D_r aggatgatcatccacattgtcctggggg Homo sapiens none 
HsATG16L_A300E_f gtggatgaacatcctggttctggtaaag Homo sapiens none 
HsATG16L_A300E_r aggatgttcatccacattgtcctggggg Homo sapiens none 
DDB1_F598_r cttttctcggagagacacctcatagg Homo sapiens none 
HsATG16L_S287E_f cgcgaagtctcttccttcccagtcccccaggac Homo sapiens none 
HsATG16L1_S287E_r gaaggaagagacttcgcgtctcccaaagatattag Homo sapiens none 
HsATG16L1_S290E_f tctgtctctgaattcccagtcccccaggac Homo sapiens none 
HsATG16L_S290E_r gaattcagagacagagcgtctcccaaagatattag Homo sapiens none 
HsATG16L_S304E_r ctttaccttcaccaggatgagcatccacattg Homo sapiens none  
HsATG16_2xE_f cgcgaagtctctgaattcccagtcccccaggac Homo sapiens none 
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oligonucleotide name sequence (5’ -> 3’) Organism RE 
HsATG16_2xE_r gaattcagagacttcgcgtctcccaaagatattag Homo sapiens none  
HsATG16_3xE_f cgcgaagtcgaagaattcccagtcccccaggac Homo sapiens none 
HsATG16_3xE_r gaattcttcgacttcgcgtctcccaaagatattag Homo sapiens none  
HsATG16_A320_f aagaatgcggccgcgcacatgatggggaagtcaac Homo sapiens none 
HsATG16L_S289E_f tctgtcgaatccttcccagtcccccaggacaatg Homo sapiens none 
HsATG16L_S289E_r gaaggattcgacagagcgtctcccaaagatattagtg Homo sapiens none 
HsATG16L_S304E_f cctggtgaaggtaaagaagtgagagtac Homo sapiens none  
HsATG16L1_WD40_SER1_f gacgccgccattcgtttctgggacattcgatcag Homo sapiens none 
HsATG16L1_WD40_SER1_r cgaatggcggcgtcaaaatgtccactcattacacattg Homo sapiens none 
HsATG16L1_WD40_SER2_f ggagccgcctgtgagttcaagggttccctatc Homo sapiens none 
HsATG16L1_WD40_SER2_r acaggcggctccaaatacttcccaaagcttaacc Homo sapiens none 
HsATG16L1_WD40_SER3_f gtggccgccgttctttcaaagcagcacagctcatc Homo sapiens none 
HsATG16L1_WD40_SER3_r gaacggcggccactttccctgtgagcacactc Homo sapiens none 
HsATG16L1_WD40_SER4_f ggtgccgccgtgagggttccagctactgcc Homo sapiens none 
HsATG16L1_WD40_SER4_r cacggcggcaccagaaccaggatgggtatcc Homo sapiens none 
HsNod1_N_M1_f aagaatgcggccgcatggaagagcagggccacagtg Homo sapiens NotI 
HsNOD1_K_106E_r ggggtaccctccagcagccaaggcctgag Homo sapiens KpnI 
HsTMEM59_N_T263_f aagaatgcggccgcacagctgtggagcagtatgttcc Homo sapiens NotI 
HsTMEM59_K_I323_stop_r ggggtaccttaaatttcagaatgagcaagattcac Homo sapiens KpnI 
HsTMEM59_N_T263_start_f aagaatgcggccgcatgacagctgtggagcagtatgt
tcc 
Homo sapiens NotI 
HsTMEM59_K_I323_r ggggtaccaatttcagaatgagcaagattcacttttg Homo sapiens KpnI 
HsLC3C_B_f cgggatccatgccgcctccacagaaaatcc Homo sapiens BamHI 
HsLC3C_N_r ttcttagcggccgctcgagttagagaggattgcagggt
ctgtcctcaaggc 
Homo sapiens NotI 
Table 8: List of oligonucleotides used for gene amplification. (RE = restriction sites)  
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3.1.4 Sequencing primers 
Primers used for sequencing are listed in Table 9. 
primer name sequence (5’ -> 3’) 
pFB1_5’_f tattccggattattcatacc 
pFB1_3’_r cctctacaaatgtggtatgg 
T7_f  taatacgactcactataggg 
T7_r  gctagttattgctcagcgg 
pGEX_f atagcatggcctttgcagg 
pGEX_r gagctgcatgtgtcagagg 
DuetUP1 ggatctcgacgctctccct 
DuetDOWN1 gattatgcggccgtgtacaa 
seq_pFliptomam_r cctcaagacccgtttagaggcc 
pFlpBtM_seq_for_II cattttatttacaatcaggatccg 
Table 9: List of primers used for in-house sequencing of genes used in this study 
3.1.5 Bacterial strains and cell lines 
Bacterial strains are listed in Table 10. DH5α and Rosetta 2(DE3) are used for E. coli expression 
system. DH5α are used for cloning while Rosetta 2(DE3) cells are used for protein expression and 
production. DH10EMBacY cells are used to generate baculovirus for insect cell protein expression.  
strain Genotype manufacturer 
DH5α F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG 
Φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(rK- mK+), λ– 
Invitrogen 
Rosetta 2(DE3) F- ompT hsdSB(rB- mB-) gal dcm (DE3) pRARE2 (CamR) Novagen 
DH10EMBacY F-mcrA Δ(mrr-hsdRMS-mcrBC) φ80(lacZ) ΔM15ΔlacX74 
recA1 araD139 Δ(ara,leu)7697 galU galK l- rpsL nupG 
/BacloxP/pBADZ-His6Cre/pMON7124 
EMBL 
Table 10: List of bacterial strains  
3.1.6 Insect cell lines  
IPLB-SF-21AE (Sf-21) isolated from ovaries of an armyworm Spodoptera frugiperda (Vaughn et al. 
1977) and adapted for growth in suspension. Sf-21 is used for generation of baculovirus and its 
propagation. 
BTI-Tn-5B1-4 (High Five) was originally isolated from ovaries of a cabbage looper Trichoplusia ni 
(Wickham and Nemerow 1993) and is commercially available as High Five™ from Invitrogen. This cell 
line is used for protein production.  
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3.1.7 Mammalian cell lines 
HEK293-6E is a subclone of a human embryonic kidney epithelial cell line HEK293 (Graham, Smiley, 
Russell, & Nairn, 1977). This subclone is adapted to suspension and carries a truncated Epstein-Barr 
nuclear antigen 1 (EBNA1) (Durocher et al. 2002). This cell line is used for transient test expression. 
3.1.8 Antibiotics 
Antibiotics listed in Table 11 were used to select for plasmids caring the corresponding resistance 
gene. In addition to antibiotic section, Blue-Gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) 
and IPTG (isopropyl β-D-1-thiogalactopyranoside) were used for blue-while screening of 
DH10EMBacY cells.  
Antibiotics and chemicals Final concentration (µg/ml) 
Ampicillin (Amp) 100 
Chloramphenicol (Cm) 25 
Gentamicin (Gm) 7 
Kanamycin (Kan) 50 
Tetracyclin (Tet) 10 
Blue-Gal 100 
IPTG 40 
Table 11: List of antibiotics and chemicals used for growth and selection of desired colonies 
3.1.9 Antibodies 
Antibodies used for detection of proteins and tags are listed in the Table 12.  
Antibody Manufacturer 
ATG5 GeneTex 
GST-HRP conjugate AmershamBioscience 
LC3A/B  Cell Signaling 
ATG16L Sigma 
ImmunoPure Avidin, AP conjugated ThermoScientific 
Table 12: List of antibodies and their manufacturers 
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3.1.10 Columns and resins used in this study 
A list of affinity resins and ion exchange and gel filtration columns used in this study is presented in 
Table 13. 
Resin Manufacturer 
Ni Sepharose® 6 Fast Flow GE Healthcare 
Glutathione Sepharose® 4 Fast Flow GE Healthcare 
Strep-Tactin® Sepharose® 50% suspension Iba 
Strep-Tactin® Macroprep® 50% suspension Iba 
Strep-Tactin® Superflow® high capacity 50% suspension Iba 
Pierce® Monomeric Avidin Agarose Thermo Fisher Scientific 
Anti-DYKDDDDK (FLAG) Tag (L5) Affinity Gel Biolegend 
Columns Manufacturer 
Source15Q ion exchange (8ml) GE Healthcare 
HiLoad 16/600 Superdex 200 prep grade GE Healthcare 
HiLoad 16/600 Superdex 200 prep grade GE Healthcare 
Superdex 200 10/30 GE Healthcare 
Table 13: List of resins and columns used for protein studies in this work 
3.1.11 Media and buffers 
3.1.11.1 Media for eukaryotic systems 
Media used for propagation of insect and mammalian cells are listed in Table 14. 
Cell culture media Cell lines Manufacturer 
Ex-Cell™ 405 HighFive SAFC 
Ex-Cell™ 420 Sf-21 SAFC 
F17 HEK293-6E Gibco 
Table 14: List of media for insect and mammalian cells 
F17 medium from HEK293-6E cells is supplemented by 0.025mg/L G418, 1g/L Pluronic F68 and 
7.5mM L-Glutamine prior to use.  
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3.1.11.2 Media for prokaryotic systems 
Bacterial culture media Composition 
Luria Bertani (LB) 10g/L tryptone, 5g/L, NaCl, 5g/L yeast extract 
Terrific Broth (TB) 12g/L tryptone, 24g/L yeast extract, 4ml/L glycerol, buffered with 10% 
0.17 M KH2PO4, 0.72 M K2HPO4 
SOC-Medium 20g/L tryptone, 5g/L yeast extract, 0.5g/L NaCl, 2.5mM KCl, 10mM 
MgCl2, 20mM glucose 
TFB1 30mM KOOCH3, 100mM RbCl, 10mM CaCl2, 50mM MnCl2, 15% glycerol, 
buffered with 5M acetic acid to pH 5.8    
TFB2 10mM MOPS, 75mM CaCl2, 10mM RbCl2, 15% glycerol, buffered with 
50% (w/v) NaOH to pH 6.5 
3.1.11.3 Buffers 
Buffers Composition 
PBS buffer 137mM NaCl, 3mM KCl, 12mM Na2HPO4, 2mM K2HPO4, pH 7.4 
PBS-T buffer PBS buffer, 0.1% (v/v) Tween-20 
AF4 running buffer PBS, 0.003M sodium azide 
Blocking buffer 5% (w/v) skim milk in PBS-T 
2xDTT loading buffer 100mM Tris/HCl pH 6.8, 4% SDS, 20% glycerol, 200mM DTT, 0.2% (w/v) 
bromphenol blue 
SDS-PAGE lower buffer 
(4x) 
1.5M Tris/HCl, pH 8.8 
SDS-PAGE running 
buffer 
25mM Tris/HCl, 192mM glycine, 0.1% (w/v) SDS  
SDS-PAGE sample buffer 
(2x) 
1ml 1M Tris/HCl pH 6.8, 2.4mM glycerol, 0.8g SDS, 2mg Coomassie blue G-
250, 0.31g DTT, add H2O to 10ml 
SDS-PAGE separating gel 10ml Polyacrylamide solution, 5ml 4x Lower buffer, 0.2ml SDS (10%), 
4.7ml H2O, 20 µl TEMED, 50µl APS (25%) 
SDS-PAGE stacking gel 1.5ml Polyacrylamide solution, 2.5ml 4 x Upper buffer, 5.9ml H2O, 15µl 
TEMED, 25µl APS (25%) 
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Buffers Composition 
SDS-PAGE staining 
solution 
30% (v/v) ethanol, 10% (v/v) acetic acid, 0.25% (w/v) Coomassie R-250  
SDS-PAGE Upper buffer 
(4x) 
0.5M Tris/HCl pH 6.8, 0.4% (w/v) SDS  
TAE buffer 40mM Tris/HCl pH 8.2, 20mM sodium acetate, 1mM EDTA 
DNA loading buffer 
(10x) 
10mM Tris/HCl, pH 7.5, 0.05% (w/v) bromphenol blue, 1mM EDTA, 50% 
glycerol 
Transfer buffer 20mM Tris pH 8.0, 192mM glycine, 15% methanol 
CD buffer 10mM NaH2PO4, pH 8, 10mM NaCl, 5mM DTT, 1mM MgCl2 
Hank’s Buffered Salt 
Solution (HBSS)  
0.127M NaCl, 5.4mM KCl, 0.25mM Na2HPO4, 0.1g/L glucose, 0.44mM 
KH2PO4, 1.3mM CaCl2, 1.0mM MgSO4, 4.2mM NaHCO3  
3.1.12 Crystallization Screens 
Crystallization screens used for initial screening and optimization are listed in Table 15. 
Screen Manufacturer 
JCSG Core I-IV Qiagen 
AmSO4 Qiagen 
Morpheus Molecular Dimensions 
Midas Molecular Dimensions 
Index Hampton Research 
Additive Screen Hampton Research 
Silver Bullet Screen Hampton Research 
Table 15: List of commercial crystallization screens used in this study, with their respective manufacturers 
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3.2 Methods 
3.2.1 Molecular Cloning 
3.2.1.1 Polymerase chain reaction (PCR) 
Gene amplification was done by PCR using standard procedure. PCR reaction mix is represented in 
Table 16. 
Component Volume 
DNA template (10 ng/µl) 1 µl  
10xBuffer 1 for KOD Hot Start 5 µl 
MgSO4 (25 mM) 3 µl 
dNTPs (2 mM each) 5 µl 
Primer frw (10 pmol/µl) 2 µl 
Primer rev (10 pmol/µl) 2 µl 
KOD HotStart Polymerase 1 µl 
MQ H2O 31 µl 
Table 16: Composition of PCR mix, final volume of 50 µl 
The PCR-cycling parameters shown in Table 17 are used. Annealing temperature is chosen according 
to the melting temperature of primer pairs. Elongation time is adjusted depending on the length of 
the PCR product according to the manufacturer’s instructions.  
Step T(°C) Duration (s) Repeat 
Initial denaturation 95 120  
Denaturation 95 30 
40 Annealing 55 15 
Elongation 72  
Final extension 72 420 
 
Hold 4 ∞ 
Table 17: PCR cycle stages and their duration 
3.2.1.2 DNA agarose gel electrophoresis and gel extraction purification 
PCR products are visualized on 0.8 % agarose gel (unless otherwise noted) with 0.5µg/ml ethidium 
bromide. Samples were mixed with 10xDNA loading dye. 1xTBE was used as running buffer. Agarose 
gels are visualized under UV light (Ultrospec 3000, 245nm). Extraction of PCR products from the 
agarose gel is done using the Qiagen Gel Extraction Kit according to the manufacturer‘s protocol.  
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3.2.1.3 Restriction digest 
Cloning vectors and PRC products were digested at 37°C for 1hr with respective enzymes (Table 18) 
in 40µl reactions. 
 Vector PCR product 
DNA amount 2 µl x µl 
NEB 10x Buffer 4 4 µl 4 µl 
KpnI 1 µl 1 µl 
NotI 1 µl 1 µl 
MQ H2O 32 µl ad 40 µl 
Table 18: Restriction reaction composition 
Upon digestion, cloning vectors are additionally treated with CIP for 1hr, 37°C to dephosphorylate 
the ends and reduce the re-ligation rate.  
Following restriction digest, PCR products are purified using QIAGEN PCR Purification Kit. Vectors are 
loaded on 0.8% agarose gel with 0.5µg/ml ethidium bromide and bands corresponding to the 
digested plasmid are cut out and purified using QIAGEN Gel Extraction Kit according to the 
manufacturer’s protocol. Concentration of purified DNA is determined by NanoDrop spectrometer 
(ND-1000, PeqLab Biotechnology). 
3.2.1.4 Ligations 
Ligations are performed using 50-100ng of vector with 5 fold molar excess of insert. A final reaction 
volume of 20µl is set up with 2µl 10x T4 ligase buffer and 1µl T4 DNA ligase. As control, same 
reaction is set up with vector only, to assess the success of digestion. Ligation reactions are incubated 
at room temperature for 1hr.  
3.2.1.5 Chemocompetent cells 
An overnight 5ml culture of chemocompetent cells in inoculated into 250ml fresh LB media and 
grown at 37°C to OD600 of 0.5. Culture is chilled on ice for 10 min prior to centrifugation at 4°C, 300 
rpm, 5 min. Bacterial pellet is carefully and thoroughly resuspended in 100 ml TFB1, chilled on ice for 
10min and centrifuged at 4°C, 300rpm, 5min. This time pellet is resuspended in 10ml TFB2. Cells are 
shock frozen in liquid nitrogen in 100µl aliquots and stored at -80°C.  
3.2.1.6 Transformation  
Transformations are performed by heat shock. Chemocompetent E. coli (100µl) are incubated either 
with 10µl of the ligation reaction, or with 1µl of purified DNA for 30min on ice. Cells are heat shocked 
at 42°C for 1.5min, followed by 2min incubation on ice. Pre-warmed 800µl of SOC media is added to 
the cells and incubated at 37°C, 550rpm (Thermomixer 5436, Eppendorf). In case of DH5α and 
Rosetta 2(DE3), cells are incubated for 1hr; DH10EMBacY are incubated for 4hr. Bacteria are 
centrifuged at the table top centrifuge (Fresco21, ThermoScientific) for 1min, 14000rpm. Excess 
media is decanted and cells are plated on LB-Agar plates containing appropriate antibiotics. 
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3.2.1.7 Colony PCR 
To confirm the presence of the insert, colony PCR was performed using sequencing primers. PCR 
reaction mix is represented in Table 19.  
Component (per colony) Volume 
Colony  
2x PCR Red dye Mix 10 µl 
Primer frw (10 pmol/µl) 1 µl 
Primer rev (10 pmol/µl) 1 µl 
MQ H2O 8 µl 
Table 19: PCR mix composition for colony PCR. Total reaction volume is 20 µl 
The PCR-cycling parameters shown in Table 20 are used. Annealing temperature is chosen according 
to the melting temperature of primer pairs. Elongation time is adjusted depending on the length of 
the PCR product according to the manufacturer’s instructions.  
Step T(°C) Duration (s) Repeat 
Initial denaturation 94 300  
Denaturation 95 30 
26 Annealing 55 30 
Elongation 72  
Final extension 72 420 
 
Hold 4 ∞ 
Table 20: Colony PCR cycle stages and their duration 
Colonies positive for inserts are inoculated in 5ml LB media supplied with appropriate antibiotics and 
grown overnight at 37°C, 130rpm in shaking incubator (Infors Af 110). 
3.2.1.8 Plasmid purification 
Plasmid purification is done using QIAprep Spin MiniPrep Kit for DNA extraction from overnight 
cultures according to the manufacturer’s protocol. Purified plasmids are sent for in-house 
sequencing. Plasmids are kept at -20°C for long term storage, and glycerol stocks are kept at -80°C. 
For transient transfection of HEK293-6E cells, plasmids are prepared according to the PureYieldTM 
Plasmid MidiPrep System.  
3.2.1.9 Isolation of bacmid  
The bacmid DNA is prepared according to the protocol in the BAC-TO-BAC® system manual from Life 
Technologies. 5ml LB media supplemented with 50µg/ml kanamycin, 7µg/ml gentamicin, 10µg/ml 
tetracycline are inoculated with a single white, isolated colony and incubated overnight at 37°C, 130 
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rpm in a shaking incubator (Infors Af 110). Following 3 min centrifugation at 14000 rpm, pellet from 
2ml of culture is suspended in 300µl P1 solution (QIAgen). After addition of 300µl P2 solution 
(QIAgen) and gentle agitation, the mixture is incubated at room temperature for 5 min. Another 
300µl of P3 solution (QIAgen) is added, mixed and incubated on ice for 5-10 min. Solution is cleared 
by centrifugation at 14000 rpm, 10 min, 4°C. The supernatant is transferred into a tube containing 
800 µl isopropanol, mixed gently and incubated 5-10 min on ice. Following another centrifugation at 
14000 rpm, 10 min, 4°C and supernatant is decanted and the pellet is washed with 500µl 70% 
ethanol. Ethanol is removed by centrifugation at 14000 rpm, 5 min, 4°C followed by air drying at 
room temperature. Finally, DNA pellet is dissolved in 40µl EB-buffer (QIAgen) and stored at -20°C. 
3.2.2 Cell culture methods 
3.2.2.1 Transfection of Sf-21 with bacmid DNA and virus amplification 
Sf-21 and HighFive cells are cultivated at 27°C, 100 rpm and passaged every two to three days to 
maintain cell density between 3x105 and 3x106 cells/ml. To generate recombinant viruses, 1ml of 0.6-
0.8x106 adherent Sf-21 cells is seeded on 6-well plates and transfected with recombinant bacmids. 
For each transfection reaction, 10µl Superfect (QIAGEN) and 5-10µl purified bacmid are mixed with 
150µl ExCell 420 media and incubated at room temperature for 10 min. Following the incubation, 
total volume is brought to 1ml with 5% FCS/ExCell420 mixture and gently added to the cells. Cells are 
incubated at 27°C. The supernatant containing first generation viruses (P0) is harvested six days post 
transfection. 
For each subsequent generation (P1-P3), 10% of previous virus stock is added to 0.6-0.8x106 cells/ml 
in serum free suspension culture and incubated at 27°C, 100 rpm. Infection is determined by 
measuring yellow fluorescence on GUAVA EasyCyte Mini (Merck Milipore) and increase of cell size by 
CASY. Virus is harvested typically 3 days post infection, by centrifugation at 2000 rpm, 4 min. 
Supernatant is stored at 4°C with 5% FCS.  
3.2.2.2 Cell size determination 
Increase of cell diameter is one of the key criteria of assessment of insect cell infection. Cell diameter 
can be measured by CASY Cell Counter (Innovatis). The measurements were performed according to 
the manufacturer’s guidelines.  
3.2.2.3 Preparation of baculovirus infected insect cells (BIIC) 
The baculovirus infected insect cells (BIIC) method is developed as an improvement for long term 
storage of recombinant baculoviruses (Wasilko et al. 2009). BIIC stocks are made by infecting 300 ml 
Sf-21 cells (1x106 cells/ml) in serum free media with 20% of P2 or P3 virus. The culture is incubated at 
27°C, 100 rpm, and cell diameter and vitality are monitored daily. Cells are harvested latest 48 hr 
post infection, once the cell diameter increased by 3-5µm (10-20% of the size on the day of infection) 
and the vitality was >85%. Harvesting is done by centrifuging the culture at 180 rpm for 4 min. 
Supernatant is decanted and the pellet is resuspended in freshly prepared freezing media (90% ExCell 
420, 10% DMSO) at 1x107 cells/ml. Each cryo-tube (Nunc) is filled with 1.5ml suspension. The cryo-
vials are stored in Mr. Frosty (Nalgene) at -80°C for 24 hr to provide a constant cooling rate of 
1°C/min. Subsequently, cryo-vials are stored in the vapor phase over liquid nitrogen for long term 
storage.  
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3.2.2.4 Transient transfection of HEK293-6E cells with plasmid DNA 
HEK293-6E cells are cultivated in supplemented F17 media at 37°C, 100 rpm, 5% CO2 by Nadine 
Konisch. For transfection 2µg of plasmid DNA per 1x106 cells were incubated in 200µl F17 media 
according to the standard transfection conditions as described by Bollin et al. (Bollin et al. 2011) The 
HEK293-6E cells were seeded in a total volume of 1.8ml at a concentration of 0.6x106 cells/ml and 
afterwards the 200µl transfection mix was added.  
3.2.3 Protein expression and purification 
3.2.3.1 Protein test expression from E. coli 
Plasmids are transformed into Rosetta 2 (DE3) cells and protein expression is tested in TB media 
(unless otherwise specified) at 20°C and 37°C. Overnight cultures are used to grow a larger culture to 
OD600=0.5-0.6. Protein expression is induced by 50 or 500µM IPTG and bacterial pellets are collected 
after 3 hr or overnight to test protein expression under corresponding conditions. Cells are harvested 
(10ml/condition), resuspended in 1ml lysis buffer (50mM Tris pH 8, 200mM NaCl, 1mM PMSF, 5mM 
BME) and lysed by sonication. Following 45 min centrifugation at 14000 rpm, 4°C, clear lysate is 
incubated with 30µl appropriate beads and incubated for 1 hr, 4°C, on a rocking platform. Beads are 
subsequently washed and dissolved in 2x DTT loading buffer for SDS-PAGE analysis. Additionally, 
samples are taken from pellet and supernatant prior to addition of beads.  
3.2.3.2 Protein test expression from insect cells 
Plasmids are transformed into EMBacY cells and used for virus production and amplification in Sf-21 
cells. After passage 2 (P2), Sf-21 cells are tested for protein expression. Cells are harvested (10ml), 
resuspended in 1ml lysis buffer (50mM Tris pH 8, 200mM NaCl, 1mM PMSF, 5mM BME, 0.1% Triton 
X-100) and lysed by sonication. Following 45 min centrifugation at 14000 rpm, 4°C, clear lysate is 
incubated with 30 µl appropriate beads and incubated for 1hr, 4°C, on a rocking platform. Beads are 
subsequently washed and dissolved in 2x DTT loading buffer for SDS-PAGE analysis.  
3.2.3.3 Protein production and purification of ATG16L1  
3.2.3.3.1 Protein production and purification of ATG16L1 full length 
Human ATG16L1 was cloned by PCR using cDNA from Open Biosystems (Table 4) as a template. Petra 
Völler manipulated this clone to eliminate internal KpnI site by introducing a silent mutation. 
ATG16L1 was cloned into E. coli and insect cell expression vectors by Petra Völler and tested for 
expression in E. coli. I transformed EMBacY cells, prepared bacmid and transfected Sf-21 insect cells 
for virus production. After P2 test expression and subsequent production of P3 virus, HighFive cells 
are used for protein production. Recombinant virus harboring full length ATG16L1 was not stable and 
thus BIIC stock is generated and used for infection of HighFive cells. 
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Strep-ATG16L1 full length: 
HighFive cells (0.5-0.8x106 cells/ml) (unless otherwise noted) are infected with 5-10% P3 virus or with 
one BIIC aliquot/1L culture and incubated at 27°C, 100 rpm for 72 hr. Cells are harvested 3 days post 
infection in Sorvall RC 6+ centrifuge using F9S-4x1000y PTI rotor at 2000 rpm, 5 min, 4°C. Pellet is 
resuspended in Lysis Buffer (Table 21). Cells are lysed by Bandelin SonoPlus HD200 sonicator and 
pelleted by centrifugation at 60000 rpm, 1 hr, 4°C in 70 Ti rotor (Beckman Coulter). 
The supernatant is incubated with 2-3ml of Strep-Tactin® SuperFlow® High Capacity resin (IBA) 
(unless otherwise noted) equilibrated with Lysis Buffer, for 1 hr, 4°C with gentle stirring. 
Nonspecifically bound proteins are washed by 10 column volumes (CV) of Washing Buffer (Table 21). 
The target protein is eluted with 5x 5ml Elution Buffer (Table 21). 
Affinity Chromatography  
Buffers Composition 
Lysis Buffer 50mM Tris pH 8, 200 mM NaCl, 0.1% Triton X-100, 5mM BME 
and Protease Inhibitor Cocktail tablet (Sigma) 
Wash Buffer 50mM Tris pH 8, 200mM NaCl, 5mM BME 
Elution Buffer 50mM Tris pH 8, 200mM NaCl, 5mM BME, 5mM desthiobiotin  
Table 21: List of buffers used for purification of Strep-tagged ATG16L1 full length 
FLAG-ATG16L1 full length: 
HighFive cells (0.5-0.8x106 cells/ml) are infected with 5-10% P3 virus and incubated at 27°C, 100 rpm 
for 72 hr. Cells are harvested 3 days post infection in Sorvall RC 6+ centrifuge using F9S-4x1000y PTI 
rotor at 2000 rpm, 5 min. Pellet is resuspended in Lysis Buffer (Table 21). Cells are lysed by Bandelin 
SonoPlus HD200 sonicator and pelleted by centrifugation at 60000 rpm, 1 hr, 4°C in 70 Ti rotor 
(Beckman Coulter). 
The supernatant is incubated with 4ml of anti-DYKDDDDK tag (L5) affinity gel (BioLegend) and 
purified according to the manufacturer’s technical bulletin. 
3.2.3.3.2 Protein production and purification of His-tagged ATG16L1 WD-40 
domain constructs 
Construct boundaries for WD-40 propeller domain of ATG16L1 were based on secondary structure 
predication of human ATG16L1 gene by PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred/) and designed by 
Dr. Andrea Scrima. WD-40 constructs were cloned into E. coli and insect cell expression vectors by 
Petra Völler. Petra Völler tested expression in E. coli. I transformed the insect cell constructs into 
EMBaCY cells, prepared bacmid and transfected Sf-21 cells for virus production. After P2 test 
expression and subsequent production of P3 virus, HighFive cells are used for protein production.  
HighFive cells (0.5-0.8x106 cells/ml) are infected with 5-10 % P3 virus and incubated at 27°C, 100 rpm 
for 72 hr. Cells are harvested 3 days post infection in Sorvall RC 6+ centrifuge using F9S-4x1000y PTI 
rotor at 2000 rpm, 5 min. Pellet is resuspended in Lysis Buffer (Table 2.18). Cells are lysed by 
Bandelin SonoPlus HD200 sonicator and pelleted by centrifugation at 60000 rpm, 1 hr, 4°C in 70 Ti 
rotor (Beckman Coulter). The supernatant is incubated with 2-3 ml of Ni Sepharose® 6 Fast Flow (GE 
Healthcare) equilibrated with Lysis Buffer, for 1 hr, 4°C with gentle stirring. Nonspecifically bound 
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proteins were washed by 25 CV of Washing Buffer (Table 22). The target protein was eluted with 20 
ml Elution Buffer (Table 22). 
Affinity Chromatography  
Buffers Composition 
Lysis Buffer 50mM Tris pH 8, 200mM NaCl, 0.1% Triton X-100, 5mM BME 
and Protease Inhibitor Cocktail tablet (Sigma) 
Wash Buffer 50mM Tris pH 8, 200mM NaCl, 5mM BME, 10mM Imidazole 
Elution Buffer 50mM Tris pH 8, 200mM NaCl, 5mM BME, 150mM Imidazole 
Size Exclusion Chromatography  
Running Buffer 20mM HEPES pH7.4, 200mM NaCl, 5mM DTT 
Table 22: List of buffers used for purification of his-tagged ATG16L1 WD-40 domain constructs 
Eluted protein is concentrated (Vivaspin®, 30000 MWCO, GE Healthcare) to ~1ml and applied on 
equilibrated Superdex75 16/60 (GE Healthcare) column connected to Äkta Purifier (GE Healthcare). 
All fractions of affinity and size exclusion chromatography are analyzed on 12% SDS-PAGE. Fractions 
containing pure protein are concentrated to ~20mg/ml, aliquoted, shock-frozen in liquid nitrogen 
and stored at -80°C.  
3.2.3.3.3 Protein production and purification of DDB1 
Human DNA damage-binding protein 1 is cloned and purified as presented in Scrima et al. 2008. His-
tagged DDB1 is expressed from insect cells using standard protocol. Shortly, HighFive cells (0.5-
0.8x106 cells/ml) are infected with 5-10% P3 virus and incubated at 27°C, 100 rpm for 72 hr. Cells are 
harvested 3 days post infection in Sorvall RC 6+ centrifuge using F9S-4x1000y PTI rotor at 2000 rpm, 
5 min. Pellet is resuspended in Lysis Buffer (Table 23). Cells are lysed by Bandelin SonoPlus HD200 
sonicator and pelleted by centrifugation at 60000 rpm, 1 hr, 4°C in 70 Ti rotor (Beckman Coulter). The 
supernatant is incubated with 2-3ml of Ni Sepharose® 6 Fast Flow (GE Healthcare) equilibrated with 
Lysis Buffer, for 1 hr, 4°C with gentle stirring. Nonspecifically bound proteins were washed by 25 CV 
of Washing Buffer (Table 23). The target protein was eluted with 20 ml Elution Buffer (Table 23).  
 Affinity Chromatography  
Buffers Composition 
Lysis Buffer 50mM Tris pH 8, 200mM NaCl, 0.1% Triton X-100, 5mM BME 
and Protease Inhibitor Cocktail tablet (Sigma) 
Wash Buffer 50mM Tris pH 8, 200mM NaCl, 5mM BME, 10mM Imidazole 
Elution Buffer 50mM Tris pH 8, 200mM NaCl, 5mM BME, 100mM Imidazole 
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Ion Exchange Chromatography  
Low Salt Buffer 50 mM Tris pH 8, 5mM DTT 
High Salt Buffer 50 mM Tris pH 8, 1 M NaCl, 5 mM DTT 
Size Exclusion 
Chromatography 
 
Running Buffer 50 mM HEPES pH 7.4, 200 mM NaCl, 5 mM DTT 
Table 23: List of buffers used for purification of His-tagged human DDB1 
Elution fractions containing target protein are diluted with Low Salt Buffer (Table 23) to low salt 
(50mM NaCl) and loaded on Source15Q ion exchange column. After a washing step with 50 CV with 
Low Salt Buffer, protein is eluted with a 200-300mM NaCl gradient over six CV. Fractions of ion 
exchange are tested on 12% SDS PAGE gels and those containing target protein are concentrated 
(Vivaspin®, 100000 MWCO, GE Healthcare) to 1ml and loaded on equilibrated Superdex 200 16/60 
connected to Äkta Purifier (GE Healthcare) as a final purification step. Purified DDB1 is concentrated 
to 3mg/ml, aliquoted, shock frozen in liquid nitrogen and stored at -80°C for interaction studies.  
3.2.3.3.4 Protein production and purification of NOD2 CARD domains 
Caspase recruitment domains (CARDs) of NOD2 are cloned in Step-tagged pCOLADuet and GST-
tagged pGEX-derived vector and tested in E. coli for optimal expression condition. Strep-tagged 
protein showed highest yield when expressed in TB buffer at 20°C, 500µM IPTG for 3 hr. After 3 hr, 
cells are harvested in Sorvall RC 6+ centrifuge using F9S-4x1000y PTI rotor at 5000 rpm, 10 min. Pellet 
is resuspended in Lysis Buffer (Table 24) and the suspension was passed through a homogenizer 
(Avestin EmulsiFlex-C3) twice. The lysate was cleared by centrifugation at 16000 rpm, 45 min, 4°C. 
The supernatant is incubated with 5ml of Strep-Tactin® Macroprep resin equilibrated with Lysis 
Buffer, for 1 hr, 4°C with gentle stirring. Nonspecifically bound proteins are washed by 10 CV of 
Washing Buffer (Table 24). The target protein was eluted with 6x 5ml Elution Buffer (Table 24). 
Affinity Chromatography  
Buffers Composition 
Lysis Buffer 50mM HEPES pH 7.4, 300mM NaCl, 5% Glycerol, 5mM 
BME, Protease Inhibitor Cocktail tablet (Sigma) 
Wash Buffer 50mM HEPES pH 7.4, 300mM NaCl, 5% Glycerol, 5mM BME 
Elution Buffer 50mM HEPES pH 7.4, 300mM NaCl, 5% Glycerol, 5mM 
BME, 5mM desthiobiotin  
Size Exclusion Chromatography  
Running Buffer 10mM HEPES pH 7.4, 100mM NaCl, 5mM DTT 
Table 24: List of buffers used for purification of Strep-tagged NOD2 CARDs 
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Eluted protein is concentrated (VivaspinTM, 3000 MWCO, GE Healthcare) to ~1ml and applied on 
equilibrated Superdex75 16/60 (GE Healthcare) column connected to Äkta Purifier (GE Healthcare). 
All fractions of affinity and size exclusion chromatography were analyzed on 15% SDS-PAGE. 
Fractions containing pure protein are concentrated, aliquoted, and shock-frozen in liquid nitrogen 
and stored at -80°C. 
3.2.3.3.5 Protein production and purification of TMEM59 cytosolic domain 
TMEM59 T263-E281 peptide is cloned into pGEX vector. In addition, full cytosolic domain (T263-323) 
was cloned into an N-terminal GST pGEX vector, as well as in a C-terminal GST pET15b derived vector. 
All constructs were tested in E. coli for optimal conditions for protein expression and the highest 
yield for all of them was observed when expressed in TB media for 3 hr, 37°C, 500 µM IPTG. After 3 
hr of expression, cells from 4 L TB culture are harvested in Sorvall RC 6+ centrifuge using F9S-4x1000y 
PTI rotor at 5000 rpm, 10 min. Pellet is resuspended in Lysis Buffer (Table 25) and the suspension was 
sonicated for 30 min, 1 sec pulse, 4 sec pause. The lysate was cleared by centrifugation at 16000 rpm, 
45 min, 4°C. 
Affinity Chromatography  
Buffers Composition 
Lysis Buffer 1xPBS, 5mM BME, Protease Inhibitor Cocktail tablet 
(Sigma) 
Wash Buffer 1x PBS, 5mM BME 
Elution Buffer 1x PBS, 5mM BME, 20mM L-glutathione reduced 
Size Exclusion Chromatography  
Running Buffer 1x PBS, 5mM DTT 
Table 25: List of buffers used for purification of GST-TMEM59 
The supernatant is incubated with 5ml of Glutathione Sepharose® 4 Fast Flow (GE Healthcare) 
equilibrated with Lysis Buffer, for 1 hr, 4°C with gentle stirring. Nonspecifically bound proteins are 
washed by 10 CV of Washing Buffer (Table 25). The target protein is eluted with 20 ml Elution Buffer 
(Table 25). Eluted protein is concentrated (VivaspinTM, 3000 MWCO, GE Healthcare) to ~1ml and 
applied on equilibrated Superdex75 16/60 (GE Healthcare) column connected to Äkta Purifier (GE 
Healthcare). All fractions of affinity and size exclusion chromatography are analyzed on 15% SDS-
PAGE. Fractions containing pure protein are concentrated, aliquoted, shock-frozen in liquid nitrogen 
and stored at -80°C. 
3.2.3.3.6 Protein production and purification of TLR2 TIR domain 
Toll/interleukin receptor (TIR) domain of TLR2 is cloned in pET15b derived vector with His tag. His-
tagged TIR TLR2 protein resulted highest yield when expressed at 37°C, 3 hr, 50 µM IPTG in LB buffer. 
After 3 hr of expression, cells are harvested in Sorvall RC 6+ centrifuge using F9S-4x1000y PTI rotor at 
5000 rpm, 10 min. Pellet is resuspended in Lysis Buffer (Table 26) and the suspension is passed 
through a homogenizer (Avestin EmulsiFlex-C3) twice. The lysate is cleared by centrifugation at 
16000 rpm, 45 min, 4°C. 
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Affinity Chromatography  
Buffers Composition 
Lysis Buffer 20mM MOPS pH 7, 200mM NaCl, 5% Glycerol, 5mM BME, 
Protease Inhibitor Cocktail tablet (Sigma), DNase, 
lysozyme, 0.5mM MgSO4 
Wash Buffer 20mM MOPS pH 7, 200mM NaCl, 5% Glycerol, 5mM BME 
Elution Buffer 20mM MOPS pH 7, 200mM NaCl, 5% Glycerol, 150mM 
Imidazole, 5mM BME 
Size Exclusion Chromatography  
Running Buffer 20mM MOPS pH 7, 200mM NaCl, 5mM DTT 
Table 26: List of buffers used for purification of His-TIR-TLR2 
The supernatant is incubated with 2-3ml of Ni Sepharose® 6 Fast Flow (GE Healthcare) equilibrated 
with Lysis Buffer, for 1 hr, 4°C with gentle stirring. Nonspecifically bound proteins are washed by 25 
CV of Washing Buffer (Table 26). The target protein is eluted with 20 ml Elution Buffer (Table 26). 
Eluted protein is concentrated (Vivaspin™, 3000 MWCO, GE Healthcare) to ~1ml and applied on 
equilibrated Superdex75 16/60 (GE Healthcare) column connected to Äkta Purifier (GE Healthcare). 
All fractions of affinity and size exclusion chromatography are analyzed on 15% SDS-PAGE. Fractions 
containing pure protein are concentrated, aliquoted, shock-frozen in liquid nitrogen and stored at -
80°C. 
3.2.3.3.7 Protein production and purification of NOD1 CARD domain 
Domain boundaries for CARD domain of NOD1 were previously published (Srimathi, Robbins, Dubas, 
Seo, & Park, 2007) and cloned in pET15b derived vector with C-terminal His tag. Based on test 
expressions in E. coli, 3 hr expression in LB media at 37°C and 500 µM IPTG was the best condition. 
After 3 hr of expression at 37°C, cells are harvested in Sorvall RC 6+ centrifuge using F9S-4x1000y PTI 
rotor at 5000 rpm, 10 min. Pellet is resuspended in Lysis Buffer (Table 27) and the suspension is 
passed through a homogenizer (Avestin EmulsiFlex-C3) twice. The lysate is cleared by centrifugation 
at 16000 rpm, 45 min, 4°C. 
Affinity Chromatography  
Buffers Composition 
Lysis Buffer 50mM HEPES pH 7.4, 300mM NaCl, 5% Glycerol, 5mM 
BME, Protease Inhibitor Cocktail tablet (Sigma), DNase, 
lysozyme, 0.5mM MgSO4 
Wash Buffer 50mM HEPES pH 7.4, 300mM NaCl, 5% Glycerol, 5mM 
BME, 20mM Imidazole 
Elution Buffer 50mM HEPES pH 7.4, 300mM NaCl, 5% Glycerol, 5mM 
BME, 300mM Imidazole 
Size Exclusion Chromatography  
Running Buffer 10mM HEPES pH 7.4, 100mM NaCl, 5mM DTT 
Table 27: List of buffers used for purification of His-NOD1 CARD 
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The supernatant is incubated with 2-3ml of Ni Sepharose® 6 Fast Flow (GE Healthcare) equilibrated 
with Lysis Buffer, for 1 hr, 4°C with gentle stirring. Nonspecifically bound proteins are washed by 25 
CV of Washing Buffer (Table 27). The target protein is eluted with 2x 20ml Elution Buffer (Table 27). 
Eluted protein is concentrated (Vivaspin™, 3000 MWCO, GE Healthcare) to ~1ml and applied on 
equilibrated Superdex75 16/60 (GE Healthcare) column connected to Äkta Purifier (GE Healthcare). 
All fractions of affinity and size exclusion chromatography are analyzed on 15% SDS-PAGE. Fractions 
containing pure protein are concentrated, aliquoted, and shock-frozen in liquid nitrogen and stored 
at -80°C. 
3.2.4 Biochemical methods 
3.2.4.1 SDS polyacrylamide gel electrophoresis (SDS PAGE) 
SDS PAGE gels are used for quality control of purification protocols and for analysis of pull-down 
assays. The gels are composed of two parts: the upper stacking gel (5% acrylamide) and the lower 
resolving gel (12% or 15% acrylamide). The protocol is adapted from Laemmli (Laemmli 1970). 
Typically, samples are mixed with 2x DTT loading buffer, boiled at 95°C and ~10µl is loaded on the 
gel. SDS PAGE gels are run at constant current of 200V until the blue front reached the bottom of the 
gel. Following electrophoresis, gel is stained by boiling in SDS staining solution for 1-2 min in the 
microwave at maximum power, and destained by boiling in water for 5 min. Composition of buffers 
and solutions is listed in Section 3.1.11.3. 
3.2.4.2 Western blot 
For Western blotting, SDS PAGE gels are transferred onto a PVDF transfer membrane (Millipore) 
using a semi-dry blotting system (Trans-Bio® Turbo™ Transfer System) with Transfer Buffer. 
Membranes are incubated in the Blocking Buffer for 1 hr or overnight prior to 1 hr incubation with a 
primary antibody, and 1 hr incubation with secondary antibody. Membranes are developed with ECL 
reagent for HRP conjugated secondary antibodies or with BCIP (bromochloroindolyl phosphate) and 
NBT (nitro blue tetrazolium) for AP conjugated secondary antibodies. Electrogenerated 
chemiluminescence is visualized using Image Reader LAS 3000. Composition of buffers and solutions 
is listed in Section 3.1.11.3. 
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3.2.4.3 ThermoFluor assay 
ThermoFlour assay allows screening the effects of different buffer conditions on stability of a protein (Ericsson et al. 2006; Cummings et al. 2006). Main benefit 
of ThermoFlour assay is determination of an optimal buffer in which a certain protein is stable. Prior to buffer test, protein and Sypro Orange dye (Sigma) 
concentrations are optimized. The best combination is added to desired buffers (Table 28) in a 96 wells plate (Multiplate 96-Well Unskirted PCR plate, BioRad), 
sealed and measured in a CFX96 Real-Time Thermal Cycler C1000 (BioRad). Data is analyzed using Bio-Rad CFX Manager software. 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 
50mM 
Acetate 
pH4.0 
50mM 
Acetate 
pH4.4 
50mM 
Citrate 
pH5.0 
50mM 
Citrate 
pH5.4 
50mM 
MES 
pH6.0 
50mM 
MES 
pH6.4 
50mM 
HEPES 
pH7.0 
50mM 
HEPES 
pH7.4 
50mM 
Tris-HCl 
pH8.0 
50mM 
Tris-HCl 
pH8.4 
50mM 
CHES 
pH9.0 
50mM 
CHES 
pH9.4 
B 
50mM 
Acetate 
pH4.0 
100mM 
NaCl 
50mM 
Acetate 
pH4.4 
100mM 
NaCl 
50mM 
Citrate 
pH5.0 
100mM 
NaCl 
50mM 
Citrate 
pH5.4 
100mM 
NaCl 
50mM 
MES 
pH6.0 
100mM 
NaCl 
50mM 
MES 
pH6.4 
100mM 
NaCl 
50mM 
HEPES 
pH7.0 
100mM 
NaCl 
50mM 
HEPES 
pH7.4 
100mM 
NaCl 
50mM 
Tris-HCl 
pH8.0 
100mM 
NaCl 
50mM 
Tris-HCl 
pH8.4 
100mM 
NaCl 
50mM 
CHES 
pH9.0 
100mM 
NaCl 
50mM 
CHES 
pH9.4 
100mM 
NaCl 
C 
50mM 
Acetate 
pH4.0 
200mM 
NaCl 
50mM 
Acetate 
pH4.4 
200mM 
NaCl 
50mM 
Citrate 
pH5.0 
200mM 
NaCl 
50mM 
Citrate 
pH5.4 
200mM 
NaCl 
50mM 
MES 
pH6.0 
200mM 
NaCl 
50mM 
MES 
pH6.4 
200mM 
NaCl 
50mM 
HEPES 
pH7.0 
200mM 
NaCl 
50mM 
HEPES 
pH7.4 
200mM 
NaCl 
50mM 
Tris-HCl 
pH8.0 
200mM 
NaCl 
50mM 
Tris-HCl 
pH8.4 
200mM 
NaCl 
50mM 
CHES 
pH9.0 
200mM 
NaCl 
50mM 
CHES 
pH9.4 
200mM 
NaCl 
D 
50mM 
Acetate 
pH4.0 
500mM 
NaCl 
50mM 
Acetate 
pH4.4 
500mM 
NaCl 
50mM 
Citrate 
pH5.0 
500mM 
NaCl 
50mM 
Citrate 
pH5.4 
500mM 
NaCl 
50mM 
MES 
pH6.0 
500mM 
NaCl 
50mM 
MES 
pH6.4 
500mM 
NaCl 
50mM 
HEPES 
pH7.0 
500mM 
NaCl 
50mM 
HEPES 
pH7.4 
500mM 
NaCl 
50mM 
Tris-HCl 
pH8.0 
500mM 
NaCl 
50mM 
Tris-HCl 
pH8.4 
500mM 
NaCl 
50mM 
CHES 
pH9.0 
500mM 
NaCl 
50mM 
CHES 
pH9.4 
500mM 
NaCl 
Table 28: ThermoFlour Screen with buffers: salt concentration increases along the column, pH value increases along the row.  
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3.2.4.4 Circular dichroism spectroscopy 
Circular dichroism (CD) spectroscopy is used to analyze overall secondary composition of protein. CD 
is based on differential absorption of left and right circularly polarized light by chiral molecules. 
Proteins composing of β-sheets or α-helices lead to different CD spectrum due to the different angles 
in the peptide bonds. Proteins structured into β-sheets will show a typical minimum at 218nm in the 
CD spectrum, while α-helical proteins show two minima, at 208 and 222nm. Based on this, CD 
spectroscopy can analyze secondary structure composition of proteins. Before the measurement, 
protein is dialyzed in a CD buffer (Section 3.1.11.3), which is also used for baseline correction. 
Samples are filled into Quartz cells (Hellma Analytics) with 1 mm path length. Spectra are recorded in 
the range of 190nm to 250nm at 25°C with a J-810 CD spectrometer (Jasco). 
3.2.4.5 Dynamic light scattering  
Dynamic light scattering (DLS) is used to determine size distribution profile of protein in solution. 
Sample preparation is done the same as for CD spectroscopy. The sample is additionally filtered 
through 0.2µm filter and filled into a dust-free DLS cuvette (Eppendorf). DLS measurements are 
carried out on Wyatt DynaPro temperature-controlled microsampler (Wyatt Technology 
Corporation), at 25°C. Measurement and analysis is done using DYNAMICS V6 software (Wyatt 
Technology Corporation).  
3.2.4.6 MicroScale Thermophoresis (MST) 
Macromolecules, such as proteins, migrate along a temperature gradient. Microscale thermophoresis 
(MST) takes advantage of this fact to study bimolecular interaction by monitoring changes in 
hydration shell, charge and size. The experimental procedure is according to the protocol from 
NanoTemper. Analysis is performed on Monolith NT.115. WD40-ATG16L1 protein is purified from 
insect cells and labelled according to the NanoTemper instructions. Dye used in NanoTemper kit 
binds to primary amino groups on solvent exposed lysines, with typically one lysine/protein being 
labeled. In this way labeling is random and, considering the average of solvent exposed lysines in a 
protein, the chance of dye interfering with binding is low. The concentration of the label protein is 
kept constant while the concentration of interaction partners varies. The signal is recorded for each 
condition. Any change in thermophoretic property is observed as a change in fluorescence intensity. 
Data is analyzed using MST software from NanoTemper.  
3.2.5 Protein crystallization  
3.2.5.1 Screening 
Initial screening of crystallization conditions is done in 96-well sitting drop vapor diffusion Intelli® 93-
3 LVR plates (Art Robbins Instruments, Hampton Research). Purified protein is concentrated and 
0.2µl of protein, typically in the range from 5-10 mg/ml, was added to 0.2µl of reservoir solution. 
Volume of the reservoir is 800µl. Honeybee 961 crystallization robot (Zinsser Analytics) is used to 
dispense protein and reservoirs from commercially available screens (Table 15). Plates are covered 
with clear sealing tape to prevent evaporation and stored at 20°C or 4°C in an automated imaging 
robot from Formulatrix.  
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3.2.5.2 Refinement of initial crystals 
Initial crystals were tested for diffraction at the home source (Table 29). 
X ray home source MX007 (Generator) 
RA-Micro 7 HFM (Anode) 
VariMax HF (Optics) 
Rigaku 
 Cryostream 700  Oxford Cryosystems 
Table 29: In-house X-ray source used for initial testing of protein crystals 
Initial protein crystals are reproduced and crystallization conditions are optimized using three 
strategies. Firstly, optimization is done by designing a grid and random screen around the initial 
condition using Formulatrix. In this way, pH and precipitant concentration are varied. In addition to 
incubation at 20°C and 4°C, plates are incubated at 30°C as well. Secondly, crystal growth promoting 
additives are tested using the Additive Screen (Hampton Research) as well as Silver Bullet Screen 
(Hampton Research). Seeding is used as a third method. Seeding is a useful method for obtaining 
higher quality crystals or new crystal forms. For seeding, initial crystals are crushed and used as seed 
stock. Seed stock is added to the drop containing protein and reservoir solution by OryxNano 
(Douglas Instruments Ltd). Plates are covered with clear sealing tape to prevent evaporation and 
stored at 20°C or 4°C in an automated imaging robot from Formulatrix.  
3.2.5.3 Cryoprotection and flash cooling of protein crystals 
When a protein crystal is exposed to X-rays, X-rays interact with electrons in the protein and 
introduce free radicals, especially when high energy synchrotron radiation is used. Freezing of 
crystals in liquid nitrogen and cooling them in the liquid nitrogen stream during exposure to X-rays 
reduces the free radical diffusion and minimizes crystal damage during data collection. However, 
most of damage is caused by not by protein but by water radicals which can diffuse and destroy 
protein crystal lattice. Additionally, freezing of aqueous solution leads to formation of crystalline ice, 
which may also damage the protein crystal due to expansion of the ice formation in the solvent s. 
Presence of crystalline ice also reduce the quality of data collection due to its inherent diffraction, 
which masks the diffraction from the protein crystals. Addition of a cryoprotectant, a substance used 
to form vitrous, amorphous ice during freezing, minimizes damage to the protein crystal, reduces 
diffusion of free radicals in the crystal during measurement and loss of diffraction due to radiation 
damage. To preserve the crystal form, high enough concentration of cryoprotectant is added to the 
original crystallization solution to obtain vitreous, amorphous ice. For flash cooling, crystals are 
rinsed in a fresh drop of mother liquor and then in the drop of cryo solution before being shock 
frozen in liquid nitrogen. 
In this work, (2-R, 3-R)-butane-2,3-diol (Sigma) was successfully used as a cryoprotecting additive 
with a final concentration of 10 % (v/v). 
3.2.5.4 Structure determination by X-ray crystallography 
When exposed to an X-ray beam, a protein crystal diffracts a small percentage of X-rays in a certain 
direction and with certain intensities. Since X-rays are also waves, phase information is lost (and 
must be derived) due to physical detection of the diffracted photons. Thus, only intensity of the 
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diffracted X-rays is recorded during the diffraction experiment whereas the phase information is lost, 
which is referred to as the phase problem. X-ray diffraction can be represented as reflection of X-rays 
on planes, as illustrated by Bragg’s law (Figure 12).  
 
Figure 12: Graphical representation of Bragg’s law. S is a scattering vector, given by the difference between 
incoming wave s0 and scattered wave s1. The second diagram has S pointing straight up. This depicts the 
graphical representation of Bragg’s law and allows visualization of scattering waves as reflection on a set of 
imaginary parallel planes in a crystal. The distance between two planes is d. Scattering angle ϴ is related to d 
and the path difference between (purple arrows) is 2d sinϴ. This difference must equal to nλ for constructive 
interference. (adapted from “Biomolecular Crystallography” Rupp 2010) 
Bragg’s law assumes that X-rays are reflected from of sets of (imaginary) Miller planes which are 
evenly distributed throughout the crystal. Reflected waves result in diffraction only when the 
condition of constructive interference is satisfied. This condition is referred to as Bragg’s law and is 
represented by the following equation:  
)sin(2 θλ dn =
 
Where λ is the wavelength of incident wave, d is the spacing between the planes in the atomic 
lattice, and θ is the angle between the incident ray and the scattering planes.  
 
Figure 13: Geometrical construction of Ewald sphere. Bragg’s diffraction condition can be visualized by 
Ewald sphere. The scattering vector S0 is equal to 1/λ, which is the radius of the Ewald sphere. When the 
reciprocal lattice (green dots) is superimposed onto Ewald sphere, any point that crosses the Ewald sphere 
(red dots) will result in a reflection on the detector. (adapted from “Biomolecular Crystallography”, (Rupp 
2010)) 
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Conditions of positive interference resulting in diffraction can be represented by the Ewald sphere. 
Ewald sphere (Figure 13) is constructed with a radius of 1/λ around the X-ray beam. Green dots 
represent a reciprocal lattice, which is a set of imaginary points separated by a reciprocal vector. 
Reciprocal vector is easily generated based on two properties that define it: it is normal to Miller 
planes and the length of the vector is reciprocal to real space inter planar distance d. Any reciprocal 
lattice point that lies on the Ewald sphere will fulfill Bragg’s diffraction condition and result in a 
reflection. Rotation of the crystal rotates the reciprocal lattice and brings other reciprocal lattice 
points to intersect with the Ewald sphere. Crystal rotation during data collection ensures higher 
completeness of the data set. A data set consists of intensities (amplitudes) of all recorded 
reflections. 
X-ray diffraction data is collected at 100K at BESSY II synchrotron radiation source (Helmholtz 
Zentrum Berlin, Berlin, Germany). Data are processed with XDS software package (Kabsch 2010).  
3.2.5.5 Experimental phasing and molecular replacement 
Reflections that are recorded on the detector provide intensities (amplitudes) of complex structure 
factors Fhkl. This is necessary, but not sufficient for calculation of electron density and subsequent 
structure determination. Phase information is lost during physical measurement and has to be 
supplied from an external source to reconstruct the actual molecular structure from diffraction data.  
As the phase angle cannot directly be determined, several indirect methods have been developed to 
overcome the phase problem. These methods include single/multiple isomorphous replacement 
(SIR/MIR), single/multiple wavelength anomalous dispersion (SAD/MAD) and molecular replacement 
(MR). 
3.2.5.5.1 Experimental phasing 
With no prior structural knowledge (ex. homologous structures) about the protein, SIR/MIR and 
SAD/MAD techniques are used for structure determination. For SIR/MIR, a heavy atom is introduced 
into the crystal (by soaking or co-crystallization). Heavy atoms provide the source of electronic 
differences in protein crystals. In order for SIR/MIR to be successful, the heavy atom must not alter 
the structure of protein molecules in the crystal, so the only difference between native and 
isomorphous (derivative) data set is the presence of the heavy atom. Depending how many 
derivatives (heavy atoms) are used, the method is referred to as single isomorphous replacement 
(SIR) or multiple isomorphous replacement (MIR). 
Most heavy atoms, as well as other elements, are a source of anomalous signal. Due to the presence 
of anomalous signal at a certain wavelength (absorption edge of the element incorporated in the 
crystal), Friedel’s law (F(h,k,l) = F(-h;-k,-l)) is not strictly true, which means the centrosymmetric reciprocal 
lattice points are no longer the same. This difference in intensity between two Friedel’s mates is 
referred to as anomalous dispersion. By collecting data sets at different wavelengths (at the point of 
inflection, at the peak and at a high- and low- energy remote points) protein phases can be uniquely 
determined. In case of single wavelength anomalous dispersion (SAD) experiment, only peak data set 
is collected, where the anomalous difference is the largest. In case of crystal decay, the phases can 
still be calculated from the strong anomalous difference. For multiple wavelength anomalous 
dispersion (MAD) experiment, in addition to the data set at the peak wavelength, data is collected at 
the additional choices of wavelengths, in the following order: at the inflection, at low- and at high- 
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energy. The main advantage of SAD/MAD method over SIR/MIR is, that in the case of SAD/MAD a 
single crystal is often enough to solve the structure.  
3.2.5.5.2 Molecular replacement  
In molecular replacement approach, initial phases are obtained from structurally similar models. 
Generally, a known structural model should have a sequence identity of ~30 % with the protein in 
question. Structures of suitable models are normally found via homology searches. The main 
challenge is to position the known model (search probe) in the unit cell (or asymmetric unit) of the 
target protein crystal. Intuitively, the search probe can be placed in the asymmetric unit and three 
positional coordinates and three angles at each grid point are varied until the match is found. This is 
computationally demanding and can be broken down into two 3-dimensional searches: rotational 
search determines the correct orientation of the search probe, followed by translational search 
which narrows down its exact position in the unit cell. Once the correct positon is determined, the 
Fourier synthesis of the molecule provides calculated phases and calculated intensities of the search 
model.  
Fourier transform, a reciprocal transform of periodic functions between two domains, is used to 
calculate electron density of the real space structure from experimentally obtained complex 
structure factors Fhkl. Electron density equation 
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demonstrates that electron density (ρ) is a Fourier summation (synthesis) with all complex structure 
factor amplitudes and the phases (αhkl) over the entire reciprocal space (
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 is volume of the reciprocal 
lattice). This allows quick transform from real to reciprocal space, and the other way around.  
The calculated phases derived from the molecular replacement model are combined with measured 
intensities from the target protein crystal and used in Fourier transform, resulting in interpretable 
electron density map.  
3.2.5.6 Model building and refinement 
After initial phase information has been obtained by molecular replacement, the model of the 
protein can be built. Since initial phases still contain some errors, they have to be improved and 
refined. This is a reiterative process: improved phases lead to an improved map, with more details, 
resulting in a more detailed and complete model, which is then used to calculate new phases and 
leads to an even better map. During this process, two key factors to observe are observed: Rwork and 
Rfree. The first value, Rwork is a measure of the quality of fit of the built model and the experimental 
diffraction data. During refinement, the value of Rwork should improve and eventually reach 15-25%, 
depending on the quality of the data. The greatest danger with Rwork is overfitting. Overfitting is 
loosely defined as building in arbitrary atoms or allowing chemically unfavorable position to reduce 
Rwork and have a better fit. The second R value, Rfree is introduced to avoid this problem. Rfree 
compares the small subset of the data (usually 5-10 %) not included in Rwork calculation and is thus 
independent. The Rfree is always a few percent higher than the Rwork.  
In addition to R factors, average B value, or temperature factor, indicates precision of the atom 
positions. Disorder of the crystal, or flexibility of the side chain can lead to uncertainty in the exact 
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atomic position. This uncertainty is represented with high B factors. However, since exact position of 
atoms cannot be directly observed, B factors are a result of fitting of a model to the diffraction data. 
Thus, B factors are partially dependent on the model used for phase calculation and refinement 
process and cannot be used as an absolute value in direct comparison between different structures.  
The structural model of ATG16L1_G303_E354AK355A_P607Y was built using COOT (Emsley and 
Cowtan 2004) and refinement was done in Phenix (Adams et al. 2010). 
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4 Results 
4.1 Characterization and structure determination of C-terminal domain of 
ATG16L1 
4.1.1 Generation of constructs for crystallization 
A main goal of this project was structure determination of the C-terminal domain of human ATG16L1 
by X-ray diffraction analysis of protein crystals. Structural studies of any protein can be roughly 
divided into 8 main stages: bioinformatic analysis and construct design, cloning, searching for 
expression conditions, large scale purification, crystal growth, crystal diffraction, data collection and 
processing and finally structure determination and model building. Growing crystals of a desired 
protein is a crucial step in this process and all the efforts are made to make protein crystal packing 
possible. However, crystallizing a protein is a highly empirical process whose success cannot be 
predicted or guaranteed. Few of many possible obstacles on the gene to structure endeavor will be 
addressed in the following text. 
4.1.1.1 Human ATG16L1 
4.1.1.1.1 Bioinformatic analysis 
Each crystallographic study starts with gathering of information about the gene, the protein it 
encodes, and what can be assumed about it, based on related proteins or folds. Ineluctable 
requirement for any macromolecular structure determination is primary sequence of the protein. 
UniProt (http//www.uniprot.org) is a reliable database with information about protein sequences 
and annotated data. In UniProt, human ATG16L1 is classified under identifier Q676U5.  
The primary peptide sequence is used to calculate secondary structures of proteins based on amino 
acid sequence composition, taking into account homology models and proteins with similar domains 
or folds. PSIPRED v3.3 (UCL Department of Computer Science, Bioinformatics Group, 
http://bioinf.cs.ucl.ac.uk/psipred/) derives its prediction from PSI-BLAST and provides an output file 
which can be used as a guideline for construct design. PSIPRED analysis of human ATG16L1 is shown 
in Figure 14. Based on the prediction, structured, mainly helical N-terminal region of human ATG16L1 
ends by residue 230, followed by a random coil region (230-284). First predicted β-strand starts at 
position 284, and the rest of the protein (284-607) is structured in regularly distributed β-strands.  
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Figure 14: The secondary structure annotation of the human full length ATG16L1 amino acid sequence by 
PSIPRED v3.3 Pink cylinders indicate α-helices, flat black lines indicate coil, and yellow arrows represent β-
strands.  
For prediction of tertiary structure based on amino acid sequence, Phyre2 
(http://www.sbg.bio.ic.ac.uk/phyre2) compares the submitted sequence with similar proteins with 
known structures and predicts three dimensional fold of the protein. The result from Phyre2 of C-
terminal domain of human ATG16L1 is shown in Figure 15: Phyre2 model of C-terminal domain of 
human ATG16L1. Based on the Phyre2 prediction, C-terminal domain of human ATG16L1 folds into a 
WD40 propeller domain, with high confidence.  
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Figure 15: Phyre2 model of C-terminal domain of human ATG16L1 
4.1.1.1.2 Construct design 
Since protein crystallization is a rather empirical process and small changes on protein level can have 
profound impact on protein solubility and crystallization, identifying a suitable construct requires 
parallel screening of multiple protein constructs. Protein construct can be modified either on DNA or 
on protein level. First major bottleneck of crystallography is engineering of a DNA construct encoding 
a soluble domain. Construct design consists of manipulating protein on nucleic acid level to yield 
soluble, compact and stable protein prone to crystal packing. Since many details can be modified on 
a DNA level, it is more economical and practical to design and test multiple constructs in parallel at 
the beginning of the project, including orthologous proteins (discussed later), in hopes that one of 
them will yield a soluble protein that will self-assemble into diffracting crystals. 
Naturally, a structure of a full length human ATG16L1 (M1-Y607) would provide the greatest deal of 
information about the protein. However, due to its size and multiple domain architecture, it might be 
difficult to express, purify and crystallize it. As a rule of thumb, single, compact domains are 
considered to be soluble, to able to fold independently and more likely to arrange themselves in a 
way that enables formation of the few weak crystal contacts. Thus, crystallographic studies of the C-
terminal domain of human ATG16L1 was defined as a main aim of this project. PSIPRED prediction of 
secondary structure elements suggest the start of the first β-sheet of C-terminal domain of human 
ATG16L1 is at position G284, which was previously chosen as the start for one of the constructs. 
Prediction servers are based on sequence similarities between query and already known structures 
and must be taken with some reservations. The first predicted β-sheet of the C-terminal domain of 
human ATG16L1 could thus be a statistical artifact or not part of the C-terminal domain. Based on 
chemical and physical properties of amino acids following R290, the predicted end of the first β-
sheet, G303 was chosen as another construct boundary previously designed in our lab 
Since Phyre2 predicted the C-terminal domain to fold into WD-40 domain. These domains often have 
additional adjacent secondary functionally important structural elements (or entire domains). In the 
case of DDB2, a WD-40 domain involved in UV DNA damage recognition, a helix-loop-helix motif 
positioned N-terminally to the WD-40 domain is important for its interaction with DDB1 (Scrima et 
al., 2008). With this in mind, K266 was chosen as a start of another C-terminal ATG16L1 construct, in 
order not to omit potentially functional elements.  
Figure 16 shows a graphical representation of the constructs of human ATG16L1 used in this study. 
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Figure 16: Construct boundaries of C-terminal domain of human ATG16L1 based on bioinformatics 
predictions 
4.1.1.2 Mouse ATG16L1 
As previously mentioned, protein’s tendencies towards crystal formation cannot be predicted. Often, 
small adjustments on the amino acid sequence level can prove beneficial and tilt the balance towards 
crystal assembly. Apart from designing different constructs of the same protein, orthologues of 
target protein might be more likely to crystalize. Orthologues often retain the same function, thus 
ensuring conservation of functionally important, core residues, while variation between orthologues 
comes from differences in non-essential, surface-exposed residues. Thus, structural biologists often 
take advantage of construct engineering performed by nature by testing orthologues of the target 
protein.  
 
Figure 17: Amino acid sequence alignment between human ATG16L1 (hsATG16L1, UniProt ID Q676U5) and 
mouse ATG16L1 (mmATG16L1, UniProt ID Q8C0J2) by Clustal Omega.  
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Closely related species are likely to display very similar sequences between orthologues. Mouse (Mus 
Musculus) ATG16L1 is highly similar to human ATG16L1 (94 % protein sequence identity and 96 % 
protein sequence similarity) as shown by amino acid sequence alignment by Clustal Omega 
(http://www.ebi.ac.uk/Tools/msa/clustalo/) (Figure 17).  
Based on secondary structure prediction of mouse ATG16L1 (Figure 18), overall architecture is very 
similar to human ATG16L1. N-terminal, mostly α-helical part is predicted to be until position 288, 
followed by largely random coil region (288-314). 
 
Figure 18: PSIPRED v3.3 output of mouse full length ATG16L1 amino acid sequence 
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In the case of mouse ATG16L1, the first putative N-terminal β-strand of the WD-40 domain starts at 
position 315 with serine. A short valine-proline patch upstream in the sequence seems like a site with 
least potential for disturbing the overall fold. Thus, proline 311 was chosen as the start of one of the 
C-terminal construct for mouse ATG16L1. Following the same logic as in designing human ATG16L1 
construct, mouse construct starting at A320 skips the first β-strand, which is predicted to be short 
and with lower confidence than the rest of the domain, and construct starting at P271 might include 
a functionally important preceding sequence motif.  
 
Figure 19: Construct boundaries of C-terminal domain of mouse ATG16L1 based on bioinformatics 
predictions 
All mouse ATG16L1 constructs (Figure 19) are cloned directly into pFastbacDual vector with Strep and 
His tags, for virus production and expression in insect cells.  
4.1.2 Expression and purification of human ATG16L1 constructs 
Most proteins used for crystallization studies are recombinantly overexpressed from heterologous 
hosts. Many different expression systems are available, each with its advantages and disadvantages. 
Two most commonly used, which were also used in this work, are Escherichia coli (E. coli) and insect 
cells. E. coli is the most prevalent bacterial expression system. Due to a wide range of cloning and 
expression tools, E. coli provide a very versatile expression platform. Small scale test expression of all 
the constructs of human ATG16L1 was previously screened in E. coli but did not yield soluble protein 
production for any of the ATG16L1 constructs. 
The second most common expression platform for proteins is a eukaryotic system based on insect 
cells and baculoviruses. Baculoviruses infect insect cells and viral genome has been manipulated to 
enable large scale recombinant protein production. In the baculovirus expression vector system 
(BEVS), naturally occurring polyhedron gene, produced during very late stage of viral replication, is 
under control of a very strong promoter. For in vitro protein production, polyhedrin gene is replaced 
with DNA coding for the recombinant protein of interest by homologous recombination. Virus is 
produced and amplified in Sf-21 cells. At P2 stage, Sf-21 cells are tested for protein production. If 
protein is soluble and over-expressed, P3 virus is used for large scale protein production from High 
Five cells. More than three passages of the virus are not recommended, due to high mutation rate of 
their genomes and their selection for infectious viruses, which do not necessarily encode the gene of 
interest. Apart from higher cost and longer time needed for protein production, variability between 
different batches is high, due to both virus and insect cells. Amount of virus used for protein 
production and harvest time has to be optimized for each virus, since protein expression depends on 
culture and infection conditions. Viral titer varies with each production cycle, and cell culture passage 
number and rate of division play an important role in the infection process. Additionally, stability of 
the virus is different depending on the gene of interest it encodes. The reason for this is not well 
understood and stability of the virus cannot be predicted but has to be experimentally tested. Some 
viruses which can be stored in the media with 5% FCS at 4°C with no detectable reduction in quality 
of protein production. Such are the viruses carrying the gene for C-terminal domain of human 
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ATG16L1. On the other hand, viruses used for expression of full length human ATG16L1 must be used 
up within days of production. To circumvent this problem, BIIC (baculovirus infected insect cells) with 
virus coding for full length human ATG16L1 were produced. In this way, also the variability in virus 
quality and titer is under better control.  
Insect cells are quite tedious to maintain under optimal conditions for infection. If the cells divide too 
fast, they might grow too quickly and enter lag phase before virus can infect enough of the cells for 
successful protein production. In case of cell passage number being too low, or too high, cells might 
not be as receptive for the virus uptake. This is also the case when the cells reach a cell density above 
their usual range (above 3-4x106 cells/ml). Thus, much time is invested in keeping both insect cells as 
well as the virus under optimal conditions, in order for protein production to be effective. 
4.1.3 Expression and purification of full length ATG16L1 
4.1.3.1 Strep tagged full length human ATG16L1 
Since proteins are expressed in cells, they are cloned with a tag, which assists in separation of target 
proteins from other cellular content. In the case of full length human ATG16L1, due to its size, only 
small tags were added on the N-terminal end. Initially, human ATG16L1 was cloned with N-terminal 
His and Strep tag, separated from the protein by a TEV cleavage site, and expression was tested in 
insect cells. Full length human ATG16L1 with a small tag is approximately 70 kDa in size. Protein with 
either tag was expressed (Figure 20) but the Strep tagged construct resulted higher yield and purity. 
A band corresponding to a 70 kDa protein is observed in Strep pull down from Sf-21 cells infected 
with P2 Strep ATG16L1 virus. This band has been identified as human ATG16L1 by tryptic digest and 
mass spectrometry (sequence coverage 38 %, score for human ATG16L1 of 226, next best score for 
an unnamed protein of 54). Apart from mass spectrometry, presence of human ATG16L1 was 
confirmed by Western blot against ATG16L1. The two upper bands in the Strep pull down (marked 
with asterisk (*) in Figure 20) are native to insect cells and non-specifically bind the Strep beads. The 
band bellow 14 kDa marker is Streptavidin from the beads (Figure 20). 
 
Figure 20: Small scale test expression of His tagged and Strep tagged human full length ATG16L1 from Sf-21 
cells, 3 days post infection. (Legend: p = pellet, sn = supernatant, His = Ni-NTA beads, Strep = Strep-Tactin 
Macroprep beads) Left figure: SDS-PAGE analysis of small scale test expression. Right figure: Western Blot on 
the beads of Step tagged human full length ATG16L1 from Sf-21 cells, 3 days post infection. Primary antibody: 
anti-ATG16L1 (Sigma, A7356) 1:1000, Secondary antibody: Peroxidase conjugated AffiniPure Goat Ant-
Rabbit IgG (1:2500). Detection: Lumi-Light Western Blotting Substrate (Roche). Bands marked with asterisk 
(*) is an insect cell protein unspecific binding Strep beads. 
Results 
 
57 
 
First large scale production of Strep tagged human full length ATG16L1 was done in Sf-21 cells. 
Following gravity affinity chromatography on Strep-Tactin Macroprep column, protein was 
concentrated and loaded on Superdex 200 16/60 size exclusion column. Fractions were analyzed on 
12 % SDS PAGE gel (Figure 21A).  
 
Figure 21: Large scale purification of Strep tagged full length human ATG16L1. A) 2 L culture of Sf-21 cells 
(0.8x106 cells/ml) infected with P3 Strep tagged full length human ATG16L1 virus. Cells were harvested 3 
days post infection. Cleared lysate was loaded on Strep-Tactin Macroprep 10 ml resin connected to Äkta 
Purifier system, thoroughly washed and eluted with 2.5 mM desthiobiotin (elution profile shown in the right 
panel) in 10 ml elution fractions. B) Elution fractions from affinity chromatography were combined, 
concentrated in Vivaspin 10000 MWCO, and loaded on S200 16/60 size exclusion chromatography. Each 
fraction was analyzed on 12 % SDS-PAGE gel. C) Western blot against ATG16L1. Primary antibody: anti-
ATG16L1 (Sigma, A7356) 1:1000, Secondary antibody: Peroxidase conjugated AffiniPure Goat Ant-Rabbit IgG 
(1:2500). Detection: Lumi-Light Western Blotting Substrate (Roche). D) Gene TAGnology Strep-tag AP 
Chromagenic Detection kit (iba BioTAGnology) with elution fraction after gel filtration of Strep full length 
human ATG16L1. Control: sample from test expression (Strep_ATG16L1). 
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The most prominent band from fractions D11-D5 did not correspond to the size of the full length 
ATG16L1 (70 kDa) but to a protein of a molecular weight of approx. 37 kDa. However, since it is the 
main band observed (Figure 21B) it was sent for mass spectrometry identification. Tryptic digest and 
mass spectrometry of peptides was not able to find a hit in the human database. Since affinity 
purification using Step tag is generally quite specific, elution fractions were submitted to anti-
ATG16L1 Western blot (Figure 21C) and a Gene TAGnology Strep-tag AP Chromagenic Detection kit 
(iba BioTAGnology), which detects Strep tag on the principle of a Western Blot (Figure 21D). As a 
control for Strep-tag Detection kit, samples from small scale test expression of Step tagged full length 
human ATG16L1, (already confirmed as human ATG16L1 by mass spectrometry and anti-ATG16L1 
Western blot), were used. From the Western blot analysis of size elution fractions, full length 
ATG16L1 is in the void volume, indicating a large soluble aggregate. A weak signal for ATG16L1 is 
present in the fractions marked with a blue bar (Figure 21C). However, Strep-tag detection kit 
confirmed the presence of the Strep tag on the protein in the fractions marked with a blue bar 
(Figure 21D), which would indicate that it is a degradation product of the full length ATG16L1. The 
tag was fused to the N-terminal end of the protein, and is still present in the degradation product. 
Based on this, it can be assumed that the N-terminal part is intact. To identify C-terminal boundary of 
the degradation product, it was sent for full mass determination. Measured mass of the sample was 
38108 Da. Primary amino acid sequence of full length ATG16L1 including the sequence for the tag 
and the TEV cleavage site was used to calculate that C-terminal residue of the degradation product is 
E307. Based on the secondary structure prediction of the full length human ATG16L1 (Figure 14), 
E307 residue is located at the beginning of the C-terminal domain, predicted to be a WD-40 (Figure 
15Figure 15). Since position 307 is close to 303, which was already used as a construct boundary 
(Figure 16), no additional constructs were generated. 
Large scale production of full length human ATG16L1 proved to be a major challenge. Due to low 
yield from Sf-21 cells, large scale production was attempted in HighFIve cells. Since the virus was 
unstable, BIIC stock was used for infecting large scale production in HighFive cells. Protein expression 
was confirmed by measuring yellow fluoresce by Guava EasyCyte Mini (Merck Milipore) and small 
scale test expression protocol on 10 ml of 1 L culture. The protein was soluble in test expression, 
when beads used for binding to the protein were boiled and loaded on SDS PAGE gel. However, when 
elution of the bound protein was attempted in large scale production, initially it appeared that the 
protein is not expressed, or only at a very low level (Figure 22). 
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Figure 22: Large scale purification of Strep tagged full length human ATG16L1. A) Affinity chromatography 
was done by gravity flow, using Step High Capacity beads. 10 ml of the 1 L culture were used for test 
expression and beads were loaded as a control of protein expression (Test expression lane). Protein is eluted 
in 5x   5 ml fractions with 5 mM desthiobiotin. B) First three fractions from affinity chromatography were 
concentrated and loaded on S200 10/30 connected to Äkta Purifier system. Elution fractions of gel filtration 
run were analyzed on 12 % SDS PAGE gel. 
Purification of Strep tagged full length human ATG16L1 was attempted many times, with no 
improvement of the yield. Protein production was always observed from 10 ml small test expression, 
but large scale purification showed no soluble protein. To optimize and enhance the success of the 
experiment, different culture volumes and flask diameters for growing insect cell cultures were 
extensively tested, with no detected improvement in protein production. Furthermore, in addition to 
High Capacity beads used for the purification in Figure 22, elution was tested from two additional 
resins used for Strep affinity: Sepharose (Figure 23A) and Macroprep (Figure 23B). 
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Figure 23: Large scale purification of Strep tagged full length human ATG16L1. A) 4 L HighFive cells (1x106 
cells/ml) were infected with an aliquot of BIIC stock/1 L culture. Cells were harvested 3 days post infection. 
Cleared lysate was loaded on 2 ml Steptactin Sepharose gravity column, thoroughly washed and eluted with 
5 mM desthiobiotin in 6x   5 ml factions. All samples were analyzed on 12 % SDS-PAGE B) 4 L HighFive cells 
(1x106 cells/ml) were infected with an aliquot of BIIC stock/1 L culture. Cells were harvested 3 days post 
infection. Cleared lysate was loaded on 2   ml Streptactin Macroprep gravity column, thoroughly washed and 
eluted with 5 mM desthiobiotin in 5x   5 ml factions. All samples were analyzed on 12 % SDS-PAGE. Second 
elution fraction was concentrated in Vivaspin 10000 MWCO to 0.5 ml (3 mg/ml) and loaded on S200 10/30 
size exclusion chromatography column connected to Äkta Purifier system. Elution fractions were analyzed on 
12 % SDS PAGE gel. Bands marked with asterisk (*) is an insect cell protein unspecific binding Strep beads. 
Macroprep beads were shown most successful in the case of ATG16L1. Compared to HighCapacity 
and Sepharose, a fraction of the expressed protein was eluted from Macroprep beads. Upon loading 
of the post elution beads on the SDS PAGE gel, a band corresponding to the full length ATG16L1 
could still be observed (Figure 23A, last lane and Figure 24A, first lane). Based on this, a part of the 
protein could be eluted with 5 mM desthiobiotin, but the majority of the protein still remained on 
the beads. Even upon incubation of the beads with 10 mM desthiobiotin and additional 5 elution 
fractions (Figure 24, lanes labelled 7-11), no additional protein was eluted. In an attempt to further 
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enhance elution, half of the resin was incubated at 4°C overnight with 10 mM desthiobiotin. The 
other half was incubated with 100 µl TEV protease (1 mg/ml), at 4°C overnight. TEV protease would 
cleave off the tag, provided the cleavage site is accessible. This would allow the protein to detach 
from the beads. However, following the overnight incubation with either TEV or 10 mM 
desthiobiotin, protein did not elute from the beads (Figure 24B).  
 
Figure 24: Additional elution attempts. A) Resin was eluted with 10 mM deshtiobiotin for another 5 fractions, 
before it was split. B) Half (1 ml) of the resin was incubated with 100 µl TEV, overnight at 4°C; the other half 
(1 ml) was incubated overnight with 10 mM desthiobiotin. Following the overnight incubation, resin (b) and 
supernatant (sn) were analyzed on 12 % SDS PAGE gel.  
Strep purification is based on a strongest non-covalent bond known in nature, between avidin and 
biotin. Since avidin-biotin interaction cannot be broken, avidin is modified into Streptavidin, and a 
short peptide (Strep tag) is designed to bind in the biotin pocket. This interaction can be displaced by 
binding of desthiobiotin. Since human ATG16L1 was not eluted from the beads, it might be that the 
human ATG16L1 is biotinylated. Biotinylated protein would bind the beads directly, not via tag only. 
During elution with desthiobiotin, even if the Strep tag is displaced, the protein would remain on 
bound to the resin. To test for the biotinylation of human ATG16L1, a sample of full length ATG16L1 
was subjected to a Western blot using AP conjugated avidin (Figure 25), which does not bind the 
Strep-tag. To narrow down the region of the ATG16L1 undergoing biotinylation, untagged C-terminal 
construct (ATG16L1_G303-Y607) was included as well. To exclude the possible effect of the Strep tag 
on the full length ATG16L1, another Strep tagged protein (Strep_ATG5~ATG12) was used as a control. 
 
Figure 25: Western blot against biotin. Primary antibody: ImmunoPure Avidin, AP conjugated 1:500. 
Detection: AP colorimetric method using BCIP/NBT substrate. 
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Apart from the two high molecular weight bands (representing proteins from insect cells binding to 
Streptavidin, observed also in Figure 20) present in the purified Strep_ATG16L1 sample, a third band 
positive for biotinylation is ATG16L1. Since no biotinylation signal is seen for the construct 303-607, 
Western blot against biotin suggests the possible biotinylation occurs before position 303 of the 
human ATG16L1. To further pinpoint the biotinylation site, a sample was sent for mass spectrometry 
analysis. Mass spectrometry can detect post translational modification when they result in a size 
difference of peptides generated by tryptic digest. If the identification of the biotinylated site was 
possible, a mutant could be designed to circumvent this modification and hopefully enable elution of 
ATG16L1 from affinity resin. The SDS PAGE band from a fresh purification was sent to the CPRO 
Group for analysis and search for biotinylation sites. However, mass spectrometry studies did not 
yield any conclusive results.  
Considering biotinylation site on human ATG16L1, purification of the Strep tagged ATG16L1 was 
attempted using Pierce® Monomeric Avidin Agarose (Thermo Fisher Scientific) resin, which enables 
purification of biotinylated molecules and shows no binding specificity towards the Strep tag. 4 L of 
HighFive cells were infected with BIIC stock of Strep tagged human ATG16L1. The cells were 
harvested 3 days post infection, and lysed according to the protocol described above. To ensure 
protein production, 10 ml of the culture were used for test expression with MacroPrep Strep beads. 
The Avidin Agarose beads (1.5 ml) were primed with 1x PBS and 2 mM biotin in 1x PBS according to 
the manufacturer’s instructions. Biotin bound to reversible binding sites was washed with 0.1 M 
glycine, pH 2.8 and resin was equilibrated with 1x PBS. Beads were added to the supernatant 
containing full length ATG16L1 and incubated at 4°C, 1 hr, on a rocking platform. Unbound protein 
was washed with 1x PBS, and elution was done with 2 mM biotin, collecting 6x   1ml fractions. 
Additionally, beads were washed with 0.1 M glycine, pH 2.8, and 2x   1 ml fractions were collected. 
All samples were loaded on 12 % SDS PAGE for analysis (Figure 26). 
 
Figure 26: Avidin resin purification of Strep full length human ATG16L1. 4 L HighFive insect cells (0.8x106 
cells/ml) was infected with BIIC stock. Cells were harvested 3 days post infection. Cleared lysate was loaded 
on 1.5 ml avidin resin. Purification was done according to the instructions provided by Thermo Fisher 
Scientific. Elution fractions 1-6 were eluted with blocking buffer (2 mM biotin in 1x PBS). Elution fractions 7 
and 8 were eluted with 0.1 M glycine pH   2.8. Control: test expression using 10 ml of culture and Macroprep 
beads.  
Purification of Strep tagged full length human ATG16L1 using Avidin resin resulted was not 
successful. The protein either did not bind to the beads, or was not eluted from the beads neither 
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with 2mM biotin nor with 0.1M glycine, pH 2.8. However, based on test expression using 10ml of the 
culture and Macroprep beads, a band was observed on the beads corresponding to the size of full 
length human ATG16L1. This band was also identified as human ATG16L1 with tryptic digest and 
mass spectrometry (ATG16L1 with Score 135, next best hit: Rab GDP dissociation inhibitor with Score 
42). 
4.1.3.2 FLAG tagged full length human ATG16L1 
Majority of the proteins are captured from the cellular content using affinity tags. Addition of tags to 
the protein sequence is a double edged sword. For some proteins, tags are important for solubility, 
and in some cases tags also participate in crystal contact formation. On the other hand, cleavage of 
solubility tags renders some proteins insoluble, thus unusable for structural studies. Along the same 
line, tags, no matter how small, can introduce enough disturbances in the process of crystal packing 
that some proteins crystallize only without them. Thus, the type of tag and its position has to be 
empirically tested to observe the effects it has on the protein or crystal. In this work, all fusion tags 
are separated from the protein sequence with TEV cleavage site (unless otherwise noted). 
Recombinant expression of human ATG16L1 is not high enough to be able to separate the protein 
without an affinity tag. Since Step tag purification was not progressing, and His tag version resulted 
low yield and purity, full length ATG16L1 was cloned into a FLAG tagged vector. FLAG tagged 
ATG16L1 was expressed from insect cells, following the protocol described above. Cell lysate was 
incubated with FLAG beads for 3-4 hr, 4°C on a rocking platform. Purification protocol was performed 
according to the manufacturer’s instructions.  
 
Figure 27: Purification of FLAG tagged full length human ATG16L1. 4 L of HighFive insect cell culture 
(0.8x106 cells/ml) were infected with P3 Flag full length human ATG16L1. Cells were harvested 3 days post 
infection. Cleared lysate was incubated with FLAG beads according to the protocol from BioLegend. Elution 
buffer contained 100 µg/ml FLAG peptide. All fractions were analyzed on 12 % SDS PAGE gel. 
Elution fractions 2-4 were concentrated, however during the concentration process, all of the protein 
precipitated and could be collected by centrifugation at 14000 rpm at the bottom of the tube as a 
white pellet. FLAG beads were regenerated according to the manufacturer’s protocol, and used for 
the fresh purification. It appeared the protein could not be removed from the beads completely and 
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the next purification resulted in lower amount of protein eluting from the beads, and a greater 
amount of protein remaining on the beads, compared to the previous use. Even a more aggressive 
elution with 0.2 M glycine, pH 2.8 could not detach the protein.  
 
Figure 28: Purification of FLAG tagged full length human ATG16L1. 4 L of HighFive insect cell culture 
(0.8x106 cells/ml) were infected with P3 Flag full length human ATG16L1. Cells were harvested 3 days post 
infection. Cleared lysate was incubated with FLAG beads according to the protocol from BioLegend. Elution 
buffer containing 100 µg/ml FLAG peptide was used for fractions 1-5. Fractions 6-10 were eluted with 0.2 M 
glycine pH 2.8 and immediately neutralized with 1 M Tris pH 8. All fractions were analyzed on 12 % SDS 
PAGE gel. 
Since stability and purity of the sample are important determinants for successful protein 
crystallization, the small amount of ATG16L1 eluted from FLAG beads was concentrated to 1 mg/ml 
and used for biophysical studies in hope to understand the nature of the protein better and find a 
way to obtain enough pure, soluble and homogenous protein for crystallization. 
4.1.4 Biophysical studies of full length human ATG16L1 
4.1.4.1 ThermoFluor of full length human ATG16L1 
Protein solubility is influenced by many factors among which pH, ionic strength and presence of 
other components play a major role. At a pH close to the isoelectric point (pI), protein usually has the 
least solubility. Calculated pI of the full length ATG16L1 is 6.2. Buffers used for purification steps 
(both lysis and elution) were above pH of 6.2. At the pH above the pI, the net charge of the protein is 
negative, and more water molecules can interact with it, keeping it soluble. In the case of ionic 
strength, salt ions interact with oppositely charged groups on the protein, causing more interactions 
between a protein and the solvent than between protein molecules themselves. However, screening 
the effects different pH values and ionic strengths have on protein solubility can be of great 
advantage. 
ThermoFluor assay, a fluorescence-based thermal stability method, monitors the effects of different 
buffers on the stability of the protein. A hydrophobic fluorescent dye is mixed with the protein 
solution and upon thermal denaturation the dye binds to the hydrophobic patches resulting in an 
increased fluorescence. The fluorescent signal is monitored as a function of temperature.  
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Due to the low stability and solubility in the elution buffer during purifications, FLAG tagged human 
full length ATG16L1 was subjected to the ThermoFluor buffer test to identify buffer conditions that 
increase the stability of the protein. Low amount of available pure protein did not allow for 
ThermoFluor conditions to be optimized. Nonetheless, the ThermoFluor assay showed two melting 
curves, for 50 mM HEPES pH 7, 100 mM NaCl and for 50 mM HEPES pH7, 200 mM NaCl, both with 
melting temperature of 54°C.  
 
Figure 29: ThermoFlour melting curves for FLAG full length human ATG16L1. 1 mg/ml of protein was mixed 
with 10x   SyproOrange and aliquoted into ThermoFluor Buffer screen.  
4.1.4.2 Circular dichroism (CD) spectroscopy of full length human ATG16L1 
The small amount of purified FLAG tagged full length human ATG16L1 was enough for recording a 
circular dichroism (CD) spectrum. The spectrum was recorded from 190 nm to 260 nm at 20°C.  
 
Figure 30: Circular dichroism curve for full length ATG16L1. 300 µl of 1 mg/ml of protein was dialyzed 
overnight in 2 L CD buffer. 0.8 mg/ml of protein was recovered in 350 µl and a CD spectrum was measured 
from 190 nm to 260 nm at 20°C. 
Based on CD spectra of the full length human ATG16L1, the protein appears to be folded. A 
maximum at 190 nm together with the two minima at 208 nm and 222 nm are a typical features of α-
helical secondary structure. K2D2 (http://cbdm-01.zdv.uni-mainz.de/~andrade/k2d2//) calculated 
11.53 % of the protein are α-helical and 28.35 % are β-strands. However, these values have to be 
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considered with caution. CD spectra reflect an average over the entire molecule, and the percentage 
of secondary structure elements is not an absolute assessment. What the CD spectra of the full 
length human ATG16L1 does show with certainty is that the protein is folded with distinguishable 
secondary structure elements. 
4.1.4.3 Dynamic light scattering (DLS) of full length human ATG16L1 
Same sample used for CD was subsequently used for DLS. Every macromolecule has an ability to 
scatter light and this scattering is dependent on the overall size of the particle. Size distribution of 
the particle in solution as well as homogeneity of the sample can be studied using DLS. Homogeneity 
is crucial for crystallization of a protein, since a sample with mixed population will hardly arrange 
itself into well-ordered periodic assemblies such as a crystal. Based on the scattering of the laser 
light, full length human ATG16L1 has two populations. Large portion of the protein in solution 
(96.1 %) has a molecular weight of 165 kDa, which is close to a molecular weight of a dimer 
(monomer is around 70 kDa in size). This makes sense because the coiled-coil region of the ATG16L1 
is responsible for dimerization of the protein. A small portion of the sample (3.9 %) is a large 
aggregate or oligomer with an average molecular weight of 318 000 kDa.  
 
Figure 31: Dynamic light scattering analysis full length ATG16L1 
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The sample used for both CD and DLS was shock frozen in liquid nitrogen and stored at -80°C. 
Eventually, the sample was thawed, centrifuged at 10 000   rpm, 15   min, 4°C and sent for SAXS 
analysis at ESRF. However, the measured scattering curve was uninterpretable.  
4.1.4.4 Co-expression of ATG16L1 with ATG5/ATG12 conjugate 
Difficulties with purification of full length ATG16L1 might be attributed to its tendency towards 
aggregation. Full length ATG16L1 could not be successfully eluted from affinity columns, with only a 
small fraction of the protein in the elution, and majority of the protein remaining on the resin. This 
could be explained by formation of large insoluble aggregates. If the protein precipitates on the 
affinity resin, it will not be eluted with standard methods. However, even the small part of soluble 
protein which was eluted from the affinity resin was in the void volume of size exclusion, indicating 
formation of large aggregates. As mentioned above, protein solubility depends on pH, ionic strength 
and other components present in solution. The effect of pH and salt ions can be tested by a 
ThermoFlour assay. The category of other components often include organic solvents (PEGs or 
glycerol) or reducing reagents (such as BME or DTT) as well as known interaction partners. 
Interaction partners often solubilize proteins by masking the hydrophobic, solvent exposed regions, 
which, in the absence of an appropriate binding partner, lead to aggregation of the protein. To test 
this, Strep tagged full length ATG16L1 was co-expressed with its well-known partners ATG5~12. 
Expression and purification of ATG5~12 has been optimized by Archna in our lab. Strep tagged 
ATG16L1 with His-ATG5/GST-ATG12 and untagged ATG7/ATG10 (ATG7/ATG10 are required for 
ATG5~12 conjugation) were co-expressed together in insect cells. Since insect cells have their own 
GST protein, first purification step was Ni-NTA to avoid oversaturating GST beads with endogenous 
protein. Elution fraction from Ni-NTA was subsequently incubated with GST beads (Figure 32 A and 
B). To confirm the presence of ATG16L1, GST elution fraction was subjected to Gene TAGnology 
Strep-tag AP Chromagenic Detection kit (iba BioTAGnology) (Figure 32C).  
 
Figure 32: Co-expression of ATG16L1 with ATG12~5. 1 L of HighFive insect cell (0.8x106 cells/ml) was 
infected with three viruses: one containing His-ATG5/GST-ATG12, one with untagged ATG7 and ATG10 and 
BIIC stock of Strep-ATG16L1. Cells were harvested 3 days post infection. A) First affinity step was Ni-NTA: 
protein was eluted with 100 mM Imidazole. Beads after elution were loaded as control of elution efficiency. B) 
First elution fraction from Ni-NTA affinity was incubated with 2 ml GST beads. GST elution was performed 
with 20 mM reduced glutathione in 4x   3ml fraction. Beads after elution were loaded as control of elution 
efficiency. C) GST elution fraction 1 (E1) was loaded on a separate gel and Strep tag on ATG16L1 was 
detected using Gene TAGnology Strep-tag AP Chromagenic Detection kit.  
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Thus, when co-expressed with ATG12~ATG5, ATG16L1 expression as well as its elution was also 
successful. When the purification principle was shown to work, the culture volume was increased to 
6 L and repeated. Fresh virus for Strep tagged ATG16L1 was produced for infection to eliminate 
possible delay in virus release by BIIC. Elution fraction after GST purification was concentrated and 
loaded on Superose 6 10/30 column connected to the Äkta Purifier system. Fractions were analyzed 
on 12 % SDS PAGE gel (Figure 33). Most of the protein was present in the void volume. Thus, problem 
of ATG16L1 aggregation was not solved by co-expression with its interaction partners. 
 
Figure 33: Co-expression of Strep ATG16L1 with His-ATG5/GST-ATG12. 3 mg/ml of the complex following 
GST affinity were loaded on Superose6 10/30 gel filtration column. All fractions were analyzed on 12 % SDS 
PAGE gel.  
4.1.5 Phosphomimetic variants of ATG16L1 
Apart from the classical role of ATG16L1 in complex with ATG5~ATG12 in autophagosome formation, 
this protein has additional roles, not necessarily always exclusive to autophagy. A mutation from 
threonine to alanine on position 300 has been linked to Crohn’s disease. This variant was tested to 
see if it has an effect on the interactions with DDB1. Since threonine is one of the classical residues to 
undergo phosphorylation, phosphomimetic substitutions T300E and T300D were introduced. 
Glutamate (E) and aspartate (D) are both negatively charged amino acids and mimic a 
phosphorylated site. In addition, four more positions on the human ATG16L1 were predicted to be 
phosphorylated: S287, S289, S290, and S304. Each of these is substituted with a glutamate. Viruses 
harboring S287 and S290 could be successfully amplified to P2 level. Interaction of the 
phosphomimetic variants (T300E, T300D, S287E and S304E) with DDB1 was tested by co-infection 
and pull down assay (Figure 34). In the pull down assay, tested phosphomimetic variants of ATG16L1 
behave similarly to the wild type, in that they show no interaction with DDB1. 
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Figure 34: Co-expression of His-DDB1 with Strep-ATG16L1 constructs (wt: ATG16L1_M1-Y607, T300E: 
ATG16L1_M1_T300E_Y607, T300D: ATG16L1_M1_T300D_Y607, S304E: ATG16L1_M1_S304E_Y607, S287E: 
ATG16L1_M1_S289E_Y607) in 20ml Sf-21 (1x106 cells/ml). Cells were harvested 3 days post infection. 
Samples were analyzed on 12% SDS-PAGE gels (h= His pull down; s= Strep pull down). Bands marked with 
asterisk (*) is an insect cell protein unspecific binding Strep beads. 
This concludes the attempts towards expression and purification of the full length human ATG16L1. 
Despite reasonable expression of the protein in small scale from insect cells, high yield and purity of 
full length human ATG16L1 which is needed for crystallographic studies and further biochemical 
characterization could not be obtained during the time period of this work.  
4.1.6 Expression and purification of C-terminal domain of human ATG16L1 
Constructs containing C-terminal domain of human ATG16L1 were designed as described in Section 
4.1.1.1.2 and cloned with either His or Strep tag into both bacterial and insect cell expression vectors. 
Test expression from E. coli was previously done by Petra Völler in our lab, with no success in 
obtaining soluble expressed protein. Baculoviruses containing C-terminal constructs were tested in 
insect cells. SDS PAGE gel displaying P2 test expression of C-terminal ATG16L1 constructs from insect 
cells is shown in Figure 35. 
 
Figure 35: SDS PAGE of small scale test expression of His tagged C-terminal constructs (K266-Y607, G284-
Y607 and G303-Y607) of human ATG16L1 produced with P2 virus in Sf-21 cells.  
C-terminal constructs of human ATG16L1 were successfully expressed with a His tag and P3 virus was 
used for large scale production in HighFive cells. Purification protocol consists of two steps: affinity 
chromatography and gel filtration. Since affinity purification for His tag is not very specific, impurities 
were removed by gel filtration, yielding a highly soluble and pure C-terminal ATG16L1 construct. Gel 
filtration retention volume indicates a monomeric protein in solution. All of the C-terminal constructs 
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were purified using the same procedure. Sample purification for His tagged ATG16L1_G284-Y607 is 
shown in Figure 36.  
In the case of ATG16L1, the single domain shows higher solubility and stability compared to the full 
length multi-domain protein. In this work, main focus is given to C-terminal domain of human 
ATG16L1. Following gel filtration step, C-terminal constructs of human ATG16L1 were concentrated 
to 25 mg/ml and either frozen in liquid nitrogen and stored at -80°C, or used for crystallization 
screens. Trials were set with 5 and 10 mg/ml of protein with and without a tag, at both 4°C and 20°C. 
The initial screens did not result any protein crystals. 
First major bottleneck in structural biology was already mentioned during construct design and 
cloning, hoping for a soluble and homogeneous construct with high production yield. Second major 
bottleneck is obtaining crystals of that protein. Since initial crystallization trials with C-terminal 
constructs of ATG16L1 were not successful, protein is further analyzed using biochemical and 
biophysical methods to assess the quality of the protein and improve its crystallization. 
 
 
Figure 36: Purification procedure for C-terminal constructs of human ATG16L1. 1 L culture of High Five 
insect cells (0.8x106 cells/ml) was infected with 5-10 % P3 virus coding for His tagged C-terminal domain of 
human ATG16L1. Affinity chromatography was done with Ni-NTA beads; bound protein was eluted with 
200 mM Imidazole. Eluted fractions were concentrated and loaded on Superose 75 16/60 connected to the 
Äkta Purifier system. Fractions were analyzed on SDS PAGE gel, pooled, concentrated and shock frozen in 
liquid nitrogen or used for crystallization trials. Purification for His_ATG16L1_G284-Y607 is represented 
here. 
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4.1.7 Biophysical studies of C-terminal domain of human ATG16L1 
4.1.7.1 ThermoFluor assay with C-terminal domain of human ATG16L1 
C-terminal domain of human ATG16L1 was purified as described and subjected to the ThermoFluor 
assay, to study effects pH and salt concentration have on the protein.  
 
Figure 37: ThermoFluor melting curves for C-terminal domain of human ATG16L1. 2 mg/ml of protein was 
mixed with 10x SyproOrange and aliquoted into Thermofluor Buffer screen. 
According to the melting curves recorded (Figure 37), it was difficult to determine one single best 
condition, since many buffers gave similar melting curves resulting in the same level of protein 
stability. Buffers in the pH range between 6 and 8, with NaCl concentration between 200 mM and 
500 mM keep the melting temperature of the protein between 62°C and 66°C. The buffer used for 
purification of C-terminal domain of human ATG16L1 falls within the range observed as optimal by 
ThermoFluor.  
4.1.7.2 Circular dichroism (CD) and dynamic light scattering (DLS) with C-
terminal domain of human ATG16L1 
Secondary structure composition and folding properties of the C-terminal constructs of ATG16L1 
were investigated using circular dichroism. The spectrum was recorded from 190 nm to 260 nm at 
20°C.  
 
Figure 38: Circular dichroism curve for C-terminal domain of human ATG16L1 (G303-Y607). 300 µl of 
2 mg/ml of protein was dialyzed overnight in 2 L CD buffer. 1.6 mg/ml of protein was recovered in 350 µl and 
a CD spectrum was recorded from 190 nm to 260 nm at 20°C. 
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CD spectra reflect an average over the entire molecules. Based on the curve for C-terminal domain of 
ATG16L1, protein was properly folded (Figure 38). The overall shape of the recorded spectra 
represents a typical β-sheet composition. A typical β-sheet has a characteristic minimum at around 
217 nm and a maximum around 198 nm. This confirms the prediction that secondary structure of C-
terminal domain of human ATG16L1 is mainly β-sheets. K2D2 (http://cbdm-01.zdv.uni-
mainz.de/~andrade/k2d2//) calculated 12.53 % of the protein is α-helical and 35.2 % are β-strands. 
 
Figure 39: Dynamic light scattering analysis of C-terminal domain of human ATG16L1 (G303-Y607) 
Apart from good solubility upon expression and purification, protein must also be homogeneous, 
ideally as a single population, for crystallization. Dynamic light scattering was used to determine size 
distribution of protein sample in solution. According to the DLS (Figure 39), C-terminal domain of 
human ATG16L1 exists as a monomer in solution, which is in agreement with the gel elution profile 
of the protein.  
4.1.8 In search of interaction partners of C-terminal domain of human ATG16L1 
As already mentioned in the case of full length ATG16L1, co-expression of the target protein with its 
interaction partners might boost production levels and solubility. In case of full length ATG16L1, 
interaction partners were used in an attempt to solubilize the protein and possibly enhance its 
expression. C-terminal domain of human ATG16L1 was expressed in high yield and was quite soluble. 
However, crystal growth was not very promising. Following the same logic as for co-expression, co-
crystallization would provide new surfaces for crystal contacts and might lead to crystal packing. This 
was the hope for the C-terminal domain of human ATG16L1. Not only would the interaction partners 
help in crystallization, but a crystal structure of the complex would provide molecular detail of the 
mode of action of C-terminal part of human ATG16L1 and help define the function of this domain 
more precisely. 
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C-terminal half of the human ATG16L1 is present only in higher eukaryotes and is not essential for 
canonical autophagy process. Literature search suggested a few candidates for interaction partners 
of specifically this domain. We have chosen to focus our attention on the following list: DDB1, CARD 
domain of NOD1, CARD1 domain of NOD2, TIR domain of TLR2, cytosolic domain of TMEM59.  
4.1.8.1 Pull-down assays 
Since most of the interaction partners reported in the literature for C-terminal domain of human 
ATG16L1 are identified using immunoprecipitation method, one way to confirm those results is by a 
pull-down assay. Pull-down assay is based on affinity principle, and is used to either enrich a 
population of a certain protein or to detect interaction partners. In the case when interaction 
partners are known, both the target protein and the partner are tagged with different tags. Proteins 
are captured through the affinity tag on the affinity resin specific for the tag. Immobilized proteins 
are incubated with the source of interaction partner, either cell lysate or solution with purified 
protein. Affinity resin is washed and at the end loaded on the SDS PAGE gel for analysis.  
Apart from DDB1, putative interaction partners of C-terminal domain of human ATG16L1 are 
relatively small domains, and could be expressed from E. coli, and will be presented first. The longest 
construct (K266-Y607) of the C-terminal domain of ATG16L1 with a Strep tag was purified from insect 
cells are described above. Purified Strep_ATG16L1-K266-Y607 was mixed with the lysate of E. coli 
culture expressing the respective interaction partners: His-TLR2, GST-NOD2 and GST-TMEM59. For 
the putative interaction partners expressed as GST-fusion constructs, GST alone was used as control 
to analyze unspecific binding via the large GST-tag. Following a 1hr incubation at 4°C, the mixture 
was split and one half was incubated with Strep beads, and the other half with the beads 
corresponding to the tag of the interaction partner. After another 1hr incubation at 4°C, beads were 
washed and loaded on SDS PAGE gel for analysis (Figure 40).  
 
Figure 40: Pull-down studies with putative interaction partners of C-terminal domain of human ATG16L1. 
Strep G284-Y607 was purified from HighFive cells. Interaction partners (His-TLR2 (626-784), GST-NOD2 (1-
209) and GST-TMEM59 (263-323)) were expressed from 50 ml E. coli, each according to their individual 
optimal expression conditions. Pellets from each expression were lysed and mixed with beads according to the 
figure above. Pull down samples were analyzed on 15 % SDS-PAGE gel. Bands marked with asterisk (*) are 
contamination/unspecific protein bands.  
The previously reported and published interaction of ATG16L1 WD40 with TIR domain of TLR2, CARD 
domains of NOD2 and cytosolic domain of TMEM59 could not be confirmed using the pull-down 
assay. This could be attributed to the relatively low sensitivity of the pull-down method. Usually, 
stable protein:protein complexes with high affinity can be identified using pull-down assay. However, 
complexes with low affinity or transient interactions are more challenging to detect and often broken 
during washing steps in pull-down assay. 
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To test interaction between DDB1 with C-terminal domain ATG16L1, I took advantage of the fact that 
their expression system is the same. His tagged DDB1 was co-expressed with all constructs of 
ATG16L1 (three C-terminal constructs and full length protein) and their interaction was tested by 
pull – down assay. As a control, DDB2 co-expression was included, a DCAF protein which is known to 
form a stable DDB1-DDB2 complex. On the left hand side in Figure 41 are single expressions of all 
proteins, and on the right hand side is the gel with co-expressions.  
 
Figure 41: Co-expression of His-DDB1 with Strep-ATG16L1 constructs (fl: full length, K266: K266-Y607; K284: 
K284-Y607; K303: K303-Y607) in 20 ml Sf-21 (1x106 cells/ml). Cells were harvested 3 days post infection. 
Samples were analyzed on 12 % SDS-PAGE gels. Control: His-DDB1 and His-DDB2. Bands marked with 
asterisk (*) are proteins from insect cells which unspecifically bind to Strep beads. Legend: h = Ni-NTA beads, 
S = Strep-Tactin Macroprep beads. 
Based on interaction studies between DDB1 and ATG16L1 using pull-down assay, complex formation 
between these two proteins could not be detected. In addition to low sensitivity, pull-down assay 
also require one or both proteins to be immobilized, which might interfere with complex formation. 
Size exclusion chromatography allows protein to be free in solution. Change in protein size due to 
complex formation is detected by the shift of the elution peak. Single protein will elute at one 
retention volume, while the complex will elute earlier, indicating a larger molecular weight. The shift 
between a large protein alone and a large protein bound to a small domain will not be as prominent 
as a shift between a small domain alone and a small domain bound to a large protein. 
With this in mind, C-terminal domain of human ATG16L1 starting at position G284 was expressed 
from insect cells. Following affinity chromatography, protein is concentrated and loaded on analytical 
S200 10/30 gel filtration column. This run is shown in dark blue in Figure 42. To test the interaction 
with DDB1, equal molar amounts of the purified C-terminal domain are mixed with DDB1. 
Additionally, 2% TEV (incubated with the sample at 4°C, 6 hr) was added to cleave off tags, in case 
they interfere with the complex formation. To keep variation of external factors at the minimum, 
both runs were performed on the same purification system, on the same column, using the same 
running buffer, and one right after the other. Elution fractions were analyzed on SDS PAGE gel.  
Elution profiles were overlaid to observe if there is any shift of the retention volume of the C-
terminal domain of ATG16L1 when allowed to interact with DDB1. However, the elution volume of 
ATG16L1_G284-Y607 is the same with and without DDB1. Additionally, in case of interaction, bands 
for both proteins should be present in the same elution fraction, in the same amounts, when tested 
on the SDS PAGE gel. However, protein band corresponding the DDB1 is present only in the early 
peak, while ATG16L1_G284-Y607 is in the second peak, indicating no co-elution of the proteins on 
size exclusion chromatography. 
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Figure 42: Analytical gel filtration of DDB1 and C-terminal human ATG16L1_G284-Y607 (1 mM of DDB1 and 
1 mM of C-terminal human ATG16L1), green curve. Control: C-terminal human ATG16L1 alone (2.5mM), blue 
curve. Elution profiles are overlaid and fractions were analyzed on 12 % SDS-PAGE gel. 
4.1.8.2 Microscale thermophoresis  
Pull-down assay and size exclusion chromatography (SEC) are able to detect only strong interactions 
between proteins. Weaker interaction could be broken and disrupted during washing steps or on the 
column. Since there is no evidence to the affinity between C-terminal domain of ATG16L1 with any of 
the mentioned interaction partners, pull-down assay and SEC might not be a suitable method of 
detection in this case. A more delicate way to detect protein interaction is by microscale 
thermophoresis (MST). MST requires relatively low amount of protein and allows proteins to be free 
in solution during measurement. During an experiment, a microscopic temperature gradient is 
applied using infrared laser. Migration of molecules along the temperature gradient is measured and 
quantified. A change in protein migration rate along the temperature gradient is caused by an 
increase in size and change in charge or hydration shell during complex formation. C-terminal domain 
of ATG16L1 (G284-Y607) was labeled according to the NanoTemper instructions, and the interaction 
with proposed, unlabeled binding partners (His-TLR2, GST-NOD2, NOD1-His and GST-TMEM59) was 
tested using MST.  
MST was repeated varying buffer conditions: salt concentrations and pH were varied to test an effect 
on the interaction. However, graphs recorded in different buffers show the same trend as the graphs 
in Figure 43. Based on these results, C-terminal domain of ATG16L1 does not form a direct 
interaction with proteins tested here. 
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Figure 43: Thermophoresis experiment of C-terminal domain of human ATG16L1 with putative interaction 
partners (His-TLR2 (626-784), GST-NOD2 (1-209), NOD1-His (1-106) and GST-TMEM59 (263-323)). C-
terminal domain of human ATG16L1 (G284-Y607) was labelled according to the NanoTemper protocol at 
concentration of 20   µM. Each point on the graph represents 1:1 dilution of the previous concentration. 
Maximum (starting) concentrations of each interaction partner are indicated below the corresponding 
thermophoresis graph. 
So far interactions between C-terminal domain of ATG16L1 and its putative partners were tested in 
vitro, in buffer systems and in cellular systems such as insect cells. In case of strong, stable 
interactions, this level of testing would be enough to detect the complex formation and use it in 
structural studies. However, this was not the case, indicating a possibility of another element 
essential for the interactions with C-terminal domain of ATG16L1 but missing in the experimental 
systems used so far. To search for additional partners in a more comprehensive system, transient 
transfection of HEK293 6E was considered and tested. Due to time limitations and complexity of the 
autophagy process, no conclusive results can be reported at this time.  
This concludes attempts to confirm known and putative interaction partners of ATG16L1. To achieve 
the aim of this project, and crystallize the C-terminal domain of ATG16L1, additional approaches 
were considered. Since the search for interaction partners was unrewarding, further engineering 
strategies at the protein level, such as limited proteolysis and surface entropy reduction 
mutagenesis, were instigated.  
4.1.8.3 Limited proteolysis 
One method for protein engineering and modification of already expressed, soluble protein is by 
limited proteolysis. Since the construct boundaries used in this study are based on prediction 
methods, it is possible that flexible regions are still present which might prevent crystal formation. 
Limited proteolysis provides information about the compactness and proteolytic stability of C-
terminal domain of human ATG16L1. Each construct was purified as described above, and subjected 
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to 12 proteases from the Proti-Ace Kits 1 and 2 from Hampton Research. The hope of this approach 
was that the small amount of proteases would cleave off flexible loops and ends, yielding a more 
compact fragment. 
 
Figure 44: Limited proteolysis of human ATG16L1 G284-Y607 and G303-Y607 constructs. Undigested protein 
(uncut) was loaded in the first lane as a control. Proteases from Proti Ace Kits 1 and 2 (Hampton Research) 
were diluted to 0,01 mg/ml and 10 µl of each protease was mixed with 10 µl of each protein (10 mg/ml) and 
incubated at 37°C for 1 hr. Reaction was stopped by mixing the sample with 2x SDS loading buffer. Samples 
were analyzed on 15 % SDS PAGE gel. (Legend: α-C: α-chymotrypsin; TR: trypsin; EL: elastase; PA: papain; 
SU: subtilisin; EG-C: endoproteinase Glu-C; P-K: proteinase K; CL: clostripain (endoproteinase-Arg-C); PE: 
pepsin; TH: thermolysin; BR: bromelain; A-E: actinase)  
Based on limited proteolysis (Figure 44), ATG16L1_G284-Y607 appears to be more prone to 
degradation compared to ATG16L1_G303-Y607 construct. Three proteases (trypsin, α-chymotrypsin 
and bromelain) digest ATG16L1_G284-Y607 into smaller, stable fragments. These three proteases 
were used for in-situ proteolysis (0,01 mg/ml) by adding the proteases to crystallization trails. As 
cleavage occurs, more stable fragments become available and could separate out of the solution and 
lead to crystal formation. However, this method did not prove successful for obtaining crystals of the 
C-terminal domain of human ATG16L1.  
Additionally, bromelain produced a shorter, stable fragment of ATG16L1_G284-Y607. This lower 
band was transferred onto a PVDF nitrocellulose membrane, stained with Coomassie stain and 
submitted for N-terminal sequencing. Based on the results, the lower fragment starts with position 
S304, which is very close to the ATG16L1_G303-Y607 construct. Since limited proteolysis of 
ATG16L1_G303-Y607 was not as prone to proteolysis as ATG16L1_G284-Y607, and the degradation 
product of ATG16L1_G284-Y607 was one amino acid shorter than ATG16L1_G303-Y607, it would 
appear the ATG16L1_G303-Y607 represents a compact domain with no major flexible regions.  
4.1.8.4 Surface entropy reduction mutagenesis 
Another method to modulate already expressed and soluble protein and possibility to increase the 
chances of crystallizing it, is reducing the entropy of the system. Formation of crystals is dependent 
on the free energy change, to which enthalpy and entropy contribute. Intramolecular contacts 
resulting in a crystal are relatively few (around 15 contacts per macromolecule) and the enthalpy 
values favoring crystal formation are usually small. Thus, protein crystal formation is mainly an 
entropy driven process. In order for proteins to form intramolecular contacts in a solution, they have 
to get close enough to each other, resulting in displacement of water (solvent) molecules. Once 
protein molecules are close enough and crystal contacts are formed, this results in the loss of 
entropy of protein; compared to the entropy protein has when free in solution. Since formation of 
crystal contacts releases water molecules normally bound to the protein surface, gain of entropy of 
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the solvent is one of the major driving forces of crystal formation. To promote crystallization through 
reduction of the entropy of the protein, clusters of flexible, surface exposed residues are mutated to 
alanine. Surface entropy reduction mutations can facilitate crystal formation in one of two ways: 
either by reducing the entropy of the protein, a desired effect by introducing SER-mutations, or by 
simply removing residues with steric hindrance. Changing one residue or a cluster of long, flexible 
residues might be enough to tilt the balance in favor of crystal formation. SERp server 
(http://services.mbi.ucla.edu/SER/) predicts secondary structure sequence by PSIPRED and surface 
conformational entropy based on the submitted amino acid sequence. SERp server predicts patches 
of surface exposed, charged, flexible residues with high intrinsic entropy which are then mutated to 
small amino acids with low entropy side chains, such as alanines.  
Single predicted surface entropy clusters (Figure 45) were introduced to each of the three C-terminal 
construct of human ATG16L1 (G266-Y607, G284-Y607 and G303-Y607) for a total of 12 different SER 
constructs and expressed from HighFive insect cells. Purification procedure for surface entropy 
mutants was the same as that of the wild type protein. Following gel filtration step, surface entropy 
mutants of human ATG16L1 were concentrated to 25 mg/ml and either frozen in liquid nitrogen and 
stored at -80°C, or used for crystallization trails.  
 
Figure 45: Patches with high surface entropy predicted for C-terminal domain of human ATG16L1 (R284-
Y607) by SERp server. A) SERp output. Amino acid sequence submitted to SERp started at position 266 
(which in the prediction is position 1) until 607 (in the prediction position 341). B) Surface entropy reduction 
mutations predicted by SERp on the secondary structure elements of C-terminal domain of ATG16L1, 
predicted by PSIPRED v3.3. 
4.1.9 Crystallization of C-terminal domain of human ATG16L1 
Crystallization trials of surface entropy reduction variants were set using 5 and 10 mg/ml of protein, 
with and without tag, at 4°C and 20°C and resulted in many conditions with phase separation. The 
appearance of phase separation can indicate a metastable transition, a state in which crystals may 
form. Keeping in mind the concept of small changes of amino acid composition leading to a big 
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change in the crystallization behavior of a macromolecule, naturally optimized constructs 
(homologues) might provide the change in sequence needed for crystal formation. Human and 
mouse ATG16L1 (Figure 17) have a few differences at the C-terminal domain. As a start, the most C-
terminal human tyrosine 607 was mutated to mouse proline 607 in combination with the surface 
entropy reduction mutants. Finally, crystals were formed by a construct of human C-terminal domain 
of ATG16L1 starting at position G303, including surface entropy mutations E354A/K355A along with 
the Y607P mutation. Initial crystals appeared in three conditions presented in Table 30. 
Screen Protein 
Concentration 
Temp Composition Crystal Morphology 
JSCG Core III 5 and 10 mg/ml 20°C 1.6M (NH4)2SO4;  
0.1M NaCl;  
0.1M HEPES pH 7.5 
multiple flower-like cluster 
of plates 
JSCG Core III 5 and 10 mg/ml 20°C 1.6M (NH4)2SO4;  
10%v/v 1,4-Dioxane;  
0.1M MES pH 6.5 
multiple flower-like cluster 
of plates 
JSCG Core II 5 mg/ml 20°C 2M (NH4)2SO4;  
2%v/v PEG400;  
0.1M HEPES pH 7.5 
Microcrystals 
Table 30: Initial crystallization conditions of C-terminal domain of human ATG16L1 
Crystals grew in clusters of plates, at both 5 mg/ml and 10 mg/ml at 20°C and first appeared after 
one or two days and stopped growing after six days. Microcrystals were detected after five to six 
days under the same conditions as the clusters. 
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Figure 46: Initial crystals of C-terminal domain of human ATG16L1. Inital drops and conditions are presented 
on the left hand side. Red areas of interests were imaged under higher resolution and under polarized light 
and presented on the right hand side. 
Initial crystals were reproducible, however always present in a cluster of plates. This might indicate 
multiple crystal growth from the same origin. However, due to multiplicity of overlapping crystals, 
collection of a unique diffraction pattern was not possible. Thus, crystals from initial conditions were 
used to confirm their content. A few of the larger crystals from JSCG Core III C3 and JSCG Core III E3 
were harvested, rinsed and dissolved in 2x SDS loading buffer.  
 
Figure 47: SDS-PAGE analysis of crystals from JSCG Core III C3 and JSCG Core III E3 
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A single band observed on the gel in Figure 47 corresponds to the size as protein construct used for 
crystallization trials (ATG16L1_303-607 has a size of 35kDa). The band was sent for tryptic digest and 
identification of peptides by mass spectrometry. The analysis confirmed that the protein belongs to 
human ATG16L1 (with protein sequence coverage of 25% and top score of 119).  
4.1.9.1 Crystal optimization 
The composition of the three conditions that yielded crystal formation is quite similar, with high 
concentration of ammonium sulfate as main precipitate, in the buffer of pH in the range from 6.5 to 
7.5. To optimize the crystal form and obtain single crystals suitable for data collection, random and 
grid screens were designed taking into account components from the three initial conditions. First 
round of optimization gave three new conditions at 20°C (Figure 48). There was no crystal growth at 
4°C. 
Addition of 10 % PEG 3350 to the fine screen caused the crystals to grow slower, appearing only after 
five days. In addition, it would seem 10 % PEG 3350 reduced the number of nucleation events. In the 
drops with 10 % PEG 3350, only one to two big crystals were visible, regardless of protein 
concentration. The condition with 0.1 M NaCl had crystals after two days, with two crystals in the 
condition with 5 mg/ml of protein, and multiple crystals with 11 mg/ml of protein. Even though many 
new crystals grew, they were all still multiple, with many crystals growing from the same origin 
(Figure 48). 
 
Figure 48: First round of crystal optimization 
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For the second round of optimization, another random screen was designed with the following 
ranges: 
Parameter Range 
pH 6.0-7.5 
(NH4)2SO4 1.5-2-0 M 
PEG 3350 0-10 % 
NaCl 0-200 mM 
PEG400 0-100 % 
1,4-Dioxane 0-5 % 
LiCl 0-200 mM 
Table 31: List of compounds and their range included in the generation of a random screen 
The second optimization screen was set up with 10 mg/ml of protein, in 96-well plates, at 20°C and 
30°C, as well as in 15-well plate at 20°C. All the crystals that grew from the second round of 
optimization were still multiple and clustered. Conditions grown in a 15 well plate did not yield any 
crystals. Additive screen and silver bullet screens were also tested with the following condition: 
1.6 M (NH4)2SO4, 10 % PEG 3350, 0.1 M MES pH 6.4. All the crystals grew in clusters. 
To overcome clustered crystal growth, some of the crystals from the optimization trials were used to 
prepare a seed stock and set the first optimization screen with the seed and 3 or 7 mg/ml of protein. 
The first round of seeding did not yield any single crystals.  
The second fine screen set up at 30°C showed some promising crystals. One crystal in particular was 
a solid three dimensional rectangle on one side, while the other half was a cluster (Figure 49). 
 
Figure 49: One of the crystals harvested for data collection. Crystal circled in green had a well-structured 
rectangular half which was used for data collection.  
The solid rectangular part of the crystal was frozen in 12 % 2-3 butane-diol as cryoprotectant and 
measured at BESSY beamline 14.2, Berlin. A data set of 360 degrees was recorded on Pilatus 
detector. Initial processing was done with XDSAPP. The space group was determined to be centered 
monoclinic C2, space group number 5. C2 space group has 4 asymmetric units. An asymmetric unit is 
the smallest part of the unit cell, which can be used to reconstruct the unit cell by applying all the 
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symmetry operations. Thus, one asymmetric unit contains all the information needed to reconstruct 
the entire crystal.  
Wavelength  0.918409 nm 
Detector distance  213.97 mm 
No. of frames 360 
Oscillation range 1 degree/frame 
Space group 5 (C2) 
Table 32: Data collection 
Estimation of the number of macromolecules in the crystallographic asymmetric unit is one of the 
first steps in structure determination. Matthews coefficient (Vm = volume of asymmetric 
unit/molecular weight) is directly correlated with the protein crystal solvent content. Based on the 
unit cell dimensions, space group and molecular weight of the protein, distribution of Matthews 
coefficient can estimate the number of macromolecules present in the asymmetric unit of the 
crystal. For the C-terminal domain of ATG16L1, presence of one molecule/AU is most probable with a 
Matthews coefficient calculated to be 1.90 Å3/Da and solvent content of 35.34 % (Kantardjieff & 
Rupp 2003; Matthews 1968; Weichenberger & Rup, 2014). The self-rotation function is another tool 
used for determination of the number of macromolecules in the asymmetric unit and how they are 
related. Figure 50 depicts the self-rotation function calculated using the data set of C-terminal 
domain of ATG16L1 and the two strongest peaks at 90°/-90° indicate the twofold crystallographic 
rotation axis.  
 
Figure 50: Self rotation function. The κ = 180° section of the self-rotation function calculated for the 
ATG16L1_303-607 data set using POLARRFN (Collaborative Computational Project No. 4, 1994) with an 
integration radius of 20 Å and data in the resolution range 20–4 Å. 
4.1.9.2 Structure determination 
Structure of C-terminal domain of ATG16L1 was solved using a molecular replacement approach. This 
method relies on the existence of already known protein structures which are similar to the target 
protein. The most well-known algorithm that allows comparison of the protein sequence against a 
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non-redundant database of all known sequences is BL AST (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
Peptide sequence for C-terminal domain of human ATG16L1 (303-607) was submitted for BLAST 
alignment against the PDB data base and resulted in the following list of hits: 
Database: PDB protein database 
77,857 sequences; 19,029,097 total letters 
Query Length=305 
Sequences producing significant alignments Score (Bits) E Value 
pdb|3N0E|A Chain A, Crystal Structure Of Wdr5 Mutant (W330y) 108 5e-27 
pdb|3N0D|A Chain A, Crystal Structure Of Wdr5 Mutant (W330f) 108 6e-27 
pdb|3MXX|A Chain A, Crystal Structure Of Wdr5 Mutant (S62a) 108 8e-27 
pdb|2CNX|A Chain A, Wdr5 And Histone H3 Lysine 4 107 2e-26 
pdb|2YMU|A Chain A, Structure Of A Highly Repetitive Propeller 109 2e-26 
pdb|2CO0|A Chain A, Wdr5 And Unmodified Histone H3 Complex 107 3e-26 
pdb|2G99|A Chain A, Structural Basis For The Specific Recognition 105 6e-26 
pdb|2H68|A Chain A, Histone H3 Recognition And Presentation By Wdr5 105 6e-26 
pdb|3SMR|A Chain A, Crystal Structure Of Human Wd Repeat Domain 105 6e-26 
pdb|2H13|A Chain A, Crystal Structure Of Wdr5 histone H3 complex 105 6e-26 
Table 33: BLAST results of C-terminal domain of ATG16L1 against the PDB data base. Only first top hits 
shown.  
According to BLAST search, ATG16L1 G303-Y607 has highest similarity with WDR5 (PDB code 2CNX) 
with sequence identity of 27 % and sequence similarity of 51 %. The structure of 2CNX was submitted 
to CHAINSAW (Stein 2008) from CCP4, a program which aligns the target and model sequence and 
modifies the side chains of the model in one of three ways: either by reducing all the side chains to 
the Cβ, or by reducing all the side chains to Cγ, or it preserves all the atoms the target and the model 
have in common. Since WDR5 and ATG16L1 are not homologs, CHAINSAW reduced the side chains of 
the WDR5 to the Cβ, thus generating a poly-alanine backbone from the 2CNX PDB file. The poly-
alanine model was then submitted to Phaser-MR in Phenix (Python-based Hierarchical Environment 
for Integrated Xtallography (Adams et al. 2010)). Placement of the search PDB poly-alanine model 
resulted in Top LLG (log likelihood gain) of 122.297, which indicated the molecular replacement was 
successful, but the side chain electron density might be difficult to interpret (Figure 51). SHELXE 
(Sheldrick 2007; Sheldrick 2002) is another program used for improvement of molecular replacement 
solutions. SHELXE was originally designed for experimental phasing using MAD/SAD/SIRAS data, by 
providing iterative phase improvement by density modification. This same approach can be used to 
improve phases of the poly-alanine model using phases calculated from the molecular replacement 
model rather than experimental phases. SHELXE uses calculated phases from the model with 
experimental, measured intensities as Fourier coefficients for calculation of the electron density. 
Poly-alanine chain from the model is then built in the electron density, which undergoes rounds of 
refinement to reduce model bias. SHELXE resulted in a map with more clearly defined electron 
density for side chains of the target protein. The difference between initial electron density maps 
calculated by Phaser-MR and SHELXE is represented in Figure 51. Bulky and/or characteristic residues 
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of the target protein are chosen to demonstrate the difference between Phaser-MR and SHELXE 
initial electron density solutions. 
Output file from SHELXE is further refined in Phenix. Model building was done in COOT (Emsley et al. 
2004; Emsley et al. 2010), an application for model building and validation of macromolecular 
structures. COOT displays an electron density map and atomic models and allows its manipulation 
through the use of various optimization algorithms. Structure of ATG16L1_303-607 had a defined 
density and could be built from amino acid 307 to 607. The N-terminal part, namely residues 
corresponding to the His tag, TEV cleavage site, and to a short stretch from position 303 to 306 were 
not visible in the electron density map. Refinement statistics are summarized in Table 34. 
 
Figure 51: Initial electron density map with poly-alanine model. Light pink is electron density map calculated 
by Phaser-MR: Blue is electron density map calculated by SHELXE. Third set of panels represents the overlay 
of two maps. Residues of the target protein corresponding to each panel set are listed on the left. All maps are 
contoured at 1σ level. Atoms of the poly-alanine chain are colored according to the following scheme: carbon 
in gray, nitrogen in blue and oxygen in red.  
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Space group C 2 
Unit cell dimensions  
a, b, c (Å) 
158.1  38.3  45.8  
Unit cell angles 90.0  105.7  90.0 
Resolution (Å) 50.0 - 1.7 (1.8 - 1.7) 
Measured reflections 198313 (30838) 
Unique reflections 29397 (4553) 
I/σ 20.8 (4.8) 
Completeness (%) 99.8 (99.2) 
Redundancy 6.7 
Wilson B factor (Å2) 17.46 
R factor observed (%) 6.1 (39.2) 
R factor expected (%) 6.1 (38.7) 
R-meas (%) 6.6 (42.5) 
Solvent content (%) 35.34  
  
Rwork (%) 16.82 
Rfree (%) 19.74 
Protein atoms 2323 
Solvent atoms 144 
r.m.s.d. from ideal geometry:  
-Bond lengths (Å) 0.006 
-Bond angles (°) 1.13 
Average B factor (Å2): 26.75 
Ramachandran plot (%):  
-Favored region 95.5% 
-Allowed region 3.8% 
-Outliers 0.7% 
Table 34: Data collection and refinement statistics. Statistics for the highest-resolution shell are shown in 
parentheses. 
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Since phases are either experimentally determined by SIR/MIR or SAD/MAD methods, or inferred by 
molecular replacement, the quality of macromolecular structure has to be judged by several 
parameters to ensure the integrity of the data and minimize the amount of errors introduced during 
model building and refinement process. The program POLYGON (Urzhumtseva et al. 2009) compares 
different indicators of model quality with a number of PDB structures with similar resolution. Quality 
criteria, such as R factors and average B factor, are also presented in the refinement statistics in 
Table 34. However, POLYGON compares these values together with three additional quality 
indicators (r.m.s.d. for bonds and angles, and a clash score) with values calculated for 824 different 
structures at the same resolution. Analysis of structural parameters such as bond length and bond 
angles provide information about the quality of the structure. For a high quality structure, r.m.s.d. 
values for bond lengths should be below 0.02 Å and below 4 degrees for bond angles. Clashes are 
defined as non-covalent unfavorable contacts. Value for the clash score should be as low as possible, 
though a clash score of 0 is unusual. Values for the target structure are plotted as a point on a ruler, 
and connected to with a black line to form a polygon. POLYGON plot for the structural model of C-
terminal domain of human ATG16L1 calculated during this work is presented in Figure 52. 
 
Figure 52: Polygon plot by Phenix. Polygon shows histograms of the distribution of selected statistics across 
824 PBD entries of similar resolution, with the range specified by numbers in red. Statistics for the structure 
of C-terminal domain of human ATG16L1 are printed in black. Frequency of observed values in the reference 
set of structures is color coded: red represents low frequency, blue represents high frequency)  
Three torsion angles define the configuration of a polypeptide backbone. The peptide bond, with its 
partial double bond character, can have torsion angle omega (ω) values of 0° or 180°. The other two 
torsion angles, phi (φ) and psi (ψ) are constrained by steric clashes within each isolated amino acid 
and handedness of the amino acids. Favored combinations of conformational angles (phi and psi) for 
each residue along the peptide chain are greatly restricted and described by a Ramachandran plot. 
Torsion angles phi and psi define either side of the Cα of each residue: phi is defined by N-Cα bond, 
while psi is defined by Cα-C bond. Ramachandran plot reveals plausibility of the geometry of the 
polypeptide backbone and is used as tool for validation of structures.  
Typically, residues involved in β-sheet formation are in the preferred upper left region of the plot. 
For the crystal structure of C-terminal domain of human ATG16L1, 99% of all amino acids fall into 
favored and additionally allowed regions of the Ramachandran plot (Figure 53). 
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Figure 53: Ramachandran plot for all non-proline and glycine residues of C-terminal domain of human 
ATG16L1. Dark blue regions represent torsion angle combinations that give no steric hindrance, while light 
blue areas result in modest repulsion. 
4.1.9.3 Structure of C-terminal domain of human ATG16L1 
X-ray crystal structure of C-terminal domain of ATG16L1 (303-607) was solved by molecular 
replacement with a human WDR5 structure as a model. WDR5 is a WD repeat containing protein 
involved in histone modification (Ruthenburg et al. 2006). Crystal structure of the C-terminal domain 
of ATG16L1 (303-607) confirms this domain folds into a WD-40 propeller, as predicted by Phyre2 
(Figure 15). WD-40 domain of ATG16L1 has a characteristic donut shape with seven β-sheets, each 
composed of four anti-parallel β-strands. From the side view, a narrow top side and a wider lower 
side is observed (Figure 54).  
 
Figure 54: Crystal structure of the C-terminal domain of human ATG16L1 in cartoon representation. The 
peptide chain is colored according to rainbow scheme from the N-terminus (blue) to C-terminus (red).  
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Figure 55: Stereo view of the WD-40 domain of human ATG16L1. The peptide chain is colored according to 
rainbow scheme from the N-terminus (blue) to C-terminus (red) 
The model shown in Figure 54 and Figure 55 is based on the data set with a maximum resolution of 
1.7 Å. Structures in the 1.2-2.0 Å resolution range are considered high resolution structures since the 
level of detail is good enough to clearly distinguish between different amino acid side chains. This can 
be observed in the selection of electron density frames from the model of the WD40 of ATG16L1 
displayed in Figure 56. 
 
Figure 56: 2mFo-DFc maps. First panel shows a tryptophan residue at 2σ level. Second panel shows a proline 
residue with carboxyl terminus at 1σ level. Third panel shows two cysteine residues at 2σ level. 
4.1.9.4 Crystal packing 
C-terminal domain of human ATG16L1 crystalized in centered monoclinic C2 with one monomer in 
the asymmetric unit.  
 
Figure 57: Crystal packing of crystals of C-terminal domain of ATG16L1. Symmetry-related molecules are 
shown in gray. 
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5 Discussion  
5.1 WD-40 proteins 
Most proteins are composed of one or more domains, building blocks of protein structures. A 
domain is considered an independent structural and functional unit of a protein. Some domains are 
well characterized and specific, and their presence in an unknown protein strongly suggests the 
function of the protein. In other cases, the same domain can have multiple, unrelated functions 
depending on the protein it belongs to. One such domain with functional diversity is the WD-40 
domain. Proteins containing WD-40 domain are widely present in eukaryotes and are involved in RNA 
processing, signal transduction, gene regulation and development, vesicular transport, cell cycle 
control, apoptosis and chromatin dynamics (Neer et al. 1994; Xu and Min 2011). The main common 
function of all WD-40 proteins described so far is to facilitate reversible interactions with other 
proteins, peptides or nucleic acids. WD-40 domains have also been reported to catalyze enzymatic 
reactions (Suzuki et al. 2005) adding to the ever growing repertoire of functions described for this 
domain. Based on secondary structure predictions of the primary sequence, C-terminal half of 
human autophagy core protein ATG16L1 is a WD-40 propeller domain (Figure 14). 
WD-40 domain comprises of WD-40 repeats, highly conserved in eukaryotes, with a characteristic 
sequence and structural features. A WD-40 repeat was first described as a reiterated pattern of a 43 
amino acid long β-sheet with highly conserved arginine (R) at position 6, glycine-histidine (GH) 
dipeptide at position 13 and 14, aspartic acid (D) at position 36 and a terminal tryptophan-aspartic 
acid dipeptide (WD) at positions 42 and 43 (Fong et al. 1986). This definition was further refined to 
define the WD-40 repeat as a peptide of 44-60 amino acids, with conserved GH dipeptide at 11-24 
position and a C-terminal WD (Neer et al. 1994; Smith et al. 1999). The name of the motif is based on 
the terminal WD dipeptide, and an approximated initial length of around 40 amino acids.  
Secondary structure of a WD-40 repeat is an anti-parallel β-sheet composed of four β-strands (Figure 
58(iii)). A number (typically seven) of anti-parallel β-sheets fold together into a doughnut-like β-
propeller scaffold structure (Figure 58(i and ii)). A single anti-parallel β-sheet is commonly referred to 
as a blade, because it resembles a blade in a propeller. Using X-ray crystallography methods, a high 
resolution structural model of the C-terminal domain of human ATG16L1 confirmed the WD-40 
propeller of human ATG16L1 folds into a typical WD-40 domain, with seven β-sheets (blades), each 
composed of four anti-parallel β-strands (Figure 54). 
A WD-40 propeller has three large surfaces: a narrow top, a wider, bottom surface and the entire 
circumference of the doughnut (Figure 58(i)). Top surface is defined as the side with the loop 
connecting strand D from one blade with strand A from the next (Smith et al. 1999; C. Xu & Min, 
2011). One of the arguments why WD-40 domains are so conserved and versatile at the same time 
comes exactly from the great interaction platform this domain provides.  
 
Discussion 
 
91 
 
 
Figure 58: Overall WD-40 domain architecture. (i) Side view of the WD-40 propeller. (ii) Top view of the WD-
40 propeller with 7 anti-parallel β-sheets numbered. Each β-sheet is composed of 4 β-strands. (iii) Structural 
arrangement of one WD-40 repeat, formed by three (A-C) β strands of one, and the forth β-strand (D) from 
another β-sheet. (Stirnimann et al., 2010) 
Such arrangement, where each blade is composed of three strands of one WD-40 repeat and the last 
for the next, provides stability and rigidity to the overall domain. This characteristic arrangement is 
also present in the WD-40 domain of ATG16L1 (Figure 54). 
Each blade of the typical seven-bladed WD-40 domain has two main variable regions, which are not 
essential for the fold of the domain, but more likely provide the specificity and the function. The 
largest flexible region, represented in green in Figure 59, is between strand C of one blade and strand 
A of the next (including strand D). This region can vary between 11 and 150 residues in length. The 
loop between strands C and D protrudes from the bottom of the propeller, while the loop between 
strands D and A of the next blade is exposed to the top surface. Strand D is exposed to the outside 
surface of the propeller. Second variable region (Figure 59, in red) is shorter, between strands A and 
B of the same blade, and forms a loop exposed to the bottom of the propeller (Smith et al. 1999).  
 
Figure 59: Two flexible regions of WD-40 domain. Typical, seven bladed WD-40 domain is represented in 
gray. The largest flexible region between strand C of one blade and strand A of the next is colored in green. 
Second variable region between strands A and B of the same blade is colored in red.  
Due partially to these variable regions, interaction surface of the WD-40 proteins with other proteins 
and peptides are more often at the top, narrow end (Russell et al. 1998). However, the bottom 
surface of the propeller with the variable region between strands C and D as well as the 
circumference composed mainly of un-conserved D strands have also been shown to provide a 
platform for protein binding (Figure 60). The variability in the regions of binding areas might be 
another reason why these domains are so common. Creating a new binding site by introducing 
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changes to one or two WD-40 repeats, while preserving the common fold, might be evolutionarily 
more efficient than generating an insertion or deletion which might lead to drastic changes in the 
structure of other domain families, lacking the regular repeats to maintain the overall domain fold. 
(Stirnimann et al. 2010). 
 
Figure 60: Interaction surfaces of WD-40 domain. (a) Side view of the WD-40 domain showing 13 known 
interaction partners. Most of the interactions are concentrated on the top surface, close to the center. (b) Top 
view of the WD-40 domain showing 6 known interaction partners occupying all three possible binding 
surfaces: top, bottom and the circumference. (Stirnimann et al., 2010) 
5.2 WD-40 domain of human ATG16L1 
5.2.1 Conservation of WD-40 domain of ATG16L1 in higher eukaryotes 
A key member of core autophagy machinery involved in nucleation and elongation of the 
phagophore membrane is ATG16L1. In yeast, this protein is 150 amino acids long and composed of 
an ATG5 binding domain and a coiled coil domain. This basic architecture present in the yeast ATG16 
protein is conserved through eukaryotic systems and essential for canonical autophagy. In addition 
to these two fundamental domains, ATG16 in higher eukaryotes additionally has a WD-40 domain, 
absent from the yeast homologue (Figure 61).  
 
Figure 61: Graphical domain representation of human ATG16L1 and yeast ATG16 
Absence of the WD-40 domain from the yeast ATG16 indicates this domain is not involved in 
canonical, bulk autophagy induced by starvation or rapamycin treatment. Comparison of human 
ATG16L1 protein sequence across species shows WD-40 domain is well conserved in higher 
eukaryotes. This cross-species conservation of the WD-40 domain indicates certain structural and 
functional importance. WD-40 domain of human ATG16L1 (303-607) was used in BLAST-p to search 
for non-redundant orthologues. A broad range of orthologues was detected including invertebrates, 
amphibians, fish, birds and mammals. An alignment of WD-40 domain of ATG16L1 from five 
representative species was performed using Clustal Omega and the result is presented in Figure 62. 
ATG5-BD CCD WD40M1 Y607ATG16L1 (H. sapiens)
ATG16 (S. cerevisiae) ATG5-BD CCDM1 K150
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Figure 62: Clustal Omega multiple alignment of the WD-40 domain of ATG16L1 in higher eukaryotic 
organisms. X. = Xenopus laevis (African clawed toad), H. = Homo sapiens (human), M. = Mus musculus (house 
mouse), A. = Acanthisitta chloris (small bird), C = Chelonia mydas (green sea turtle). An * (asterisk) indicates 
positions which have a single, fully conserved residue. A : (colon) indicates conservation between groups of 
strongly similar properties. A . (period) indicates conservation between groups of weakly similar properties. 
Human WD-40 domain of ATG16L1 has 95% sequence identity with the mouse orthologue, 89% with 
A. chloris (a small bird), 86% with X. laevis (African clawed toad) and 84% with C. mydas (green sea 
turtle). Amino acids marked with an asterisk (*) in Figure 62 are conserved across higher eukaryotic 
species. On the structural model of WD-40 domain of ATG16L1, these conserved residues are marked 
in orange (Figure 63) and are distributed throughout the WD-40 domain of ATG16L1. 
 
Figure 63: Conserved WD-40 domain residues. Residues marked with * (asterisk) in Figure 62 are marked in 
orange on the WD-40 domain of ATG16L1 (represented in cartoon, in gray). 
In the case of lower eukaryotes, both sequence similarity and conservation in this region of the 
protein are low (Figure 64). Human WD-40 domain (303-607) has 56 % sequence identity with 
Camponotus floridanus, 51 % with Crassostrea gigas, and 45 % with Echinococcus granulosus.  
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Figure 64: Clustal Omega multiple alignment of the WD-40 domain of ATG16L1 with lower eukaryotic 
organisms. E. = Echinococcus granulosus (type of tape worm), Cr. = Crassostrea gigas (oyster), H. = Homo 
sapiens (human), Ca. = Camponotus floridanus (carpenter ant). An * (asterisk) indicates positions which have 
a single, fully conserved residue. A : (colon) indicates conservation between groups of strongly similar 
properties. A . (period) indicates conservation between groups of weakly similar properties 
Naturally, the sequence identity between human and low eukaryotic organisms is very low. However, 
the ATG16L1 of tape worm and oyster have what seems to be a more complete WD-40 domain 
compared to the carpenter ant. The fact that the WD-40 domain is missing from yeast ATG16 but is 
partly present in other lower eukaryotes and conserved in higher eukaryotes indicates that the WD-
40 domain of ATG16L1 evolved with different species, and is possibly still evolving, adjusting itself to 
the unique requirements and needs of organisms it belongs to and their environments.  
5.2.2 Comparison between WD-40 domain of ATG16L1 and other WD-40 
domains 
WD-40 domain proteins are one of the largest domain families present in eukaryotes with the widest 
range of interaction partners (Stirnimann et al., 2010). WD-40 domain can interact with other 
proteins, peptides and nucleic acids using one of three large surfaces (top, bottom and 
circumference) (Stirnimann et al., 2010). Most structurally characterized WD-40 domains have seven 
blades and secondary structure prediction suggests the WD-40 domain of human ATG16L1 is 
composed of 30 β-strands (Figure 14). Furthermore, Hampe et al. proposed this domain to have eight 
C-terminal repeats with 32 β-strands based on extensive use of alignment and prediction algorithms 
together with already structurally characterized WD-40 domains (Hampe et al. 2006). However, the 
high resolution X-ray structure of WD-40 propeller of ATG16L1 revealed during this work clearly 
shows the complete propeller is composed of seven blades, each comprising of four anti-parallel β-
strands (resulting in a total of 28 β-strands, Figure 54). As already mentioned, due to low sequence 
conservation and high functional diversity of WD-40 domains, results obtained by prediction 
algorithms must be treated with great caution. They are very powerful and their importance in 
crystallography and protein study should not be underestimated, however their shortcomings must 
also be considered. In the case of the WD-40 domain of ATG16L1, and possibly in many other cases, 
prediction and modeling studies have been enough to predict the overall fold of the domain, but only 
high resolution structural determination could show the amount of detail needed for more in depth 
understanding of this promiscuous domain.  
To determine the structure of human ATG16L1 WD-40 domain with molecular replacement method, 
WD-40 domain of ATG16L1 (303-607) was used in BLAST-p to search for structurally similar models in 
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the protein data base (PDB). From the results, top five structures with highest alignment score are 
listed in Table 35.  
PDB code Protein Organism Cellular 
process 
PyMOL 
r.m.s.d. 
(Å) 
Max 
Score 
Seq 
ident 
(%) 
2CNX_A Wdr5 Homo sapiens transcription 1.1 107 27 
4WJV_A Rsa4 Saccharomyces 
cerevisiae 
ribosome 
biogenesis 
7.5 89.4 26 
1VYH_C Paf-Ah Mus musculus signal 
transduction 
1.5 85.9 23 
2OVP_B Skp-1 Homo sapiens cell cycle 3.2 79.3 24 
4LG9_A Tbl1xr1 Homo sapiens unknown 2.8 77.8 24 
Table 35: List of top five structurally characterized WD-40 domains identified used BLAST-p and PDB. The 
root-mean-square deviation (r.m.s.d.) is the measure of the average distance between the Cα atoms of 
superimposed proteins. Max score described the highest alignment score between the query sequence and the 
database sequence segment.  
The result with the highest score, Wdr5 (PDB: 2CNX_A, (Ruthenburg et al., 2006)) was successfully 
used as a molecular replacement model for structure determination of WD-40 domain of ATG16L1. 
Superposition of WD-40 domain of ATG16L1 with the top hit from Table 35, Wdr5, (Figure 65) 
resulted in lower r.m.s.d. value compared to other structures, which confirms the assumption that 
based on current structural knowledge of WD-40 domains, Wdr5 is the best fitting model for WD-40 
domain of ATG16L1.  
 
Figure 65: Superposition of the WD-40 domain of ATG16L1 (in gray) with Wdr5 (PDB: 2CNX, (Ruthenburg et 
al., 2006), in lemon).  
5.2.3 Discrepancies between predicted and actual secondary structure elements 
of WD-40 domain of ATG16L1 
Since not all WD-40 propeller domains have seven blades, and due to the low sequence conservation 
of the domain, prediction algorithms often omit or add one or two β-strands at the beginning or at 
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end of the domain. However, without a structural model, these predictions are the best information 
available. Since structural studies rely on the predictions of secondary structures for construct 
design, it is also essential that the shortcomings of these predictions be understood and considered 
during determination of construct boundaries. Once the structural model is available, true 
arrangement and architecture of the domain is evident, and can then be compared to the predicted 
elements. For the WD-40 propeller of human ATG16L1 this comparison is presented in Figure 66.  
 
Figure 66: Human ATG16L1 with experimental structural elements for the WD-40 domain compared with the 
PSIRPED v3.3 output (predicted secondary structure). Purple line represents loops and turns in the structural 
model. Green arrows with purple outline represent β-strands in the structural model.  
Construct which resulted crystals started at position G303. However there was no electron density 
for residues 303-306 which suggests these residues are flexible with high degree of freedom. 
Glutamate (E) at position 307 is the first residue with defined electron density for the α carbon. 
According to the secondary structure prediction, the first β-strand starts with R286 to S290 and the 
second β-sheet is V309-R310 (Figure 66A). The fact that R286-Y607 construct never resulted in a 
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crystal suggests the peptide stretch from R286-E307 is a flexible tail which might prevent crystal 
contacts from forming or from persevering long enough for crystal growth. ATG16L1 E307-Y607 
arranges into a complete WD-40 domain, which supports the notion that the predicted R286-S290 β-
strand is an algorithmic artifact, or at the very least, that it is not part of the WD-40 domain. The 
dipeptide V309/R310, predicted to be a short β-strand, is part of the N-terminal tail of the G303-
P607 structure. Thus, this short strand is clearly an algorithmic artifact. These first two predicted β-
strands are thus both incorrectly predicted as belonging to the WD-40 propeller. However, the 
majority of the predicted β-strands are quite accurate within one to two residues error margin, with 
the exception of last β-strand and the seventh β-strand from the C-terminus (Figure 66). The seventh 
β-strand was predicted from W537 until F542. Structure of WD-40 of ATG16L1 revealed this strand is 
much shorter spanning from V540 to F542. The last β-strand was predicted from A601 until L603, but 
in reality is four residues longer, from K600 to A605.  
5.2.4 Discrepancies between wild type and crystalized WD-40 domain 
Crystals are periodic arrangements of fundamental building blocks (proteins), with a very limited 
number of interactions forming and maintaining the network of proteins together in a crystal. Inter-
molecular interactions are not only few but also weak, and very sensitive to environmental change. 
The few, weak, essential interactions are inherent of the particular protein and cannot be predicted 
beforehand. Thus, manipulation of the protein is essential in to overcome this obstacle and increase 
the chances of crystal contact formation. For this purpose, charged, flexible residues with high 
surface entropy can be successfully mutated to alanine for improved crystallization. In the case of 
WD-40 propeller of ATG16L1, surface entropy reduction mutations (E354A/K355A) were necessary 
but not sufficient for crystallization. Surface entropy reduction mutations, shown in Figure 67 on the 
gray molecule, together with solvent exposed side chains of the neighboring molecule show E354A 
and K355A reduced long flexible side chains and eliminated steric hindrance, which would have 
otherwise prevented the two molecules from coming close together. 
 
Figure 67: Surface entropy reduction mutations on WD-40 domain of ATG16L1. In green are two alanine 
residues, which in wild type are glutamine and lysine (E354A/K355A). Sand colored molecule is symmetry-
related, neighboring protein and solvent exposed side chains.  
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In addition to the two surface entropy mutations (E354A/K355A), carboxy-terminal tyrosine is 
mutated to a proline (Y607P). Tyrosine is present in the human ATG16L1 while proline is in the 
mouse ATG16L1 (Figure 17). This mutation should not lead to any functional disruption since mouse 
and human ATG16L1 have high sequence identity (95%). The carboxyl terminus is positioned in such 
a way that it forms hydrogen bonds with the backbone on the neighboring molecule (Figure 68A). C-
terminal proline might form Van der Waals interaction with the phenylalanine from the neighboring, 
symmetry-related molecule in the crystal (F467) (Figure 68B). If the human wild type tyrosine is 
modeled in place of proline, it becomes evident the same crystal contacts could not be maintained 
due to steric clashes (Figure 69). However, a single C-terminal tyrosine to proline substitution was 
not enough to produce crystals. Thus, it was a combination of both surface entropy reduction 
mutants and the C-terminal tyrosine to proline substitution resulted in elimination of steric obstacles 
and allowed formation of the few, weak crystal contacts sufficient for successful crystal growth 
(Figure 68B).  
 
Figure 68: A) Hydrogen bonds between two proteins in the crystal. Proline at the carboxyl terminal of WD-40 
propeller of ATG16L1 is labeled on the gray molecule and distances are shown, with dashed lines (in Å) 
between two symmetry related molecules (gray and sand). B) Wan der Waals contacts between two proteins 
in the crystal. Gray molecule has A354 and A355 (green) and P607 (purple) labeled. Distances to the side 
chains on the neighboring molecule (sand) are shown with a dashed line, in Å. 
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Figure 69: Model of tyrosine at the C-terminal end in crystal structure of WD-40 of ATG16L1. The top panel 
shows proline at C-terminus. Six panels represent modeled tyrosine (green) at the C-terminus. Red circles 
represent steric clashes. Each of six panels represents one rotamer of tyrosine, with its probability value in 
the lower left corner of the panel. Two neighboring molecules are shown in gray and sand color.  
5.2.5 Quaternary structure of WD-40 propeller of human ATG16L1 
Human ATG16L1 is a member of core autophagy machinery, involved in initiation and elongation 
step. It is a 607 amino acid long protein, roughly composed of three main functional units: N-terminal 
ATG5 binding domain (ATG5 BD), coiled coil domain (CCD), and C-terminal WD-40 propeller. 
Recently, high resolution structure of C-terminal WD-40 domain was solved during the course of this 
work (Figure 54). C-terminal domain of human ATG16L1 folds into a typical, seven bladed WD-40 
propeller. Up to date, both ATG5 BD and CCD of yeast ATG16 have been solved (Figure 70). In the 
case of human ATG16L1, Otomo et al. recently solved the structure of the N-terminal ATG5 BD, a 
short helix involved in interaction with ATG5 (Mizushima et al. 1999; Otomo et al. 2013). Structural 
studies of the yeast ATG16 (Fujioka et al. 2010) together with biophysical analysis of CCD of human 
ATG16L1 (Parkhouse et al. 2013) show that the CCD assembles into a parallel dimer, resulting in 
dimerization of ATG16L1, and in turn dimerization of the ATG12~ATG5/ATG16 complex. By analogy, 
this would indicate that the WD-40 propeller of ATG16L1 may also form a WD-40/WD-40 interfacing 
dimer.  
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Figure 70: Current state of structural knowledge of human and yeast ATG16. Structure of human ATG16L1 
ATG5 binding domain (in orange) has been solved in complex with ATG5~ATG12 conjugate (ATG5 in purple, 
ATG12 in light blue) (Otomo et al. 2013). The structure is here modeled into a dimer using PyMOL. Structure 
of the coiled-coil domain of yeast ATG16 (in green) was solved and showed that the CCD domain assembles 
into a parallel dimer (Fujioka et al. 2010) indicating that ATG16 self-dimerizes. WD-40 domain is solved in 
this work and is represented here as rainbow colored from N to C-terminus.  
In biophysical studies, WD-40 propeller of ATG16L1 behaves as a monomer (Figure 36, Figure 39). In 
the crystal, two symmetry mates of the propeller are present with the N-terminus pointing in the 
same direction (Figure 71). Such orientation of WD-40 propellers is in agreement with the 
physiological parallel dimer of the full length ATG16L1. AREAIMOL (Saff & Kuijlaars 1997; Lee & 
Richards 1971) calculated the buried surface area of the interface of 3367Å2 (Table 36). Contacts 
between the two molecules are dominated by hydrophobic interactions. It is possible this interaction 
is a result of high protein concentration and crystallographic forces. 
 
Figure 71: Symmetry mates of WD-40 domain of ATG16L1. Two symmetry related molecules of the WD-40 
domain of human ATG16L1 colored in gray (chain A) and sand (chain A*). N-terminal tail is labeled in blue 
on both molecules. 
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Total area of chain A 11499.0 Å2 
Total area of chain B 11494.4 Å2 
Total overall area 22993.4 Å2 
Total contact area of chain A 3367.5 Å2 
Total contact area of chain B 3366.1 Å2 
Total overall contact area 6733.6 Å2 
Table 36: AREAIMOL calculated surface area of two symmetry related WD-40 molecules 
Since the WD-40 domain of ATG16L1 is a monomer is solution, it might form a dimer only when 
certain forces are applied: either crystallographic forces or dimerization of the entire ATG16L1 
molecule. The dimerization of ATG16L1 through the coiled coil domain might bring the two WD-40 
domains in the correct orientation and close enough to facilitate domain dimerization as well. 
Alternatively, the overall dimer conformation of the ATG16L1 might be enough to maintain the WD-
40/WD-40 platform with no additional dimerization surfaces on the propeller. However, lack of full 
length structure of ATG16L1 prevents us from knowing if the WD-40 domains really generates an 
even greater interaction platform, or if they have enough freedom of movement within the dimer to 
act independently from one another. Structural studies of full length ATG16L1 are needed to answer 
this question.  
5.2.6 B-factor analysis and DWD/WDxR box 
Proteins are not static molecules. Peptide backbone and atoms in the side chains change due to 
kinetic energy and thermal motion. The B-factor of a protein structure reflects displacement of 
atoms from their average position. Low B-factors usually indicate rigid parts of the protein. High B-
factors indicate areas of the protein with high flexibility and mobility. Based on the B-factor map of 
the WD-40 domain of ATG16L1 (Figure 72), the constriction of the propeller has low B-factors, 
implying a rigid and stable fold with low flexibility. The constriction is made up of strands A of each 
blade. B-factor increases towards the outside of the WD-40 propeller, with strands A having the 
lowest and strands D having the highest B-factor. As far as β-strands are concerned, strands D 
belonging to blades 2, 3, 4 exhibit the highest level of flexibility. Blade 3 is particularly interesting for 
two reasons: strand C of blade 3 has highest B-factors of all strands C, and blade 3 loops facing the 
bottom of the propeller (between strands A and B and strands C and D) are also quite flexible. Region 
between strand C of one blade and strand A of the next (including strand D and the loops) is where 
greatest variation is found in WD-40 propellers (Figure 59). The second variable region is the loop 
between strands A and B. In the case of WD-40 propeller of ATG16L1, the loop between A and B 
could not be completed during model building due to the lack of electron density in this region. 
Absence of electron density in the part of the protein could be due to one of two reasons: either 
there was a cleavage event, or the disorder level is too high. However, since dissolved crystals did not 
result in a double band nor in a size decrease when dissolved and loaded on an SDS PAGE gel (Figure 
47), high level of disorder in this loop is a more likely explanation for the absence of electron density.  
Notably, the loop between strand A and B of the blade 3 participates in formation of no contacts 
with neighboring symmetry related mates, which might be a reason for the lack of electron density in 
that region. Alternatively, the flexibility of this loop might have functional relevance.  
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Figure 72: B-factor distribution on WD-40 propeller of ATG16L1. Core of the propeller has low B-factors, 
indicating low flexibility of the side chains. B-factors increase towards the outside of the propeller, with 
highest B-factors on blade 3 of the propeller.  
Based on the B-factor analysis, blade 3 of WD-40 propeller of ATG16L1 seems to be the most flexible 
part of the protein in the crystal. As alluded earlier, this flexibility might either be functionally 
important, or arise due to the lack of stabilizing crystal contacts between this area of the molecule 
with neighboring mates. Closer analysis at the crystal contact distribution (Figure 73) indicates no 
obvious or drastic reduction between contacts formed by blade 3 compared to the contacts formed 
by other blades of the propeller. This observation allows the conclusion that the flexibility of blade 3 
has functional implications. However, further studies are needed to confirm this assumption. 
 
Figure 73: Crystal contacts formed by WD-40 propeller of ATG16L1 in a crystal. WD-40 propeller is 
represented in colors according to B-factors .Crystal contacts are depicted in gray, in the radius of 6 Å.  
The top, narrow end of the WD-40 of ATG16L1 exhibits lower B-factor distribution compared to the 
bottom of the propeller. Thus, based on the B-factor analysis, it could be assumed that the functional 
surface of the WD-40 propeller of ATG16L1 is either on the bottom of the propeller, and/or at the 
circumference in the region of blade 3.  
Support for the hypothesis that blade 3 of ATG16L1 WD-40 propeller has a functional relevance is 
also found in the literature. He et al. defined the DDB1-binding and WD-40 repeat (DWD) box, a 16 
amino acid stretch present on DCAFs. Proteins containing DWD box are not limited to one, but can 
sometimes contain two DWD boxes, however seldom three. He et al. showed that ATG16L1 binds 
DDB1 via this motif (He et al. 2006). DWD box identified by He et al. is located on the strand B and 
strand C (including the loop between them and part of the loop between strands C and D) of blade 3 
of the ATG16L1 WD-40 domain (Figure 74).  
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Figure 74: DWD (the DDB1-binding and WD-40 repeat) box (green) defined by He et al. on the WD-40 
propeller of ATG16L1 (gray).  
Point mutation of an arginine to alanine at position 424 on ATG16L1 disrupted the binding with DDB1 
(He et al. 2006). However, in the DWD box identified by He et al. the only arginine is at position 438. 
For the further discussion purposes, the reported arginine 424 and arginine 438 are treated as one 
and the same. From the structural model of WD-40 of ATG16L1, this proposed functionally essential 
residue is in the loop between strands C and D of blade 3, facing the bottom of the propeller (Figure 
75).  
DWD box is an extension of a more general motif found on a variety of WD-40 propellers. This 
conserved DxR or WDxR motif is commonly found on WD-40 substrates of DDB1/CUL4. Similarly to 
the DWD box, WDxR motif often occur twice on the propeller, at the end of strand C of two 
consecutive blades (Angers et al. 2006). 
 
Figure 75: Position of conserved arginine involved in DDB1 binding on WD-40 domain of ATG16L1. In this 
figure, bottom and side view of B-factor distribution of WD-40 domain of ATG16L1 is presented. Arginine 
(R438 labeled in purple) is proposed to be the conserved residue on the DWD box present on DCAFs binding 
to DDB1-CUL4 (He et al., 2006). On WD-40 domain of ATG16L1 this arginine is on the flexible loop between 
strands C and D on blade 3.  
In the case of ATG16L1, one WDxR motif, WDLR labeled in red in Figure 76, is contained within the 
DWD box, on the loop between strands C and D of blade 3. The second WDxR motif, labeled in blue 
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in Figure 76, is on the corresponding loop on the neighboring blade 4. Both motives are located on 
the bottom surface of the propeller. 
 
Figure 76: WDxR motives on the WD-40 of ATG16L1. WD-40 propeller is labeled in gray. Two WDxR motives 
are labeled according to the following scheme: WDLR in red and WDIR in blue.   
Based on the high B-factors present identified in the crystal structure of WD-40 of ATG16L1 and the 
functional assay performed by He et al., blade 3 of the WD-40 of ATG16L1 with its loops facing the 
bottom of the propeller could play a major functional role of this domain. However, the functional 
role of the WDxR containing region is not necessarily part of the interaction surface between DCAFs 
and DDB1/CUL4, as assumed by He et al.. In case of DDB2, the WDxR motif is not part of the surface 
involved in the binding to DDB1 or to DNA. Nevertheless, disruption of the WDxR motif on DDB2 
leads to a nonfunctional protein, indicating that intact WDxR motif is important for proper folding 
and/or maintains the stability of the WD-40 propeller rather than being essential for interaction. 
(Scrima et al. 2011)  
It is evident that circumference of the WD-40 domain of ATG16L1 does not exhibit the same level of 
flexibility all around. D strands of blades 5, 6, 7 and 1 seem to be less flexible compared to D strands 
of blades 2, 3 and 4. Since this is not an artifact of crystal contact distribution (Figure 73), it might 
indicate that, if dimerization of the WD-40 domain of ATG16L1 takes place, the surface facilitating 
the dimerization is composed of a part of a region defined by blades 5, 6, 7 and 1. In this case, it 
makes sense to keep the stability of this half of the propeller. Indeed, in the two symmetry mates 
which bury enough surface area to have physiological relevance (Figure 71, Table 36), the interface 
region is composed mainly of blades 5 and 6 of each propeller. On the other hand, it would also 
mean that part of the propeller remains unused. This would only be justified if by dimerization, the 
two bottom surfaces (with parts of blade 3) create a greater super-interaction surface, compensating 
for the part used in dimerization. Additional analysis and identification of the WD-40 domain surfaces 
responsible for interaction with other macromolecules might provide further clues on whether and 
how the WD-40 domain of ATG16L1 interact with each other. 
5.2.7 Surface analysis 
WD-40 propellers provide three main surfaces for interaction with other macromolecules: the 
narrow top, the wider bottom and the circumference. Analysis of protein surface in terms of 
electrostatic potential shows the top of the WD-40 domain of ATG16L1 has a positive charged area 
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on one half around the constriction (Figure 77A, left image). The circumference of the WD-40 domain 
of ATG16L1 is mainly neutral (Figure 77A, two middle images), possibly because the two domains 
exist relatively closely to each other in the ATG16L1 dimer, and should not repel each other by having 
two strong charges facing each other. The bottom of the WD-40 domain of ATG16L1 (Figure 77A, 
right image) shows a strong overall positive electrostatic potential. Based on all three binding 
surfaces available on the WD-40 domain of ATG16L1, the wide bottom surface seems like the most 
obvious choice in terms of areas involved in polar interactions.  
Analysis of the hydrophobic distribution on the surface of the WD-40 propeller of ATG16L1 provide 
little further insight into the possible function of this domain. From Figure 77B, the hydrophobic 
patches are distributed over all three interaction surfaces. Lower half of the circumference area 
between blades 3 and 4 (Figure 77B, second image from the right) provides the largest hydrophobic 
surface, indicating the hydrophobic interactions are facilitated through this interface. However, 
without experimental and structural data of ATG16L1 WD-40 in complex with its interaction partners, 
other surfaces on the WD-40 domain of ATG16L1 cannot be excluded at this point. 
 
Figure 77: Surface analysis of the WD-40 propeller of human ATG16L1. A) Electrostatic surface potential 
calculated by ABPS (Baker et al. 2001) and mapped onto the surface of WD-40 propeller of ATG16L1 in 
PyMOL. Areas marked in red correspond to the negative electrostatic surface potential; areas marked in blue 
correspond to the positive electrostatic surface potential. The surface potential is contoured from -5 to 5 
kBT/e (kB is the Boltzmann constant, T is temperature in Kelvin, e is charge on the electron). B) WD-40 
domain of ATG16L1 colored by hydrophobicity of the residues according to the Eisenberg scale (Eisenberg et 
al. 1984). C) The orientation of the propeller corresponding to the surface shown directly above it.  
5.3 Polymorphism of human ATG16L1  
A naturally occurring missense single nucleotide polymorphism of human ATG16L1, resulting in 
T300A substitution, has been identified as one of risk alleles contributing to Crohn’s disease. Crohn’s 
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disease is a chronic inflammatory disease that can affect any part of the gastro-intestinal track. 
Experiments using the T300A knock-in mice revealed a reduced level of bulk and selective autophagy 
in multiple cell types and diminished clearance of pathogens by macrophages (Lassen et al. 2014; 
Murthy et al. 2014). Functional studies have further shown that T300A ATG16L1 is more prone to 
cleavage by caspase 3 and caspase 7 (Lassen et al. 2014; Murthy et al. 2014). Biophysical studies of 
full length ATG16L1 identified a degradation product at position 307 (Figure 21). Taken together, this 
evidence presents a possibility that the area between 300 and 307 might be inherently fragile and 
the SNP drastically increases its susceptibility for caspase cleavage. 
Cleavage of ATG16L1 T300A full length leads to overall decrease of ATG16L1 protein levels, but does 
not result in the full loss-of-function of autophagy. This is consistent with current understanding that 
Crohn’s disease is a complex disorder caused by a combination of genetic and environmental factors. 
Additionally, this observation gives rise to the notion that the cleaved ATG16L1 might still remain 
partially functional and sufficient to carry out basal autophagy. 
When cleavage occurs at position 300, intact WD-40 domain (307-607) is separated from the full 
length protein and both fragments are still present after 4 hr of caspase activation (Lassen et al. 
2014). Thus, the N-terminal half of ATG16L1 is intact after caspase cleavage and sufficient to 
coordinate bulk autophagy process. On the other hand, WD-40 domain serves as a recruiter or a 
linker between autophagy and other cellular process and has no functional contribution to the basal 
autophagy. Thus, caspase cleavage event detaches the WD-40 domain from the rest of the 
autophagy machinery, which may still retain its ability to form a complex with its interaction partners 
but can no longer act as a physical linker between pathogen recognition and autophagy.  
In addition to the natural SNP, five splicing variants have been described for human ATG16L1 
(UniProt identifiers: Q676U5-1, Q676U5-2, Q676U5-3, Q676U5-4 and Q676U5-5) occurring in tissue-
specific manner. A novel isoform of mammalian ATG16L1 has been identified and termed ATG16L2 
(UniProt: Q8NAA4) (Ishibashi et al. 2011). Sequence comparison between human ATG16L1 and 
ATG16L2 (Figure 78) indicates overall sequence identity of 38.8 % and 67.2 % similarity.  
 
Figure 78: Sequence alignment between human ATG16L1 and human ATG16L2 by Clustal Omega. An * 
(asterisk) indicates positions which have a single, fully conserved residue. A : (colon) indicates conservation 
between groups of strongly similar properties. A . (period) indicates conservation between groups of weakly 
similar properties. 
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Both isoforms are similar in domain arrangement, in that they both have an N-terminal ATG5 binding 
domain, middle coiled-coil region and a C-terminal WD-40 domain. Consequently, both isoforms of 
mammalian ATG16L1 have been shown to form dimers (both ATG16L2/ATG16L2 and hetero-dimers 
ATG16L1/ATG16L2) and bind ATG5~ATG12 conjugate (Ishibashi et al. 2011). However, ATG16L2 
isoform was not found on the growing autophagosomal membrane (Ishibashi et al. 2011), indicating 
this isoform is dispensable for bulk, canonical autophagy and cannot compensate for the loss of 
function of ATG16L1. However, in an independent study, knock-down of ATG16L2 resulted in higher 
occurrence of autophagy (Lipinski et al. 2010) suggesting that ATG16L2 is indeed involved in 
canonical autophagy as a negative regulator.  
Regardless of the involvement of ATG16L2 in canonical autophagy, sequence analysis of the C-
terminal domain (303-607) between ATG16L1 and ATG16L2 indicates 51.2% sequence identity and 
78.1 % similarity. Due to high similarity between the C-terminal domain of the two isoforms, 
ATG16L2 might be important for other types of autophagy, such as xenophagy. Further work is 
needed to clearly define if and which role ATG16L2 pays in which type of autophagy. 
5.4 Putative interaction partners of WD-40 domain of ATG16L1  
Cellular pathways are often regulated by transient assemblies of dynamic complexes. Common 
feature of all WD-40 domains characterized so far is a scaffolding function. As a scaffold, WD-40 
domains serve as an interaction platform for proteins, peptides and nucleic acids. Other than being 
essential for autophagy, ATG16L1 has been implicated in pathogenic control (Kuballa et al. 2008), 
antigen presentation (Cooney et al. 2010) and Crohn’s disease (Barrett et al. 2008). More precisely, 
the WD-40 domain of ATG16L1 has been shown to bind DDB1 (He et al. 2006), CARD domain of 
NOD1 and CARD1 domain of NOD2 (Ramjeet et al. 2010; Travassos et al. 2010), TIR domain of TLR2 
and a short cytosolic peptide of TMEM59 (Boada-Romero et al. 2013). Boada-Romero et al. have 
identified an ATG16-binding motif ([YW]-X(2,6)-[ED]-X(2,6)-[YWF]-X2-L) in CARD1 domain of NOD2, TIR 
domain of TLR2 and in TMEM59, responsible for an interaction with WD-40 domain of ATG16L1. This 
novel binding motif is incomplete on CARD domain of NOD1, and there is conflicting evidence if 
NOD1 interacts with ATG16L1 (Boada-Romero et al. 2013; Travassos et al. 2010). Proposed ATG16L1-
binding motif is highlighted in red on each molecule in Figure 79, and is surface exposed and in 
principle accessible for interaction by the WD-40 domain of ATG16L1. However, no corresponding 
binding motif has been identified on the side of the ATG16L1.  
 
Figure 79: ATG16L1-binding motif on the proposed interaction partners. CARD domain of NOD1 is 
represented as cartoon in green (PDB code: 2NZ7, (Srimathi et al. 2008)). TIR domain of TLR2 is represented 
as cartoon in pink (PDB code: 1FYW, (Xu et al. 2000)). CARD1 and CARD2 domains of NOD2 are represented 
as cartoon in blue, and modeled using Phyre2 server (93% modelled at >90% confidence). ATG16L1-binding 
motif suggested by Boada-Romero et al. is highlighted in red, with residues proposed to be essential for 
interaction individually labeled.  
Discussion 
 
108 
 
Since WD-40 domain of ATG16L1 is dispensable for bulk autophagy, it is only logical that this domain 
acts as a bridge between autophagy and other cellular processes (Figure 2). During the course of this 
work, different techniques have been used to test and characterize these linking interactions. Pull 
down assays (Figure 40) using recombinantly expressed and purified domains of proteins showed no 
binding between WD-40 domain of ATG16L1 and its suggested interaction partners. A more sensitive 
method (Figure 43) showed the same lack of interaction. In the experimental setting used in these 
experiments with recombinantly purified proteins, the interaction between WD-40 domain of 
ATG16L1 with proposed interaction partners is not detectable. Based on this information it is safe to 
assume that WD-40 domain of ATG16L1 does not directly bind suggested proteins, but at least one 
more factor mediates the interaction. This (or these) additional, so far undefined mediator(s) would 
naturally not be present in purified samples used for pull downs using samples from heterologous 
expression hosts and MST.  
There are, of course, multiple disadvantages when studying interactions in vitro. Since it is not a true 
representation of the environment under which cellular interactions take place, some important 
factors might be missing as well as post translational modifications. Even though phosphomimetic 
mutants were created on predicted sites, these might not be the only sites or the artificial 
modification is not fully compatible with the natural modification. In addition, some co-factors or 
small molecules might be needed for facilitate the complex formation. Alternatively, additional 
protein (or more than one) might be mediating or stabilizing the complex formation, which remained 
unidentified so far. Towards the end of this work, human embryonic kidney cells (HEK 293E) were 
transiently transfected with full length ATG16L1, WD-40 domain of ATG16L1 and N-terminal half of 
the ATG16L1 in the search for mediators. Samples were analyzed using mass spectrometry and HPLC, 
hoping to confirm already mentioned proteins as interaction partners, or identify novel ones. 
Following few rounds of optimization possible during the course of this work no definite conclusions 
were possible. Further optimization is needed to improve transfection protocol of HEK 293E with 
multiple plasmids and establish a more definite time course of autophagy in this cell line, using the 
cultivation conditions in our lab. In addition to autophagy being a very dynamic process, it is still 
unclear at which point exactly it interferes with pathogen detection. It seems un-likely that NOD2 
and all downstream events remain stimulated for prolonged periods of time. Thus, additional time 
course experiments are needed to establish a precise time line of events. According to Travassos et 
al. NOD2 recruits ATG16L1 to the site of bacterial entry, and the two proteins co-localize with 
invading bacteria. They also report that ATG16L1 lacking the N-terminal ATG5 binding domain also 
co-localized with NOD2 and invading bacteria (Travassos et al. 2010). This puts the spotlight on the 
WD-40 of ATG16L1. However, NOD2-ATG16L1 relationship is more complicated than a simple 
protein-protein interaction. Additional reports show that ATG16L1 regulates NOD2 in autophagy 
independent manner (Sorbara et al. 2013) and that an additional autophagy protein, IRGM, links 
NOD2 with ATG16L1 and the autophagy machinery (Chauhan et al. 2015). As more and more 
evidence regarding NOD2-ATG16L1 interaction and the connection between autophagy and 
pathogen detection comes to light, it becomes evident how complex and tightly regulated this 
association is. It cannot be assumed that other proposed interaction partners of WD-40 domain of 
ATG16L1 have reduced level of complexity and are under less strict spatio-temporal control. More 
research is needed in to unwind and understand this intricately connected cellular network. 
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6 Conclusions and Outlook 
ATG16L1 is a central player in autophagy, a fundamental catabolic process, conserved throughout 
eukaryotic domain of life. During this work, human ATG16L1 and more specifically the WD-40 
domain of human ATG16L1 have been studied using biophysical, biochemical and structural 
methods. Expression and purification of full length human ATG16L1 did not yield enough protein for 
crystallization setups. The biophysical analyses of this protein were also difficult due to its large size 
and its multi-domain architecture which made it readily prone to degradation. Interestingly, the main 
site of degradation was exactly at the beginning of the C-terminal WD-40 domain.  
The crystal structure of C-terminal domain was solved at high resolution and revealed geometric and 
molecular detail of this domain. As predicted, the C-terminal domain of human ATG16L1 folds into a 
WD-40 propeller domain. The WD-40 domain of human ATG16L1 is a typical seven bladed propeller 
with each blade composed of four anti-parallel β-strands. The number of blades and β-strands 
contained in the domain differs from predicted secondary structure elements. This illustrates the 
weakness of prediction algorithms, especially in cases of domains with high functional and structural 
diversity, such as WD-40 propellers.  
Biophysical analysis showed this domain was a monomer in solution. Analysis of crystal contacts 
revealed a large buried area between two molecules of WD-40 domain, with their N-termini pointing 
in the same direction. Surface area shared between two molecules indicates physiological relevance, 
while the orientation of the N-termini is reminiscent of a parallel dimer formed by the coiled-coil 
domain of full length ATG16L1. However, further experiments are needed to define a functional, 
oligomeric state of the WD-40 domain.  
WD-40 domain is among the most abundant eukaryotic domains with the widest range of interaction 
partners. WD-40 domains offer three surfaces for interactions: narrow top, wide bottom, and the 
circumference of the propeller. This partially contributes to the functional variability observed in this 
domain family and makes functional assignment to these domains difficult. The most common 
feature of WD-40 domains is to serve as a rigid molecular scaffold for protein-protein interactions. 
Based on this commonality and functional data already published, WD-40 domain of ATG16L1 might 
offer an interaction platform for proteins and protein complexes linking autophagy with pathogen 
recognition, control and clearance. 
Analysis of B-factor distribution and electrostatic surface potential provided insight into the dynamics 
of the WD-40 domain of human ATG16L1. Namely, blade 3 of the WD-40 propeller together with the 
bottom, wider face exhibit higher level of flexibility compared to the rest of the molecule. This 
information was used to help narrow down which part of the propeller is likely to be functionally 
relevant. Additional evidence for the notion that the blade 3 is involved in interactions between 
ATG16L1 and its binding partners comes from the literature. A 16 residue DDB1-binding and WD-40 
repeat (DWD) box present on DCAFs (DDB1-CUL4 associated factors), also identified on the WD-40 
propeller of ATG16L1 is sited on the blade 3 of the WD-40 propeller of ATG16L1, with a functionally 
essential arginine facing the bottom of the propeller. The DDB1-CUL4 ubiquitin E3 ligase is involved 
in cell-cycle progression, replication and DNA damage response. However, not all DCAFs have been 
identified and characterized, and the WD-40 domain of ATG16L1 has been proposed as one such 
receptor. However, during the course of this work, the interaction between WD-40 domain of 
ATG16L1 and DDB1 could not be confirmed by the in vitro assays using recombinantly expressed and 
purified proteins.  
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Apart from DDB1, WD-40 domain of ATG16L1 has been implicated as a binding partner for CARD 
domain of NOD1, CARD1 domain of NOD2, TIR domain of TLR2 and TMEM59. Various biophysical 
methods were tested with recombinantly expressed and purified proteins, however no interaction 
was detected. This observation leads to a hypothesis that these interactions are not direct, but rather 
mediated by additional factor or factors. To test this idea, transient protein expression in HEK 293E 
cells was used to identify novel partners of the WD-40 domain. However, due to the lack of time and 
expertise in the cellular biology and transfection of mammalian cells with multiple plasmids, we were 
not able to arrive to any conclusive results. Further optimization of transient transfection protocol, 
induction of autophagy and other cellular pathways, time course studies and thorough analysis of 
samples by mass spectrometry might still reveal additional molecular factors involved with the WD-
40 domain of ATG16L1. Once these factors are identified, it would be interesting to co-crystallize 
them in complex with the WD-40 domain of ATG16L1 and observe if the blade 3 and the bottom 
surface of the propeller play a role. Moreover, novel and confirmed interaction partners would 
provide correct purpose of this large, but so far not fully functionally characterized domain and 
reveal an accurate link between autophagy and other cellular processes in a mammalian system.  
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